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SUMMARY
Herpes simplex virus (HSV) has the pathogenic property of establishing latency 
during primary infection of man. Following the primary infection at a peripheral site, 
virions travel via the axons to the neuronal cell bodies in sensory or autonomic ganglia 
where latency is established and maintained. The virus can be reactivated, return down 
the axon to the periphery, replicate, be shed and transmitted to other individuals. This 
gives rise to clinically important recurrent disease, namely herpes labialis, keratitis, 
uveitis and genitalis. Reactivation is of increasing importance in immunocompromised 
individuals. Encephalitis, presumed to be due to reactivation of latent virus from the 
trigeminal ganglion, is the most serious manifestation with a mortality rate of about 
50% if untreated and considerable morbidity in half of the survivors.
The infecting virions possess the tegument protein Vmw65 which trans-activates the 
immediate early (IE) genes, thereby initiating the productive cycle. This cycle displays 
a co-ordinated sequential expression of IE, early and late genes. The IE gene products 
are important in the regulation of further viral gene expression and may determine 
whether a neurone supports a replicative or latent infection.
The HSV-1 mutant in i814 has a mutation in the gene encoding Vmw65, with a 
consequent reduction in IE mRNA and hence proteins in cells infected with this virus. 
On infection of human foetal lung (HFL) fibroblasts at a multiplicity of infection (moi) 
of 5 particles per cell, ini 814 readily establishes latency rather than undergoing lytic 
infection. At this moi 10% - 20% of cells retain at least one latent genome. To 
investigate the latent genome at the molecular level however, it was considered 
desirable that at least one if not more copies should be retained per cell. The in vitro 
latency system has been modified to enable a higher genome copy number to be 
attained.
The addition of more than 5 - 1 0  particles of ini 814 per HFL cell causes 
degeneration of the monolayer even when lytic infection is blocked by the presence of 
cytosine arabinoside, an inhibitor of DNA replication. It was reasoned that further 
measures to reduce IE protein levels after infection might reduce the cytopathic effect 
and thus enable a higher moi to be used.
IE gene expression was further reduced firstly, by replacement of the normal 
VmwllO promoter in ini 814 with the murine Moloney leukaemia virus enhancer to 
produce ini 820 and secondly, by pretreatment of HFL cells with human 
lymphoblastoid interferon alpha (IFN-ce), a known inhibitor of IE gene transcription. It 
was possible to add 100 particles of ini 820 per cell to IFN-a treated cultures and retain 
an intact monolayer with only 5 plaques forming. The additive effect of the mutation 
to produce ini 820 and IFN-a pretreatment thus allows a high initial moi to be tolerated 
by the monolayer.
Previous investigators have shown that reactivation of ini 814 requires the presence 
of VmwllO. The temperature sensitive mutant fsK, which expresses VmwllO at the 
nonpermissive temperature, was found to reactivate the double mutant ini 820 when 
superinfected into IFN-a pretreated HFL cells harbouring the latent virus. This was as 
efficient as reactivation of ini 814 from untreated cells.
In vivo latent HSV-1 DNA is non-linear and, with the exception of the latency 
associated transcripts, it is transcriptionally silent. The latent genome is therefore very 
different in terms of its physical structure and transcription pattern to the productively 
infecting DNA. In the modified in vitro latency system progression from the linear to 
the non-linear configuration over 48 hours was demonstrated by the gradual 
disappearance of the terminal sequences of the infecting DNA with persistence of the 
joint sequences. Using techniques that are able to resolve large DNA molecules, 
further characterisation of this latent non-linear genome was undertaken.
A probe from the thymidine kinase (TK) gene was able to specifically detect latent 
viral DNA in the in vitro latency system in the presence of host cell DNA . Using this 
probe and comparing hybridisation to an ini 820 DNA standard the amount of viral 
DNA from a latently infected monolayer was at least 15 viral genomes per host cell.
Reactivation of latent genomes was demonstrated by the expression of the lacZ  
gene inserted into the mutant virus. Cells expressing the enzyme product (3- 
galactosidase became blue when provided with the appropriate substrate. 
Superinfection with wild type virus was used to induce reactivation and the spread of 
reactivated virus from cell to cell, which would normally destroy the monolayer, 
prevented by brefeldin A. A cell that stains blue must therefore have contained a silent 
latent genome that had become transcriptionally active. It was shown that the majority 
of the cells in the monolayer possessed a latent genome that could be reactivated. A
superinfecting virus in which the VmwllO gene has been deleted, d/1403, was unable 
to activate the latent genome.
Previous studies have shown that cellular DNA exists in close association with a 
skeletal nuclear substructure, the nuclear matrix or cage. Nuclear matrix preparations 
from latently infected HFL cells were made, and it was demonstrated that the viral 
genome was closely associated with this structure and co-purified with it.
The chromatin structure, characteristic of all eukaryotic DNA, can be visualised by 
the formation of a ladder of multimeric units of nucleosomes when digested with 
micrococcal nuclease. Nucleosomes, and by inference a chromatin structure, were 
shown in cells transformed with the HSV-1 TK gene but, surprisingly, this was not true 
of the latent viral genome. Further studies with micrococcal nuclease showed that the 
latent genome was more sensitive to digestion. This sensitivity did not alter when the 
genome was reactivated by superinfection and the superinfecting virus remained 
relatively resistant to digestion even when prevented from replicating despite the fact 
that it was transcriptionally active.
This research has developed an in vitro model of HSV-1 latency and has permitted 
some structural analysis of the latent genome. It is a suitable model for the further 
investigation of latency and has the potential to answer some of the questions which 
will ultimately facilitate the systematic development of therapies to disrupt or disable 
the latent virus.
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1. INTRODUCTION
1.1. The herpesviruses
1.1.1. Structure
The herpesvirus family has more than 80 members. They share the same structural 
features in their virions and the pathogenic property of latency. The virion, which has 
a mean diameter of about 215nm (Schrag et al., 1989), is composed of 4 elements 
(Wildy et a l , 1960; Roizman and Furlong, 1974; Roizman, 1990). The core contains 
a single, linear, double stranded DNA genome and is surrounded by the capsid, the two 
elements together forming the nucleocapsid. The packaged DNA is in a liquid 
crystalline state and is uniformly dense filling the whole of the space, which has a 
radius of about 43nm, enclosed by the capsid (Booy et al., 1991). The capsid is a 
thick-shelled icosahedron of 14 to 15nm (Booy et al., 1991) comprised of 162 
capsomeres made up of 150 hexamers and 12 pentamers. The tegument surrounds the 
capsid and is an amorphous matrix of protein which varies in amount between different 
herpesviruses. The whole is enclosed in a triple layered lipid membrane structure, the 
envelope, derived from the host cell nuclear membrane but containing HSV 
glycoprotein molecules projecting from its surface (Stannard et al., 1987).
1.1.2. Classification
Subdivision of the herpesviruses is based on their biological properties of host 
range, reproductive cycle, cytopathology and latent characteristics. This gives rise to 
three subfamilies, the alphaherpesvirinae, betaherpesvirinae and gammaherpesvirinae 
(Roizman, 1982a) and these are described in table 1.1. This subdivision is better than 
one determined by genome structures because the biological properties dominate any 
other single set of properties and it produces a minimum number of subfamilies. The 
sequence data that are emerging are largely compatible with these subdivisions although 
there are some discrepancies. On the basis of sequence data, HHV-6 should be 
grouped with HCMV in the betaherpesvirinae subfamily but on the basis of 
permissivity of lymphoid cell lines, it is assigned to the gammaherpesvirinae subfamily.
1
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SUBFAMILY
Alpha herpes virinae
Host range
Reproductive cycle 
Cytopathology
Latent infection
in viw: generally to the 
natural host 
in vitro: variable 
short
rapid spread in cell culture 
with mass destruction 
frequently, but not 
exclusively, in ganglia
Examples:
Human herpesvirus 1 (HSV-1) 
Human herpesvirus 2 (HSV-2) 
Human herpesvirus 3 (VZV)
Betaherpesvirinae
Host range
Reproductive cycle 
Cytopathology
Latent infection
in vivo: narrow, often the 
species or genus of host 
in vitro: best in fibroblasts 
relatively long
slowly progressive lytic foci 
in cell culture; frequent 
cytomegalia in vitro and in 
vivo
possibly in secretory glands, 
lymphoreticular cells, and 
other tissues
Examples:
Human herpesvirus 5 (HCMV) 
Human herpesvirus 6 (HHV-6)
Gammaherpesvirinae
Host range
Reproductive cycle 
Cytopathology 
Latent infection
in vivo: narrow, usually the 
family or order of natural 
host
in vitro, replicative in 
lymphoblastoid cells; lytic in 
some epithelioid and 
fibroblastoid cells 
variable 
variable
frequently in lymphoid tissue
Example:
Human herpesvirus 4 (Epstein- 
Barr virus)
TABLE 1.1: SUBDIVISION OF HERPESVIRUSES ACCORDING TO THEIR 
BIOLOGICAL PROPERTIES (Roizman, 1982a)
2
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1.1.3. Pathology
There are seven human herpes viruses recognised to date and the pathology of six 
of these has been extensively described (Roizman, 1982b; 1983; 1985; Roizman and 
Lopez, 1985; Fields and Knipe, 1990). HSV-1 infection most commonly presents with 
gingivostomatitis and conjunctivitis and is usually a mild childhood illness. HSV-1 is 
able to establish latent infection in the sensory ganglia which innervate the site of the 
primary infection. Humoral and cell mediated immunity is established but this does not 
affect the latent virus and it has an uncertain role in limiting reactivation. Periodic 
reactivation of the latent virus produces recurrences in the distribution of the ganglia, 
principally herpes labialis ("cold sores") and herpes keratitis or uveitis, leading causes 
of blindness. Spread from the meningeal branches of the trigeminal nerve or via the 
olfactory pathway and connections in the limbic system to the temporal lobes, either 
during primary infection or reactivation, can lead to encephalitis which is a very 
serious complication with both high mortality and morbidity. This is particulary 
important in patients who have lymphoproliferative diseases, AIDS or are on 
immunosuppressive therapy following organ or bone marrow transplantation. These 
patients are also at risk of severe widespread infection involving the gastrointestinal 
tract and the respiratory system.
Primary infection with HSV-2 is a sexually transmitted disease and is the usual 
cause of herpes genitalis although in recent studies 20 - 40% of genital isolates have 
been found to be HSV-1 (Peutherer et al. , 1982; Corey et al., 1983; Scoular et al.,
1990). HSV-2 also establishes latency in the relevant sensory ganglia and produces 
troublesome recurrent infections. An important complication is neonatal infection 
following transmission of the virus from maternal genital lesions to the infant during 
parturition.
Varicella-zoster virus (VZV) has man as its only host and is the cause of chicken 
pox (varicella) as the primary illness and shingles (zoster) when the infection is 
reactivated from latent sensory ganglia. Varicella can have serious complications in 
those who are immunocompromised, with generalised dissemination to the skin and 
viscera. Zoster is a feature of increasing age and immunosuppression and commonly 
leads to painful, debilitating post herpetic neuralgia. This virus too causes encephalitis 
although it is usually less serious than herpes simplex encephalitis. In 
immunocompetent patients, VZV encephalitis is more likely to be caused by immune 
mediated indirect mechanisms rather than by a productive viral infection typical of 
HSV (Kennedy et al. , 1988; 1990).
3
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Epstein Barr virus infection is often asymptomatic but is the cause of infectious 
mononucleosis. Infection in immunocompromised individuals can cause severe 
lymphoproliferative disease with extensive infiltration of immature B lymphocytes into 
organs and tissues. The virus is able to transform human lymphocytes and it is 
associated with Burkitts lymphoma and nasopharyngeal carcinoma (Miller, 1990).
Human cytomegalovirus infection is usually benign and subclinical but is a 
recognised cause of meningitis and is especially important in the immunosuppressed 
patient notably after renal transplantation and in patients with AIDS. The predilection 
of HCMV for leucocytes is an important consideration in blood tranfusion and organ 
grafting. It is a major cause of congenital abnormalities which may be related to its 
susceptibility to reactivate in the uterine cervix.
Human herpes virus 6 was first described as an infection of peripheral blood 
lymphocytes in patients with lymphoproliferative disorders (Salahuddin, 1986). 
Infection is widespread (Briggs et al., 1988) but apart from a transient childhood 
illness, exanthema subitum and a mononucleosis with cervical lymphadenopathy, it 
does not have any known pathology.
Human herpes virus 7 has been isolated from CD4+ T cells of a healthy individual 
following their incubation under conditions promoting activation (Frenkel et al., 1990).
1.1.4. Genome structures
The genomes of the herpes viruses differ widely in size, base composition and the 
arrangement of reiterated sequences (Roizman, 1990). The gross structures of the six 
human herpes viruses which are linear DNA molecules when isolated from virions are 
shown in figure 1.1.
Sequence data are complete for HSV-1 strain 17 (McGeoch et al., 1985; 1986; 
1988; Perry and McGeoch, 1988); VZV (Davison and Scott, 1986); EBV strain B95-8 
(Baer et al., 1984) and HCMV strain AD169 (Chee et al., 1990). Base composition 
ranges from a G + C content of 43% for HHV-6 (Lopez and Honess, 1990) to 68.3% 
and 69% for HSV-1 (McGeoch et al., 1988) and HSV-2 (Roizman, 1982a) 
respectively. Furthermore, base composition is very variable within the genome. For 
example, the G + C content of the 6.6kbp R§ of HSV-1 is 79.5% (McGeoch et al., 
1986).
4
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FIGURE 1.1: GROSS STRUCTURES OF THE HUMAN HERPESVIRUSES.
The genome structures of six of the seven known human herpesviruses. Each linear 
genome is shown with unique sequences as lines and repeat elements as boxes with 
relative orientations indicated by arrows. After McGeoch, 1989.
MIR = major internal repeat
Ul  = unique long = unique short
Dl  = direct repeat left Dr  = direct repeat right
I/TRl  = internal/terminal repeat long I/TRs = internal/terminal repeat short
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Observations under the electron microscope of viral DNA spreads led to a proposed 
arrangement of the HSV-1 genome (Sheldrick and Berthelot, 1974) which has since 
been confirmed (McGeoch et al., 1985; 1986; 1988; Perry and McGeoch, 1988). In 
the native state it is a linear duplex and there are 152,260 residues in each strand. It 
has two covalently linked regions termed long (L) and short (S) each with unique 
sequences, U l  and U$, flanked by repeat sequences, R l  and R§. At the genomic 
termini these are denoted as T R l and TR$ and where they meet internally, to form the 
joint, as IR l and IR$. The internal repeat is identical to but inverted with respect to 
the terminal repeat. Each terminus has one overhanging residue with a free 3f 
hydroxyl group (Mocarski and Roizman, 1982). R l  and R<$ are distinct except for a 
400bp direct repeat, the "a" sequence, at the termini and one or more copies in an 
opposite orientation at the joint (Wagner and Summers, 1978; Davison and Wilkie, 
1981). The repeat regions have been designated as ab, b 'a ', ac and a'c' (Wadsworth et 
al., 1975). Families of short, directly repeated sequences of variable copy number 
between 10 and 100 bp have been found, usually in R l, in all large scale sequencing 
studies. The relative orientation of U l and U§ with respect to the joint has the 
potential to produce four isomers which have been identified from terminal and 
junction fragments and partial denaturation profiles (Hayward et al., 1975) and found 
in equimolar amounts in the DNA from plaque purified virions (Roizman, 1979). One 
isomer has been designated as the prototype and is the arrangement used for mapping 
and sequence determination. The other three isomers are produced by the inversion of 
S (Is), the inversion of L (II) and the inversion of both S and L (Isl)- All isomers are 
able to participate in a productive (Davison and Wilkie, 1983) or a latent infection 
(Wigdahl et al., 1984a; Efstathiou et al., 1986). The gross organisation of the HSV-1 
genome is shown in figure 1.2.
1.1.5. Genome contents
The open reading frames corresponding to the proposed HSV-1 genes are shown in 
figure 1.3. The U l  region has 58 genes and the U$ region 12 genes. The repeat 
segment R l  contains 2 genes, R lI  and R l2, coding for the neurovirulence factor 
ICP34.5, also known as 7 ^34.5, (Chou et al., 1990; McGeoch and Barnett, 1991) and 
the transcriptional regulator VmwllO respectively. The repeat segment R§, contains 
the IE175 gene. Thus the whole genome has at least 76 ORFs encoding 73 distinct 
proteins. There are possibly others arising from very small or extensively overlapping 
genes and those with complex intron/exon arrangements. Downstream of the IE110 
gene in R l  is the initiation site of the LATs (Stevens et al., 1987) whose function is
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FIGURE 1.2: GROSS ORGANISATION OF THE HSV-1 GENOME
A conventional representation of the HSV-1 genome is shown, with the unique (Ul  and 
Us) and the major repeat (TRL and TRs) sequences as solid lines and open boxes 
respectively. The locations of the L and S segments are marked. Terminal a sequences 
and the internal, opposite orientation a* sequence are indicated. The copy number of a 
sequences present at the junction between the L and S components of the genome is 
variable although often equal to one. The four isomers as described in the text are 
drawn beneath. From McGeoch, 1987.
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FIGURE 1.3: ORGANISATION OF THE GENES IN THE GENOME OF HSV-1
The prototype orientation represented on four lines. The locations of open reading 
frames are shown by arrows with splicing within the coding regions indicated. In the 
top three lines, genes U lI  - U l56 are shown as 1 - 56 and in the bottom line genes 
U$1 - U$12 as 1 - 12. Locations of origin of DNA replication are also indicated. 
Reproduced from McGeoch, 1989 with the addition of Ul26.5 (Liu and Roizman, 
1991a), Ul49.5/49A (Barnett et al. , 1992; Barker and Roizman, 1992) ICP34.5/RLj 
(Chou and Roizman, 1990; McGeoch et al., 1991) and LATs (Stevens et a l, 1987).
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obscure and for which no protein product has been reported yet. Most genes possess 
independent promoters and generate unspliced mRNA. All temporal classes of genes 
require host cell RNA polymerase II for their expression. They are expressed as 
immediate early (IE) genes, early genes and late genes (Honess and Roizman, 1974). 
The IE genes do not require de novo protein synthesis for their promoters to be 
recognised. The early genes encode a number of proteins many of which are required 
for DNA replication. The products of the late genes are largely involved in the 
assembly and maturation of virions.
The genes can be categorised into those which are involved in (i) control, (ii) 
nucleic acid metabolism, replication and repair and (iii) structure and assembly of 
virions. Controlling genes include the five IE genes. Of these IE110 (Rl2), IE175 
(R$l) and Ul54 (Vmw63) are transcriptional regulators whose products control 
expression of the later genes and the IE genes themselves (Everett, 1987). The other 
two IE genes, Ugl (Vmw68) and U$12 (Vmwl2) have not had a function assigned to 
them yet. The product of U l48, Vmw65, has an important regulatory role (Campbell 
et a l , 1984). It functions with one or more cellular proteins through specific upstream 
sequences to activate the expression of the IE genes (O'Hare and Goding, 1988; 
Preston et al., 1988). It has been reported that the products of U l46 and Ul47, 
another tegument protein (McLean et a l, 1990), modulate the activity of Vmw65 
(McKnight et a l , 1987) but this has only been confirmed for the latter (Zhang et a l ,
1991). Another regulatory protein Ul41, a tegument component (McLauchlan et a l, 
1992a), shuts off host cell macromolecular synthesis by degrading mRNA (Kwong et 
a l, 1988) and U g ll, also a structural protein, is a site and conformation specific RNA 
binding protein which associates with the 60S subunit of infected cell ribosomes (Roller 
and Roizman, 1991; 1992). Two other genes, Ul13 (Smith and Smith, 1989) and U§3 
(McGeoch and Davison, 1986), which may code for protein kinases, have a role in 
controlling or modulating gene expression but this has not been clearly defined to date.
Enzymes involved in nucleic acid metabolism include thymidine kinase, the product 
of Ul23 (Kit and Dubbs, 1963; Munyon et a l, 1972), ribonucleotide reductase, 
composed of a large and a small subunit (Frame et a l, 1985) encoded by U l39 and 
Ul40 respectively (McLauchlan and Clements, 1983; Preston et a l, 1984) and 
deoxyuridine triphosphatase encoded by U l50 (Preston and Fisher, 1984). 
Transfection of HSV-1 DNA fragments into cultured cells carrying plasmids with the 
HSV DNA replication origin have shown the absolute requirement for 7 genes in 
replication (Challberg, 1986) which are: U l5, U l8, U l9, U]_29, U l30, Ul42, and 
Ul52. The DNA-binding properties of the Ul37 protein and the kinetics of its
9
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appearance suggest that it may be involved in the late events in viral replication 
(Shelton et ah, 1990). The deoxyribonuclease from \I\Y1  (Banks et al., 1985) is not 
essential for viral DNA synthesis but may have a role in the processing or packaging of 
viral DNA into infectious virions (Weller et al., 1990). A DNA repair enzyme, uracil 
DNA glycosylase, is encoded by \J\2  (Mullaney et al. , 1989).
The virion contains at least 30 different species of protein molecules (Dargan, 
1986; Roizman and Sears, 1990). Three different types of capsids have been 
recognised by electron microscopy in the nuclei of infected cells. They are also 
distinguishable by their protein composition. Full or C capsids, which have a core of 
genomic DNA, are composed of a major protein VP5, encoded by U l19 (Costa et al., 
1984) and four other polypeptides: VP19c, VP23, VP24 and VP26, encoded by U l38 
(Braun et al. , 1984; Rixon et al. , 1990); Ul18 (Rixon et al. , 1990); U l26 (Davison et 
al., 1992) and Ul35 (Davison et al., 1992) respectively. Intermediate or B capsids, 
which are the progenitors of both C and A or empty capsids, have an additional two 
proteins. These are the scaffolding proteins VP22a from the Ul26.5 gene (Preston et 
al., 1983; Liu and Roizman, 1991a) and VP21 produced by self cleavage of the U l26 
gene product (Liu and Roizman, 1991a; 1991b). A number of gene products may be 
involved in the packaging process since the formation of full capsids is affected by 
mutations in the genes U l6  (Sherman and Bachenheimer, 1987); Ul25 (Addison et 
al., 1984); Ul28 (Addison et al., 1990); Ul32 (Sherman and Bachenheimer, 1987) 
and Ul33 (Al-Kobasi et al., 1991). The tegument also has a major protein, Vmw65, 
the product of Ul48; the very large tegument protein VP1, encoded by U l36 
(Batterson et al., 1983; McGeoch et al., 1988) and other species encoded by U§9 
(Frame et al., 1986) and UglO (Rixon and McGeoch, 1984). The myristylated 
tegument protein, U lI  1, may have a role in the envelopment and transport of nascent 
virions (Baines and Roizman, 1992; Maclean et al., 1992). Another major tegument 
protein is the highly phosphorylated VP22 encoded by Ul49 (Elliot and Meredith,
1992). There are a number of gene products whose hydropathy profiles suggest they 
are membrane proteins and include UlIO, Ul20, Ul34, Ul43, U l45, and 
Ul49.5/49A. They are all poorly characterised. Finally, on the surface there are at 
least 10 glycoproteins (Roizman and Sears, 1990; Hutchinson et al., 1992) which have 
been denoted as gB (UL27), gC (UL44), gD (US6), gE (US8), gG (US4), gH (UL22), 
gl (US7), gJ (US5), gK (UL53) and gL (UL1).
In addition, a region of R l  extending into R§ encodes the LATs which are the only 
transcripts detectable in latently infected cells (Stevens et al., 1987). Their function is 
unknown and their capacity for translation is uncertain.
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There are two sites and three loci which are potential origins of replication 
(Roizman and Sears, 1990). One site, o d l, lies between Uj\29 and U l30 and the 
other, ori£, in R$. All the functional signals at the R$ origin of replication occur 
within a lOObp viral DNA fragment. A prominent feature of this region is an almost 
perfect palindromic sequence of 45bp containing 18 A or T residues at its centre (Stow 
and McMonagle, 1983). The "a" sequence plays a part in packaging in that it has 
elements involved in cleavage of the concatemers generated by replication (Stow et al., 
1983), and two viral proteins have been identified which bind specifically to the "a" 
sequence and might have a role in encapsidation (Chou and Roizman, 1989). The role 
of the joint itself is undetermined but it is of interest that there are no transcripts 
spanning the junction and there is no physical separation of the L and S segments 
during the normal infective process.
Experiments analysing host range mutants have demonstrated that at least 20 genes 
are dispensible for growth in tissue culture (Roizman and Sears, 1990). As is apparent 
from the foregoing discussion there are still 14 genes whose function remains totally 
unknown.
1.1.6. Lytic infection
The major events of the viral life cycle are well documented (Roizman and Sears,
1990). HSV-1 attaches to cells by interacting with heparan sulphate which is 
covalently linked to cell surface proteoglycans (Shieh et al., 1992). Although it is not 
essential for attachment this process is facilitated by the viral glycoprotein, gC (Herold 
et al. , 1991). Other glycoproteins are probably required for successful penetration of 
the cell since mutants with lesions in the genes for gB (Cai et al., 1988), gD (Ligas and 
Johnson, 1988) and gH (Forrester et al., 1992) which are able to attach to the cell 
surface nevertheless have severly reduced infectivity. In addition, gL is required for 
the correct expression of gH (Hutchinson et al., 1992). Entry is gained by a pH- 
independent fusion of the virion envelope with the cell membrane (Wittels and Spear,
1991) and the capsid is transported, possibly by microtubules (Kristensson et al.,
1986), to the nuclear pores. At the pores and by a process dependent on the activity of 
the tegument protein VP1 (Batterson et al., 1983), the viral DNA is released into the 
nucleus.
Within an hour of infection the synthesis of host cell macromolecules is inhibited 
and as the production of cellular proteins, RNA and DNA gradually declines there is an
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increase in viral material. Early "host shut-off” is mediated by the product of Ul41, a 
tegument protein (Fenwick and Walker, 1978; Kwong et al. , 1988; McLauchlan et al., 
1992a) whereas secondary or delayed shut off is mediated by the expression of the viral 
genes (Fenwick and Clark, 1982).
The lytic cycle is characterised by a cascade of gene expression involving the 
synthesis of the IE gene products followed by the activation of the early genes and then 
the late genes (Honess and Roizman, 1974). In the infected cell, the viral genes are 
transcribed by cellular RNA polymerase n .  The virion tegument protein, Vmw65, 
initiates the cascade by selectively activating viral IE promoters shortly after infection 
(O'Hare and Goding, 1988; O’Hare et al., 1988; Preston et al., 1988). All IE gene 
promoters contain one or more copies of a far upstream element with the sequence 
TAATGARAT (where R is a purine) which is essential for transactivation mediated by 
Vmw65. Vmw65 associates with cellular factors to form the IEC which binds 
specifically to the TAATGARAT (O'Hare and Goding, 1988; Preston et al., 1988) as 
illustrated in figure 1.4. The cellular protein Oct-1 which normally binds to an 
octamer motif similar to the TAATGARAT (O'Hare et al., 1988), is a constituent of 
the IEC and is altered by association with Vmw65 to bind to the viral cis-acting 
element (O'Hare et al., 1988). Vmw65 is a phosphoprotein whose N terminal 410 aa 
are necessary for complexing with the cellular proteins (Greaves and O'Hare, 1990) 
and whose acidic C terminal region is responsible for transactivation (Greaves and 
O'Hare, 1989). Vmw65 is not absolutely required for the initiation of infection but it 
greatly enhances its efficiency, especially at low moi (Ace et al., 1989). There are 
other upstream as-acting elements in IE genes which enhance their transcription even 
in the absence of Vmw65 (Cordingley et al. , 1983).
The IE proteins, VmwllO, Vmwl75 and Vmw63 play important roles in lytic cycle 
gene expression, controlling both the early and the late genes (Everett, 1986; 1987). 
The other IE proteins, Vmw68 and Vmwl2, are poorly understood. VmwllO is a 
potent transactivator and in transfection assays it activates transcription from IE, E and 
late promoters of HSV-1 (O'Hare and Hayward, 1985a; 1985b; Everett, 1986). It is 
not essential in tissue culture but confers a growth advantage on the virus (Stow and 
Stow, 1986; Sacks and Schaffer, 1987). It may be able to interact synergistically with 
Vmwl75 (Everett, 1987). Vmwl75 is a major regulatory protein of HSV-1 (DeLuca 
and Schaffer, 1985; O’Hare and Hayward, 1985a) and is essential for activation of the 
early promoters and progression of the lytic cycle (Preston, 1979; DeLuca et al., 1985; 
Persson et al., 1985). It effects transcriptional activation by binding within a promoter
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FIGURE 1.4: REGULATORY REGIONS OF THE IE GENES SHOWING 
INTERACTION OF TRANSACTIVATING ELEMENTS
Upon entry to the cell, Vmw65 in the tegument of the virion complexes with complex 
forming factor (CFF; Katan et a l , 1990). This possibly occurs in the cytoplasm. 
Once in the nucleus, octamer sites in the IE genes are occupied by Oct-1. The 
Vmw65-CFF complex recognises Oct-1 in the context of the flanking GARAT signal 
locating the acidic activation domain onto the IE genes and thereby activating 
transcription by promoting assembly of an initiation complex. It is possible that the 
interaction with Oct-1 occurs after Vmw65 complexes with CFF and the transcriptional
target.
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region (Tedder et al., 1989). The DNA-binding domain is located within a highly 
conserved region of about 230 residues near to the N terminus (Everett et al., 1990; 
1991). Vmwl75 represses its own synthesis, probably by binding at its own 
transcriptional start site (DeLuca and Schaffer, 1988), and the products of the other IE 
genes (DeLuca and Schaffer, 1985; O’Hare and Hayward, 1985b). Vmw63 is also 
essential for viral growth. Deletion mutants over express the IE gene products and 
under express the late gene products suggesting that Vmw63 is involved in the switch 
from early to late gene expression (McCarthy et al., 1989). Vmw63 may act at the 
posttranscriptional level by selectively stimulating viral mRNA 3' processing 
(McLauchlan et al., 1992b; Smith et al. , 1992). The early and late genes of HSV-1 do 
not possess virus specific promoter sequences but have sequences corresponding to the 
binding sites of cellular transcription factors (Johnson and Everett, 1986; McKnight and 
Tjian, 1986).
Within 30 minutes of infection the linear genome loses its free ends (Poffenberger 
and Roizman, 1985). Viral DNA synthesis starts between 3 and 5 hours after infection 
and peaks between 9 and 11 hours (Rixon et al., 1983). Molecules of more than unit 
length DNA appear as head to tail concatemers generated by a rolling circle mechanism 
(Jacob and Roizman, 1977; Jongeneel and Bachenheimer, 1981) and eventually form 
large tangled masses of viral DNA filling the whole of the host cell nucleus (Rixon et 
al., 1983). The capsid shell assembles with the scaffolding proteins VP22a and VP21, 
the latter derived from the U l26 protease, to form the B capsid. The protease cleaves 
itself to release VP21 and VP24. Mature C capsids are created by the proteolytic 
degradation of VP22a and VP21 from the B capsids and the packaging of DNA. 
Empty A capsids result if there is a failure to package DNA. As it is packaged the 
newly replicated DNA is cleaved into unit length molecules (Deiss and Frenkel, 1986). 
Capsids must acquire tegument and envelope before leaving the cell but the details of 
these events are poorly understood. Nevertheless it seems that the initial stage involves 
budding of the capsid into the space between the inner and outer nuclear membranes 
(Darlington and Moss, 1968). The Golgi complex is implicated in the maturation of 
the virions since eventual release to the exterior occurs by exocytosis from Golgi- 
derived vesicles (Johnson and Spear, 1982). The U l20 membrane protein is vital for 
the successful delivery of the mature virion to the cell surface (Baines et al., 1991).
At 18 to 20 hours after infection mature virions are released from the cell.
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1.2. Latency
1.2.1. Latent infection
The phenomenon of latency has been well described since Harvey Cushing's 
publication of his observations in 1905 following surgical procedures on the trigeminal 
nerve (Cushing, 1905). In 1929 it was hypothesised that the virus remains in a non- 
infectious state within sensory ganglia (Goodpasture, 1929) and this has now been 
substantiated by many investigators (Wildy, 1967; Cook and Stevens, 1973). The virus 
reaches the sensory ganglion by intra-axonal transport in the appropriate nerve that 
innervates the site of the peripheral infection (Wildy, 1967; Cook and Stevens, 1973).
The ability to persist in their hosts in a state of latency with only occasional 
interruptions in the form of lytic infections is a characteristic feature of all 
herpesviruses. Such recurrent infections in humans are primarily responsible for the 
prevalence of these viruses. Generally, the herpesviruses are lytic but during the 
primary infection it appears that a few cells do not undergo the viral lytic replication 
cycle and establish a lifelong latent state with the virus instead. Since Vmwl75 
specifically down regulates its own promoter by up to 50-fold, dominating Vmw65 and 
VmwllO mediated upregulation in transient co-transfection assays (Roberts et al.,
1988), it is tempting to speculate that this might be significant in altering the course of 
the infection and directing it towards latency in vivo. The mechanism by which the 
switch from a lytic to a latent pathway occurs is not understood but it is likely to be the 
result of an interplay between cellular and viral factors and the immune response. 
Generally, latent virus is harboured in neural tissue and especially in neurones of 
sensory ganglia (Kennedy et al. , 1983). Latently infected sensory neurones account for 
only about 1% of the cells in the ganglion. Despite the predilection for neural tissue 
there are reports of non-neuronal sites of latency such as the mouse footpad for HSV-2 
(Clements and Subak-Sharpe, 1988) and the mouse cornea for HSV-1 (Abghari and 
Stulting, 1988). It is clear that latency is not established in all cells capable of being 
infected which suggests that the cell phenotype is important to this process. There also 
appears to be a well established role for the immune response in the maintenance of the 
latent state as well as during acute infection since immunocompromised or 
immunosuppressed patients are particularly vulnerable to severe recurrent disease. 
Latency can be operationally defined as the absence of or inability to recover infectious 
particles from tissues or cells that harbour the virus. Latency has to be distinguished
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from persistent infection where there is continued low level viral replication and 
infectious particles are recoverable from disrupted cells. Persistent infection occurs 
with chronic hepatitis B, human immunodeficiency virus or subacute sclerosing 
panencephalitis.
In the past 20 years an enormous amount of thought and research has been devoted 
to latency but an understanding at the molecular level remains elusive. It has been 
reduced to a tripartite process, namely establishment and maintenance of latency and 
reactivation from latency. To investigate the phenomenon itself as well as these aspects 
in particular, a variety of methods involving both animal and tissue culture models have 
been employed.
1.2.2. Investigation of latency in animal models
A number of animal models have been developed to facilitate the study of 
herpesvirus latency. These include the mouse, rat, guinea pig, rabbit and monkey 
although the mouse is by far the most commonly used. A variety of routes of 
inoculation have been used in these animals, such as the peripheral sites of the eye 
(Nesbum et al. , 1967; Rock and Fraser, 1983; 1985); ear pinna (Hill et al., 1975;
1978); footpad (Stevens and Cook, 1971; Scriba, 1975) and vagina (Scriba and 
Tatzber, 1981) as well as the intracerebral (Hill et al., 1975); intraperitoneal (Richards 
et al., 1981) and intravenous (Cook and Stevens, 1976) routes. Following inoculation 
at peripheral sites the virus enters the relevant sensory nerve and travels to the 
corresponding ganglion where latency is established (Wildy, 1967; Cook and Stevens, 
1973). To be useful as a model the host must not only have the capacity to retain the 
virus in a latent state but at a predictable site. The mouse eye has been a good model 
for producing a high incidence of latent infections (Rock and Fraser, 1983). The 
severity of the acute infection may affect the quantity of viral DNA in the CNS that is 
detectable 2 - 5  months afterwards (Cabrera et al., 1980; Rock and Fraser, 1983). The 
virus replicates at the inoculation site and travels via the ophthalmic branches of the 
trigeminal nerve supplying the cornea to the trigeminal ganglion where it can be 
recovered by macerating the tissue a few days later. The virus may also reach the CNS 
by travelling along the trigeminal root to the brain stem or by ascending the facial 
nerve (Anderson and Field, 1983). Neither spontaneous nor experimentally induced 
reactivation occurs readily in the model, which makes it suitable for investigating the 
establishment and maintenance of, but not reactivation from, the latent state. The 
rabbit eye model has also been used and although it supports latent infection, frequent 
spontaneous recurrences (Nesbum et al., 1967) are likely to make the interpretation of
16
Introduction
data difficult in some experimental situations. Inoculation of the mouse footpad 
(Stevens and Cook, 1971) leads to establishment of latency in the sacral ganglia 
following transport along branches of the sciatic nerve. This model is also limited by 
the failure of latently infected animals to suffer recurrent disease when stimulated 
(Stevens and Cook, 1973) and thus again is not suitable to study reactivation. In 
contrast, the guinea pig footpad model (Scriba, 1975) is subject to spontaneous 
recurrence of clinical disease which in some circumstances could be also 
disadvantageous. Intradermal or subcutaneous injection of virus in the pinna of the 
mouse ear produces erythema or paralysis (Hill et al. , 1975; 1978) and the second, 
third and fourth cervical dorsal root ganglia become sites of established latent infection. 
Reactivation can be induced from the mild trauma caused by stripping cellophane tape 
off the ear (Hill et al., 1978). This is associated with observable clinical signs, similar 
to those in the human host, but only about 30% of animals show recurrent disease 
following this stimulus. HSV-1 infection of the guinea pig vagina leads only to mild 
symptoms, a low level of persistence in the sacral ganglia and no recurrences (Scriba 
and Tatzber, 1981). This is quite unlike HSV-2 genital infection of the guinea pig 
which invades and persists in the sensory ganglia much more efficiently and readily 
establishes recurrent lesions. However, peripheral persistence in the vagina 
complicates the interpretation of recurrence (Scriba and Tatzber, 1981) since a 
recurrence rate of up to 100% may be associated with only a 60% incidence of latent 
infection in the lumbosacral dorsal root ganglia (Stanberry et al., 1982). This may 
reflect the lack of sensitivity of the methods used. Another problem with this model is 
the finding that the recurrent genital lesions are often sterile (Stanberry et al. , 1982).
The intracerebral route is not a natural route of herpesvirus infection. When mice 
were inoculated with HSV-1 directly into the right hemisphere more mice were killed 
than from the same dose inoculated intradermally (Hill et al., 1975). The difference 
between the pathogenicity of HSV-1 and HSV-2 following intradermal inoculation was 
not so great when the intracerebral route was used (Hill et al., 1975). Others have 
found HSV-2 to be more neurovirulent than HSV-1 with a greater ability to spread and 
cause disease within the CNS (Richards et al., 1981). No evidence of latency within 
the CNS was reported although the establishment of latency following intracerebral 
inoculation of mice with ts mutants has been shown by others (Lofgren et al., 1977). 
The intraperitoneal route (Richards et al., 1981) is also an unnatural route of infection 
and this makes such models inappropriate for further studies. Haematogenous spread 
of herpes simplex infections does occur in man albeit rarely, but no direct seeding into 
the mouse CNS occured from haematogenous spread and it was probable that infection 
was first established in the sensory ganglia (Anderson and Field, 1983). This accords
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with the earlier reports that viraemia caused by injection of virus into the tail vein of 
mice was followed by the establishment of latency principally in sensory ganglia 
although latent virus could be recovered from the brains of a minority (Cook and 
Stevens, 1976). Interestingly, latent infection was not apparent in any of the 
extraneural tissues examined but was demonstrated in the adrenal medulla. This tissue 
has a neural origin and contains sympathetic ganglion cells, in agreement with the 
hypothesis that latent infections are generally limited to nervous tissues and more 
specifically to the neurones in these tissues although there may be exceptions.
In man, latent infection may be activated by a number of varied stimuli which 
include fever, sunlight and trauma. Trigeminal sensory root section performed as a 
treatment for trigeminal neuralgia is also able to provoke herpetic lesions in man 
(Carton and Kilboume, 1952) and this observation has been adapted to effect 
reactivation of latent virus in animal models. Homogenisation of latently infected DRG 
of mice beyond 2 weeks following inoculation of the footpad does not result in 
detection of the infecting virus unlike explantation of the whole ganglia (Cook and 
Stevens, 1971; Walz et al., 1974). Thus homogenisation after neurectomy can be used 
as a means of measuring reactivation. Cutting the lumbosacral roots of the sciatic 
nerve of latently infected murine ganglia reactivated virus in 30% of the organs (Walz 
et al., 1974). This observation established sciatic nerve section as a reproducible model 
of viral reactivation in vivo, and this technique has been extended to other sites (Price 
and Schmitz, 1978). Neurectomy causes a profound alteration in the metabolic state of 
neurones including an increase in RNA synthesis (Langford et al., 1980). Such a 
change is part of the general chromatolytic or axon reaction which may be related to 
loss of NGF being supplied from the periphery (Tenser et al., 1988).
The first demonstration that HSV can induce a latent infection in ganglia was in 
1971 (Stevens and Cook, 1971). Mice were inoculated in the rear footpad and those 
that recovered from the initial paralysis were sacrificed at intervals up to 4 months post 
infection. The spinal ganglia were either explanted and maintained as organ cultures, 
with the supernatant being regularly examined for the presence of virus, or 
homogenised and assayed for virus. Organ cultures were positive for HSV between 7 
and 14 days but no virus was detected following homogenisation (Stevens and Cook,
1971). This established explantation of ganglia as a model of viral reactivation in vitro. 
The mouse, however, does not naturally experience recurrent disease unlike the 
herpetic rabbit eye (Nesbum et al., 1967). Explantation of the trigeminal ganglia of 
latently infected rabbits (Stevens et al., 1976) and superior cervical and vagus ganglia 
of humans (Warren et al., 1978) also effects reactivation. Co-cultivation techniques of
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chopped latently infected neural tissue with cultures of appropriate indicator cell 
monolayers has also been used to demonstrate the presence of virus in mice (Cook and 
Stevens, 1976), in rabbits (Knotts et al., 1973) and in humans (Baringer, 1974; Warren 
et al., 1978). Culture of dissociated cells from the mouse DRG has been used to 
demonstrate reactivation in neurones identified by a neurone specific 
immunofluoresence marker (Kennedy et al. , 1983).
Despite the use of explant reactivation as a method to investigate the phenomenon 
of reactivation from the latent state it must be borne in mind that it is totally unlike any 
of the usual stimuli which effect reactivation in vivo. Since it is such a drastic 
manipulation of the neurone it may not accurately mimic the subtle processes normally 
involved in the natural event and therefore be of questionable interpretation.
It is clear that one of the major problems with animal models, apart from cost, is 
that none of them exactly matches the condition in the human host. Some of the more 
experimentally suitable animals in terms of size and economy are often less permissive 
and commonly fail to mimic latency in either being very difficult, if not impossible to 
reactivate or the opposite extreme of being too easy. To establish latency in some 
animals requires high doses of virus and others infected at low doses suffer from high 
mortality rates. The different patterns of regulated viral gene expression in neuronal 
cells need to be well understood if the mechanisms controlling latency and reactivation 
are to be unravelled. However, the number of neurones available from latently 
infected ganglia in vivo are insufficient for such detailed study. Thus no one animal 
model fulfils the criteria to provide material to study latency in its entirety although it 
might allow a particular aspect to be investigated.
1.2.3. Investigation of latency in tissue culture models
Animal models not only fail to mimic the clinical features of latent infection in 
humans but are also subject to many variables that are difficult to manage in the 
experimental situation. In addition, animal experiments are limited by the low number 
of cells in the sensory ganglia that retain a latent genome that can be reactivated and the 
inaccessibility of neurones in situ. Tissue cultures have the attraction of being pure, 
can be visualised directly and permit the manipulation of the cellular environment to a 
much greater extent. The ideal in vitro latency model would have:-
(i) host cells of a neuronal origin
(ii) cells able to survive viral infection
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(iii) no infectious virus in surviving cells
(iv) complete viral genomes persisting in surviving cells
(v) viral genomes persisting as non-linear, non-integrated structures
(vi) the latency associated transcripts expressed
(vii) virus genomes that can be reliably reactivated by a defined manipulation
(viii) a high proportion of cells with a latent genome that can be reactivated
Various tissue culture models have been described. Wigdahl and co-workers have 
developed models based on cultured cells including primary neurones, infected in the 
presence of inhibitors of replication and at 40° C. It is well established that HSV 
cannot replicate in tissue culture cells at temperatures of 41 - 42°C (Crouch and Rapp, 
1972; Marcon and Kucera, 1976). The mechanism for this could be the inactivation of 
an essential viral protein normally involved in directing the lytic process or a cellular 
response to the supraoptimal temperature. Either mechanism could leave the genome 
open to be directed down the latent pathway. HEL fibroblast cultures were infected 
with HSV-1. Replication was blocked by ara-C and the viral genome maintained in the 
repressed state by subsequently raising the temperature from 37 to 40.5°C after 
removal of the inhibitor (Wigdahl et al. , 1981.) Activation of HSV-1 replication could 
be effected by either reducing the temperature or superinfecting the cultures with 
HCMV. Infectious centre assays indicated that only 0.0002 to 0.02% of the cell 
population contained a viral genome that could be activated. Subsequent experiments 
showed that about 10% of the HEL fibroblasts expressed HSV-1 antigens early after 
activation (Wigdahl et al., 1982a). To further characterise the viral genome it was 
essential to increase the number of cells containing it that could be activated into the 
replication cycle. By using combined BVDU and IFN-a treatment, the maximum 
number of surviving HEL fibroblasts containing an HSV-1 genome that could be 
"reactivated" to produce infectious virus was increased to between 1 and 3% (Wigdahl 
et al., 1982b). BVDU inhibits viral DNA polymerase after phosphorylation by 
thymidine kinase but permits the complete expression of IE genes. The cell culture 
type was broadened to include cells of a neuronal origin. Dissociated rat foetus sensory 
ganglia neurones were grown as an essentially pure culture by using antimitotic drugs 
to eradicate non-neuronal cells (Wigdahl et al., 1983). The culture was pretreated for 
24 hours with BVDU and human IFN-a prior to infection with HSV-1 at 2.5 pfu per 
cell. The virus became undetectable 3 days after infection and remained undetectable if 
the inhibitor treatment was continued. The virus could also be maintained in this non­
replicating state by continued incubation at 40.5°C even though the inhibitors had been 
removed. It was suggested that this represented the latent state. Once the incubation 
temperature of the culture was shifted down to 37° C, replication ensued and by
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analogy this was construed as representing reactivation. Infectious virus was detectable 
at 1 - 3 days following inhibitor removal and reduction of the temperature to 37°C, and 
by 4 - 7 days extensive cytopathic effect was observed. No infectious centre assays 
were performed but at 3 days following the removal of the inhibitor and at 37°C, 50% 
of the cells showed virus specific immunofluorescence. This was in contrast with the 
previous experiments where only about 10% of the HEL fibroblast population 
expressed HSV-1 antigens early after this "reactivation" (Wigdahl et al., 1982a). The 
experiments were extended to examine the state of the HSV-1 genome during 
establishment and maintenance of repressed infection in HEL fibroblasts; during 
maintenance of repressed infection in rat foetal neurones and during reactivation 
(Wigdahl et al., 1984a). It was considered likely that many of the infected rat foetal 
neurones contained more than one HSV-1 genome equivalent by finding that there were 
8 - 1 0  copies of most HSV-1 Bam HI DNA fragments per haploid cell genome 
equivalent. There was a much greater retention of latent virus in the neurones than in 
the fibroblasts. By examining restriction endonuclease digests of partly purified total 
cell DNA from latently infected cultures and comparing them with similar digests of 
reconstructed mixtures of purified HSV-1 virion DNA, no alteration in the size or 
molarity of the viral terminal or junction DNA fragments was detected. This suggested 
that the predominant form was non-concatemeric and linear. The authors concur that 
the results do not preclude the possibility of a minor undetectable, yet important, HSV- 
1 DNA species being retained in an integrated or non-integrated plasmid or 
concatemeric form and they could not completely exclude the possibility of integration 
of the viral genome into the host cell DNA. The rat is not a natural host for latent 
HSV but a later paper (Wigdahl et al., 1984b) describes this in vitro model using 
human foetus sensory neurones as the host cell type. No detailed characterisation has 
been reported.
Apart from the serious doubt as to whether repressed replication of the virus by 
non-physiological inhibitors which permit continued expression of IE genes or by 
supraoptimal temperatures is the same as being latent, there are two other important 
criticisms of these results. Firstly, the viral genome predominantly persists in the 
linear configuration and, secondly, no accurate transcription patterns have been 
reported and thus the nature of viral gene expression in the repressed state is 
undetermined. Therefore the model does not fulfil the criteria set out in (v) and (vi) 
above.
It appears that latency may occur in the non-neuronal cells of the cornea (Schimeld 
et al., 1982; Abghari and Stulting, 1988) and an in vitro tissue culture model has been
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described using rabbit comeal epithelial cells, keratocytes and endothelial cells grown 
separately in culture and infected at 0.1 pfu per cell (Cook and Brown, 1986). At an 
incubation temperature of 42°C and using acycloguanosine to eliminate any ongoing 
low level replication, two of these cell types were considered to support a latent 
infection using a moi of 0.001 pfu per cell (Cook and Brown, 1987). Latent infection 
was defined as the absence of infectious virus at 42 °C and release of infectious virus 
following transfer to 37°C. Infectious virus was also released by intratypic 
superinfection up to 29 days post infection demonstrating the continuing presence of 
input viral DNA in the culture. Furthermore, the resident "latent” genomes were 
capable of recombining with the superinfecting virus. The question arises as to 
whether the repressed virus is the same as a latent virus and there are no reports of the 
transcription patterns of the genome nor of its structure.
An in vitro latency system without the need for chemical inhibitors of viral 
replication has been described (Russell and Preston, 1986). Virus replication in HFL 
fibroblasts (essentially equivalent to the HEL cells used by Wigdahl and co-workers) 
infected with HSV-2 at 0.003 pfu per cell was suppressed by infection at the 
supraoptimal temperature of 42°C. When the culture was transferred to the normal 
growth temperature of 37°C infectious virus remained undetectable for at least 6 days. 
The virus could be reactivated by intertypic superinfection at 38.5°C with ts mutants of 
HSV-1 or with HCMV but not by cell subculture or treatments altering cell 
metabolism. The HSV-1 mutant tsK, which has a mutation in the gene encoding Vmw 
175 and hence only produces IE proteins at the non-permissive temperature, was 
equally efficient at reactivation as a late ts mutant. The reactivation efficiency was 
very high and reproducible suggesting that one or more of the IE proteins, excluding 
Vmwl75, is responsible for initiating reactivation. Further studies (Russell et al.,
1987) with another mutant of HSV-1, dR4Q3, which has a deletion of most of the 
sequence encoding VmwllO, showed that it was able to establish latency as efficiently 
as wild type HSV-1 yet it was unable to reactivate HSV-2 when used to superinfect 
latently infected cultures. This suggested a role for VmwllO in reactivation in this in 
vitro model and this conclusion has been borne out by the results of others (Harris et 
al, , 1989). VmwllO expressed by adenovirus recombinants was able to reactivate 
HSV-2 from latently infected HFL monolayers in the absence of any other known HSV 
proteins (Harris et al., 1989). Furthermore, a region in the second exon of the gene 
encoding VmwllO was shown to be important for this process (Harris et al., 1989). 
Investigations into the structure of the latent genome were able to demonstrate that the 
joint fragment was present at approximately twice the molar concentration of fragments 
from unique regions suggesting fusion of the termini (Preston and Russell, 1991).
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Thus the latent HSV-2 DNA was present in the cell nucleus in a non-linear 
configuration in keeping with that previously demonstrated in vivo for HSV-1 (Rock 
and Fraser, 1983; 1985). There are at least three differences between this model and 
those discussed above which rely upon inhibitors to induce "latency". Firstly, 
reactivation in the latter requires more than the presence of HSV IE proteins and not 
merely the provision of VmwllO (Scheck et a l , 1987), secondly, a reduction in 
temperature to 37°C is sufficient to lead to viral replication and thirdly, the DNA is 
predominantly linear. It may be that there are two populations of viral genomes in the 
inhibitor induced model, one population liable to replicate when the temperature is 
reduced and the other requiring superinfecting virus to enter the lytic cycle (Shiraki and 
Rapp, 1986). The system developed by Russell and colleagues may harbour virus 
largely as the second population.
An extension of this tissue culture system has been reported (Harris and Preston,
1991). The HSV-1 mutant m l814 which has a 12bp insertion in the Vmw65 gene with 
the consequent abolition of its transinducing properties, can be retained in HFL 
fibroblasts after infection at a low moi and incubation at 42°C. It too, like HSV-2, is 
reactivated by the provision of VmwllO from a superinfecting virus. However, 
latency could also be established by ml 814 at the physiological temperature of 37 °C 
and because it has low cytotoxicity, at a higher moi of 5 particles per cell. In the 
presence of ara-C, an inhibitor of DNA synthesis, the viral DNA was maintained at 1 
to 8 copies per latently infected cell in a non-linear configuration. Thus the absence of 
transinduction by Vmw65 predisposes the virus to latency in this system and the 
genome is in a form analagous to that found in vivo (Rock and Fraser, 1983; 1985). 
These findings support the hypothesis that the failure of transactivation by Vmw65 
leads to abortion of the lytic process and directs the virus towards latency. No gene 
expression from the ml 814 genome was detectable during latency at 37 °C using the 
polymerase chain reaction with primers specific for thymidine kinase or LATs 
(Anderson, 1991). This is in contrast to the situation in vivo, although it may be 
explicable on the grounds of the neurone specific nature of the LAT promoter. During 
latent infection, LATs are only found in cells of a neuronal origin (Batchelor and 
O'Hare, 1990).
Another tissue culture system based on neuronal cells has been described (Wilcox 
and Johnson, 1987; 1988). Primary sympathetic neuronal cultures were prepared by 
dissociating the superior cervical ganglia of prenatal rats and growing them in standard 
media containing 20jnM fluorodeoxyuridine. This antimitotic agent reduces the non­
neuronal cell population to less than 5 % and produces neuronal densities of
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approximately 5000 - 8000 per culture. The cultures could be maintained for up to five 
weeks after removing the fluorodeoxyuridine and inoculation with HSV-1 without 
evidence of viral infection. After removing the antimitotic agent the cultures were 
infected with HSV-1 and following adsorption the viral inoculum was removed and 
replaced with either medium or medium containing 2% anti-HSV antiserum. Cultures 
surviving at 14 days post infection were rinsed to remove the anti-HSV antibodies if 
appropriate. Addition of antibodies to HSV after virus inoculation was not necessary to 
establish latency but it greatly reduced the number of cultures destroyed by lytic 
infection. Reactivation was produced by the addition of antibodies to NGF to the 
surviving cultures. The model satisfied the operational definition of latency (Price, 
1986) they selected. At a moi of 0.03 pfu per cell and without the anti-HSV antiserum 
48% of the cultures were lost and 11% of the surviving cultures retained latent virus. 
If the cultures were treated with HSV neutralising antiserum for 2 weeks after the 
inoculation the moi could be increased to 1 pfu per cell and 53% of the surviving 
cultures retained the latent virus. Further increments in the moi led to the total 
destruction of the cells (Wilcox and Johnson, 1987). If the cultures were treated for 12 
hours prior to and 7 days post infection with inhibitors which block viral DNA 
synthesis such as acyclovir or phosphonoacetic acid a higher moi of 5 pfu per cell could 
be achieved (Wilcox and Johnson, 1988). This procedure totally prevented lytic 
infection and was considered a rational means to prevent spread and increase the 
survival and number of cells with latent HSV. At a moi of 5 pfu per cell there was 
100% survival and 100% reactivation of the cultures. During the latent phase no viral 
specific antigens were detected but after 24 hours of NGF deprivation they were in all 
of the neurones suggesting that the majority harboured latent HSV-1. The discovery 
that NGF was required to maintain latency in cultures of rat sympathetic neurones was 
extended and shown that it was also required to maintain latency in cultures of sensory 
neurones obtained from DRG of rats, monkeys and humans (Wilcox et al., 1990). The 
neurones of human origin were cultured from aborted foetuses at less than 10 weeks 
gestation which may not mimic the host cell in the adult. A further finding was that 
when the human neuronal cell cultures were deprived of NGF there was 100% 
reactivation of latent HSV. Since the major clinical reservoirs of latent HSV in man 
are the sensory ganglia and especially the sensory neurones of the trigeminal and DRG, 
this tissue culture model should be a close approximation in terms of the host cells to 
the in vivo situation. Subsequent workers have used strand specific Northern blot and 
RNase protection hybridisation analyses to investigate viral transcription during the 
latent infection of foetal rat DRG neurones in vitro (Doerig et al., 1991a). In their 
system the 2kb RNA was the major species detected although the 1.5kb and 1.45kb 
species were also present albeit in minor quantities. The LAT was also present 12
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hours after reactivation had been initiated by depriving the culture of NGF. The gD 
mRNA, an mRNA characteristic of the productive infection, was not detected during 
the latent state but was detected after reactivation had been triggered by NGF 
deprivation (Doerig etal., 1991a). In another study the more controversial finding of a 
protein designated a latency-associated viral antigen, LAA, encoded by a region 
corresponding to the LATs was reported. (Doerig et al., 1991b). This product has not 
been described in vivo. A number of questions remain as to the comparability of this 
model to the in vivo situation, including the unnatural host and the presence of the 
LAA, but the most outstanding is whether the configuration of the viral genome is 
linear or non-linear in the in vitro neuronal latency system. Studies on this aspect have 
not been reported.
Unfortunately, the amounts of viral DNA available from primary cultures of 
sensory neurones are insufficient for extensive study at the molecular level. C l300 
mouse neuroblastoma cells bear many of the characteristics of differentiated neurones 
including the development of neurites and the synthesis of neural enzymes and 
transmitters (Augusti-Tocco and Sata, 1969; Schubert et al., 1969; Amano et al.,
1972). They are relatively non-permissive for the lytic growth of HSV (Vahlne and 
Lycke, 1978) and this has been assigned to a failure of transcription of IE genes 
following infection (Kemp and Latchman, 1989). However no transcriptional patterns 
of LATs were detected in these cells during non-permissive lytic infection and thus 
some doubt was expressed as to whether the model was analogous to viral gene 
regulation in vivo (Wheatley et al., 1990). Such cell lines may be able to yield latent 
DNA in sufficient quantities for detailed study and indeed immortalised cell lines 
derived from neonatal rat DRG fused with a C l300 neuroblastoma cell line have been 
used to extend investigations of latency in vitro (Wheatley et al., 1990). Neonatal rat 
DRG were cultured in the presence of cytosine arabinoside for 3 days to kill the 
dividing non-neuronal cells such as fibroblasts and Schwann cells and leave a pure 
population of non-dividing neurones. These primary neuronal cells were fused with 
N18 TG2 cells, a HAT-sensitive neuroblastoma cell line derived from C1300 cells, and 
immortalised HAT-resistant cells were selected in medium containing HAT to produce 
the ND series of immortalised DRG cell lines (Wood et al., 1990). They retained 
many properties of the parental DRG neurones such as the ability to synthesise 
neuropeptides and glycolipid surface markers and respond electrophysiologically to 
sensory neurone activators and displayed features characteristic of the neurones rather 
than other ganglion cells (Dodd and Jessell, 1985). They also possessed rat specific 
markers emphasising their lineage from this animal. One of these cell lines, ND3, was 
non-permissive for HSV infection at a low moi of 1 pfu per cell to an extent
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comparable to the C l300 cells as determined by the low level of immunofluorescent 
staining with antibody to the HSV-1 IE protein Vmw 175. No transcriptional products 
from any of the 5 IE genes were detected in nuclear run on assays whereas the converse 
was shown in permissive 3T3 cells. A selected clone in which the Hpa I - Sst I 
fragment containing the IE110/LAT region had been cloned between the promoters for 
T3 and T7 RNA polymerase was used to infer the presence of the LATs. As the IE110 
and LAT genes are on opposite strands, these polymerases will transcribe ssRNA 
complementary to either IE110 mRNA or LAT RNA. The RNA preparations were 
hybridised with the radiolabelled products of nuclear run on assays and only the 
transcription of LAT RNA was detectable in infected ND3 cells and none of the IE110 
mRNA. The latter was present in permissive cells. Sensory ganglia do not provide 
sufficient material to measure the rates of IE transcription during latency in vivo so it is 
not known whether IE mRNAs are not transcribed or rapidly degraded. The authors 
suggest that this in vitro model system is suitable for studying the processes regulating 
the interaction of HSV with neuronal cells and the establishment of latency in vivo. 
Again this immortalised cell line may not necessarily equate with the natural host cell. 
To date no data pertaining to the structure of the latent genome in this model have been 
published. Thus once again the question of how such a system based on abnormal cells 
relates to the in vivo situation still needs to be fully addressed.
1.2.4. Organisation of the latent genome
The structure of the HSV-1 genome during latency in peripheral nerve ganglia and 
the CNS of mice has been investigated (Rock and Fraser, 1983). Mice were infected 
with 1 x 1()6 pfu of HSV-1 by comeal scarification. At 2 months post infection 
explanted cultures of the trigeminal ganglia all gave reactivation but there was no 
reactivation following explantation of CNS tissue i.e. brain stems, cerebella or cerebra 
at the same time. This was despite virus being recovered from the same CNS sites at 6 
days post infection. The DNA from infected ganglia and brain tissue was used for the 
analysis of the viral DNA by Southern blot hybridisation. Most, if not all of the viral 
genome was detected in the latently infected brain tissue which implied that the 
inability to reactivate the virus was not due to incomplete or defective genomes in the 
CNS as suggested by others (Cabrera et al., 1980) but more a reflection of the nature 
of the host cell or the latent virus or both. Using a nick translated ^^P-labelled Bam HI 
SP joint-spanning fragment of the viral genome hybridised to Bam HI digests of tissue 
DNA, the viral DNA from both brain tissue at 2 months post infection and pooled 
trigeminal ganglia at 5 months post infection appeared to lack the terminal fragments of 
the genome (Rock and Fraser, 1983). This was not due to a lack of sensitivity because
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latently and acutely infected brains had SP joint fragments of similar intensity with 
terminal fragments of differing intensity. In contrast, acutely infected brain tissue 
DNA when compared with virion DNA showed terminal fragments increasing in size 
by between about 300 and 500 bp consistent with a reiteration of the "a" sequence 
found during the productive infection of tissue cultures by others (Post et al., 1980) 
and in submolar concentrations with a ratio to the joint region of 0.3 as determined by 
densitometric analysis. This too has been previously observed in acutely infected tissue 
culture and attributed to the presence of concatemers during replication (Jacob et al.,
1979). The results are not compatible with any model where the latent genome persists 
as a unit length linear molecule. They imply that the viral DNA undergoes a 
biochemical change in the process of becoming latent. There was no difference in 
configuration between the latent DNA from the PNS and the CNS and thus the marked 
difference in reactivation following explant culture cannot be attributed to a failure of 
the genome to complete this structural change. The loss of the terminal fragments 
could be due to a deletion of the termini, integration of the DNA via its ends, 
circularisation of unit length DNA or the linking together of genomes to produce long 
linear or circular concatemers which may or may not integrate into the host genome 
(see figure 1.5). A subsequent report (Rock and Fraser, 1985) which examined these 
possibilities in the same model, showed that the loss of the free ends was accompanied 
by a quantitative relative increase in the joint fragments. The structure of the HSV-1 
genome dictates that circularisation or concatenation will produce a further joint 
sequence from fusion of the termini. To determine the number of copies of joint 
sequences to unique sequences the Bam HI digests of infected tissue were hybridised 
with nick translated ^^P-labelled Bam HI SP and B HSV-1 DNA fragments. The SP 
fragment hybridises to the joint and termini and the B fragment hybridises to the B and 
E fragments derived from the long repeat plus some unique sequences of the digested 
genome. Autoradiographs showed that the intensity of the terminal S and P bands from 
acutely infected tissue was reduced compared with virion DNA and absent from the 
latently infected brains and trigeminal ganglia. Quantification by densitometric 
scanning showed that the molar ratio of joint to unique sequences, taken as 1 in the 
virion, increased to 1.6 in acute infection and to 2 in the latent state. This confirmed 
the findings of the earlier experiments. Thus in vivo the latent genome cannot be a unit 
length linear molecule, neither can it have integrated by the termini since they no 
longer exist. On the basis of these results it is clearly non-linear and could be a unit 
length circular molecule or a circular or large linear concatemer. Integration remains a 
possibility but it would need to be via unique sequences otherwise the ratio of joint to 
unique sequences would fall from 2 to 1. These findings were confirmed in latently 
infected murine brain stem, spinal cord and cervical ganglia following inoculation via
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FIGURE 1.5: HYPOTHETICAL STRUCTURES OF THE LATENT HSV GENOME
The unit length, linear genome of the virion has the potential to be organised into a 
number of forms as is evident from the diagram. As discussed in the text, current 
evidence suggests that the latent genome is a circular episome.
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the ear (Efstathiou et al., 1986). This non-linear DNA was qualitatively and 
quantitatively stable in mouse neural tissue over a 4 month period, indicating that it was 
the genuinely latent genetic material rather than DNA persisting from the initial 
infection which would have been degraded. The viral DNA from human trigeminal 
ganglia was also shown to be endless and in all 4 isomeric configurations (Efstathiou et 
al., 1986).
An earlier study (Fraser et al., 1981) investigated the HSV-1 DNA in human brain 
tissue by endonuclease digestion, separation of the products by gel electrophoresis and 
hybridisation with labelled HSV-1 fragments. The method was able to detect 1 copy of 
the viral genome in 200 cells. In some samples only part of the genome was detected 
and in others the terminal fragments could be detected suggesting a linear non­
integrated form. This is completely different to the results from the in vivo studies on 
the latent viral genome in the mouse PNS and CNS (Rock and Fraser, 1983; 1985 
Efstathiou et al., 1986) and the human PNS (Efstathiou et al., 1986) described above 
and it has not been repeated nor confirmed by others.
Other investigators of the structure of the latent viral genome in vitro have reported 
it to be predominantly non-integrated, linear and non-concatemeric (Wigdahl et al., 
1984a). This was the first description of the characterisation of the HSV genome in a 
tissue culture model in which replication could be maintained in a repressed state and 
activation could be produced. It remains an unanswered question as to whether the use 
of drugs and elevated temperature to repress replication genuinely mimics the latent 
state in vivo. The DNA from HEL fibroblasts latently infected with HSV-1 was 
partially purified and digested with either Xba I, Bam HI or Hind HI. The digest was 
subjected to electrophoresis, Southern blotting and hybridisation with a 32p_ 
radiolabelled HSV-1 Bam HI SP (K) DNA fragment to detect the joint and terminal 
fragments of the HSV-1 genome. There were no detectable changes in the molecular 
weights of the HSV-1 terminal fragments obtained by these three restriction 
endonucleases. Digestion of the DNA from latently infected rat foetal neurones with 
Bam HI produced terminal DNA fragments similar in size to those obtained from a 
Bam HI digestion of HSV-1 virion DNA. Densitometric scanning of the 
autoradiographs of the restriction digested DNA isolated from either infected HEL 
fibroblasts or rat foetal neurones and hybridised with the Bam HI SP (K) DNA 
fragment demonstrated that the molar ratios of the joint SP (K) to the terminal S or P 
DNA fragments resembled those obtained by a similar digestion of HSV-1 virion DNA 
in reconstruction experiments. These results suggested that the genome was largely 
non-integrated, non-concatemeric and linear rather than circular when latent in
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fibroblasts and cells of a neuronal origin. The findings contrast with those following 
Bam HI digestion of the DNA from productively infected rat foetal neurones 24 hours 
after infection. Hybridisation with the Bam HI SP (K) DNA fragment showed the joint 
markedly increased in comparison with the terminal fragments and this was presumed 
to be due to the presence of replicating DNA concatemers.
The genome structure has been investigated in other tissue culture models of HSV-1 
and HSV-2 latency (Harris and Preston, 1991; Preston and Russell, 1991). The DNA 
from HFL fibroblasts infected with 0.03 pfu per cell of HSV-2 was digested with Bam 
HI and the viral DNA separated from host cell DNA by equilibrium density gradient 
centrifugation. This technique exploits the differences in the G + C content between 
human and viral DNA making it possible to separate the HSV-1 genome from the host 
cell DNA. The -^^P-labelled joint-spanning fragment Bam HI g was used to probe for 
the joint and two terminal fragments, Bam HI g, u and v respectively. Only the joint 
was detectable in latently infected material unlike the DNA from reconstructed controls 
or productively infected cells. Densitometric analysis of the latent genome joint 
showed an average molarity of 1.85 with respect to the unique fragment Bam HI 1. 
This result suggested a circular or concatenated molecule or one integrated at a position 
other than the termini. Both the formation of a closed circular structure or integration 
via the unique sequences but not the repeat sequences would give a joint to unique 
sequence ratio of 2. Two other important observations from this work were made. 
Firstly, the loss of the termini was a slower process than the fusion of termini occurring 
during a productive infection (Poffenberger and Roizman, 1985) and secondly, there 
were up to 8 copies per latently infected cell. This work was extended to include the 
HSV-1 mutant /n l814 (Harris and Preston, 1991). The virus readily established 
latency at a moi of 5 particles per cell if the culture was kept at 42°C. The viral DNA 
was examined for the presence of the joint fragment, Bam HI k and the terminal 
fragments, Bam HI q and s, as latency was established. At 5 hours the termini were 
still present albeit in lower concentrations than the joint and by 2 and 4 days the joint 
only was detected. The calculated copy number was between 1 and 8 copies per 
latently infected cell. The conclusion was that the latent ini 814 genome was retained 
in low abundance in a non-linear configuration. These results are in accord with the in 
vivo situation (Rock and Fraser, 1983; 1985) and are in contrast with the in vitro model 
which uses drugs to repress replication (Wigdahl et al., 1984a). The validity of the 
latter model as representative of the latent state in vivo has already been questioned.
The HSV-1 genome can also be separated from host cell DNA by CsCl buoyant 
density gradient centrifugation in acutely and latently infected mice (Mellerick and
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Fraser, 1987). Most of the viral DNA from acutely infected brain tissue was present in 
the band at the buoyant density of virion DNA. The small amount that associated with 
the mouse DNA could be released easily by recentrifugation suggesting that it had 
merely become trapped. This DNA could be composed of the high molecular weight 
replicative intermediates seen during HSV DNA synthesis (Jacob and Roizman, 1977). 
Similarly the majority of the latent viral DNA banded at the buoyant density of virion 
DNA but the small quantity remaining associated with the chromosomal DNA could 
not be disentangled and was considered artifactual. Since the latent genome was found 
primarily in an extrachromosomal state, resisted trapping suggesting it was compact 
and lacked free ends (Rock and Fraser 1983; 1985; Efstathiou et al., 1986), it was 
postulated (Mellerick and Fraser, 1987) to exist as a circular episome.
An interesting corollary occurs in EBV infection. In non-producer cell lines the 
EBV genome lacks the terminal fragments (Heller et al., 1981) and it has been shown 
that the majority of latent EBV DNA is episomal and circular (Lindahl et al., 1976).
Eukaryotic nuclear DNA is associated with histones to form chromatin. The 
proteins in the chromatin complex are believed to have a role in the regulation of gene 
activity (Weisbrod, 1982; Weintraub, 1985). The fundamental packaging unit of 
chromatin is the nucleosome which can be revealed by micrococcal nuclease digestion 
(Komberg, 1977). The enzyme attacks the linker regions between the nucleosomes 
with the histones protecting the core. Thus partial digests produce a series of 
fragments, each an integral multiple of the nucleosomal repeat unit which can be 
separated by gel electrophoresis. A typical nucleosomal cellular DNA digest produces 
a ladder of fragments (Noll, 1974), each a multiple of approximately 180bp (Shaw et 
al., 1976) reduced to a core monomer of 140bp as the digestion progresses (Whitlock 
and Simpson, 1976). Mice infected by comeal scarification and retaining latent viral 
DNA in the trigeminal ganglia as determined by explant assay were used as sources to 
investigate the genome structure (Deshmane and Fraser, 1989). Nuclear material from 
the CNS containing >3pg per jxg of cellular DNA had to be used because of the 
inadequate sensitivity of the technique. Micrococcal nuclease digestion produced a 
typical nucleosomal pattern from all the major regions in the latent DNA as determined 
by hybridisation with total HSV-1 virion genomic DNA and subgenomic cloned 
fragments. In contrast, some of the viral DNA in acutely infected brain stems was 
either resistant to nuclease digestion or was randomly digested to produce a smear 
down the gel. This latter pattern is suggestive of a naked DNA molecule or one not 
packaged into nucleosomes. Others have also found that during acute infection in 
tissue culture (Leinbach and Summers, 1980) or in the mouse CNS (Muggeridge and
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Fraser, 1986) only a small fraction of the viral DMA is in a nucleosomal form which 
implies that at least while replicating the HSV-1 DNA is predominantly in structures 
other than nucleosomes. It has been proposed (Deshmane and Fraser, 1989) that in the 
latent state viral transcription is disrupted by the association with cellular histones to 
form chromatin as a host defence mechanism or to confer long term stability on the 
genome. The latent genome in the mouse CNS is remarkably resistant to reactivation 
(Cabrera et al., 1980) which may be a consequence of being converted to chromatin. 
However, in the PNS the latent genome is reactivated with ease (Cabrera et al., 1980) 
and might reflect a continuing non-nucleosomal arrangement. Unfortunately 
insufficient material was available in the PNS for this to have been studied.
1.2.5. Transcriptional activity of the latent genome
There had been a number of reports of the presence of viral transcripts during latent 
HSV-1 infection of the mouse CNS (Stroop et al.9 1984), latent HSV-2 infection of 
guinea pig sensory ganglia (Tenser et a l ,  1982) and human sensory ganglia (Galloway 
et al., 1982) and for the HSV-1 protein product Vmwl75 in latently infected rabbit 
ganglia (Green et al., 1981) before the discovery of the LATs in latently infected 
mouse sensory neurones (Stevens et al., 1987). Using in situ hybridisation and 
confirming the findings with Northern blotting, cloned probes representing the 
complete viral genome identified transcripts arising from the long repeat regions. It 
was shown that the major species of RNA hybridised to a probe from the 
complementary strand to the IE110 gene and that it had a predominantly nuclear 
localisation. This was in contrast with acute infection where the transcript was more 
evenly distributed throughout the cell, and it suggested that the RNA was confined to 
the nucleus during the latent state. The transcripts could be recovered in the poly(A) ~ 
fraction following oligo(dT)-cellulose chromatography of RNA preparations from 
latently infected whole ganglia of mice inoculated in the footpad with HSV-1 strain 
KOS(M) (Wagner et al., 1988a). A poly(A)+ RNA species initially detected in low 
abundance was subsequently shown to be a contaminant (Wagner et al., 1988b). The 
major species accounted for more than 90% of the transcripts detected and was shown 
by agarose gel electrophoresis to be no larger than 2.3kb (Wagner et al., 1988a). The 
minor species corresponded to a band between 1.8 and 2.0kb. Diffuse signals from 
RNA originating beyond the nominal 3' and 5* endis of the major LAT were also seen 
but were of no more than 300 - 350 bases in length and accounted for less than 5% of 
the major species. No other viral transcripts were detected although species transcribed 
at low levels or rapidly degraded could not be excluded. The transcripts were mapped 
using subclones of DNA from the region of the HSV genome around the IE110 gene.
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The 5’ end of the molecule was characterised in detail and the DNA sequence encoding 
the transcript analysed. The 5* end of the LAT was located 510 bases to the left of a 
Kpn I site at 0.783 map units and the 31 end just within a 310bp Sma I fragment 660 - 
970bp to the right of the Sal I site at 0.790 map units. It was suggested that the smaller 
species was a processed form of the major one. The abundance was calculated as 2 x 
10^ - 5 x 105 molecules per infected cell and similar results were subsequently reported 
in latently infected human trigeminal ganglia (Stevens et al., 1988). Only very low 
levels were detected during the productive infection of cultured rabbit skin cells 
(Wagner et al. , 1988b) which may indicate that the promoter control regions governing 
the expression of LATs have neuronal specificity.
There are at least 3 poly(A)~ transcripts, usually designated 2.0kb, 1.5kb and 
1.45kb, present in latently infected trigeminal ganglia (Spivack and Fraser, 1987) and 
their genomic location is shown in figure 1.6. These were detected by a virion DNA 
probe in Northern blots of latently infected tissue following corneal inoculation of 
mice. The size of these transcripts is at variance with the estimated size in the earlier 
report based on KOS-M infection (Stevens et al., 1987) but technical differences as 
well as the different route of infection and site of latency, might account for this. The 
transcripts were found to accumulate suggesting synthesis during the latent state. They 
were partly collinear and all mapped to a 3.0kb Pst I - M u  I subfragment of Bam HI B, 
partially overlapping by a maximum of 950 bases the 2684 bases of the VmwllO 
mRNA which is transcribed in the opposite direction. The 2.0kb transcript was 
detectable at considerably reduced levels in acutely infected ganglia and in cultured 
CV-1 cells. The RNAs were present in latent infections with the F, KOS and HFEM 
strains of HSV-1.
The sequence of the HSV-1 DNA encoding the LAT has been scrutinised for 
features to suggest it could be eventually translated into a protein product (Wagner et 
al., 1988a). A 2400 base sequence from a Sph I site located to the left of the Kpn 1 
site at 0.783 map units to the Sma I site at 0.794 map units, 660 bases to the right of 
the Sal I site at 0.790 map units, was analysed. There are some features of an RNA 
polymerase II promoter in the sequence 5’ of the cap site and within 86 bases upstream 
of this cap site there are two potential CAAT box homologies and one possible TATA 
box homologue (figure 1.7). A pyrimidine rich region including a 26 base run of 
thymines exists immediately upstream of these homologues and a role in tissue 
specificity was suggested. Translation initiation signals exist in all three reading frames 
but only two have codon patterns considered consistent with protein coding (Fickett,
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FIGURE 1.6: THE LAT REGION OF HSV-1
The LAT region and the LATs are discussed in the text. The 6.0kb LAT which would 
result from splicing if the 2.0kb is an intron has not been detected and there is no 
convincing evidence for protein products from the transcripts. Reproduced from Fraser
et al. , 1992.
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1982). The first, ORF 1, beginning at base 1160 and extending to base 2074 
potentially codes for 305aa. The 3’ region of this ORF is complementary to 360 bases 
at the 3’ end of the ORF for VmwllO (Perry et al., 1986). Comparison with the 
sequence data of the same region of strain 17syn+ (Periy et al., 1986) shows a high 
degree of homology. The second, ORF 2, is initiated at base 625 and remains open for 
207 bases representing 69aa.
Apart from the poor TATA and CAAT box homologies already noted there are no 
obvious promoter elements within the first 195 nucleotides upstream of the 5' end of 
the LAT. Nevertheless a sequence analysis of the gene and flanking regions from 
strain F found potential promoter elements present 700bp further upstream. Some of 
the sequence elements upstream of LAT are shown in figure 1.7. There is an excellent 
consensus TATA box at —687, a good CAAT box at —817 and SP1 binding sites at — 
589, —863 and —887 (Wechsler et al., 1989). Another potential promoter was found 
just before ORF 1 and ORF 2 with a TATA box at 826 surrounded by 4 SP1 sites 
(Wechsler et al., 1989). This would however give an RNA slightly smaller than has 
been detected. Similar sequence information was found in the gene of strain 17syn+ 
(Wechsler et al., 1988). Examining the LATs from rabbit trigeminal ganglia the two 
most abundant RNAs appeared to share 5' and 3' ends and to be the result of 
alternative splicing (Wechsler et al., 1988). These products were 2.0kb and 1.3 - 
1.5kb with the smaller LAT 2 having at least one intron spliced from LAT 1. No 
consensus polyadenylation sequence was found within 4000 nucleotides of the nominal 
31 end of the LATs although a small amount of in situ hybridisation beyond the 3' end 
of LATs and within the Bam HI SP fragment has been reported (Rock et al., 1987a).
A minimal promoter region necessary for the constitutive activity of the LAT gene 
in neuronal and non-neuronal cells has been mapped between —161 and —2 (Zwaagstra 
et al., 1991). A LAT promoter binding factor (LPBF) was identified which bound 
specifically to a core palindrome within the region and appeared to have a major 
regulatory role. Deletion of the palindrome led to loss of LPBF binding and an 8 - 30 
fold fall in promoter activity (Zwaagstra et al., 1991).
A recombinant virus in which the rabbit /Lglobin gene coding sequences had been 
inserted immediately downstream of the upstream potential polymerase II promoter 
sequence expressed j8-globin mRNA but no LATs in latently infected mouse ganglia 
whereas another recombinant in which this TATA box had been removed did not 
express the LATs (Dobson et al., 1988). Such a large distance between a TATA box
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Sequence analysis has shown the presence of promoter elements 5' of the LAT cap site 
namely a TATA box and 2 CAAT boxes but as discussed in the text these are poor 
homologies. In addition there is a cAMP response element (CRE) and an LPBF 
binding site. The functional LAT promoter is located 700bp upstream of the 5 ‘ end of 
LAT with an excellent consensus TATA box at —687, a good CAAT box at —817, 
Spl motifs and a Vmw 175 binding site.
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and the 5' end of its transcript would be unusual but might confer regulatory 
properties. With the LAT promoter at this location, RNA upstream of the LAT must 
be synthesised and degraded during the latent phase. Low levels of such RNA were 
observed by in situ hybridisation but not by Northern blotting (Dobson et al., 1988). 
The RNA generated during a productive infection was used to detect a transcript 
extending from the LAT promoter to a proposed poly A signal 8.5kb downstream 
(Dobson et al., 1988) which suggests that the LAT may be processed from a larger 
product. A larger transcript from a region of the genome adjacent to the LATs had 
been reported earlier as detected by in situ hybridisation and appeared to be weakly 
transcribed during latency (Deatly et al., 1987). Later a large sized transcript at low 
abundance in both acutely and latently infected mice was detected with a LAT probe 
(Mitchell et al., 1990). Thus the LAT could be transcribed from conventional 
promoter elements far upstream of the transcription unit which encodes the stable 
species. This finding implies that the LATs which are observed are derived from an 
unstable primary transcript originating distal to the TATA box 700bp upstream of the 
cap site and extending to the poly A sequence almost 5kb downstream of the 3' end of 
the LAT. If this is the case and considering that the stable LAT is bounded by splice 
sites, not polyadenylated and confined to the nucleus, it has many features of an intron. 
Using LAT expression plasmid constructs other investigators have reported that LAT is 
a stable intron (Farrell et al., 1991).
The mutant X10-13 which has a deletion in the 5' end of the LAT transcription unit 
does not express any detectable LATs nor any other viral transcripts during latent 
infection in mouse neurones (Javier et al., 1988). This observation suggests that all 
viral transcripts present during latency are related to the expression of the major LAT 
and that there are no independent transcription units. This was in keeping with the 
demonstration of the collinearity of the smaller 1.5 and 1.45kb LATs with the major 
species except for a 730 base intron (Wagner et al., 1988b). Following comeal 
inoculation of rabbits with the McKrae strain of HSV-1, the latently infected trigeminal 
ganglia were shown to harbour the smaller 1.5kb transcript, derived by splicing a 730 
base intron from the major LAT. This represented up to 50% of the total viral RNA. 
A similar proportion was found using the KOS(M) strain in the rabbit and with several 
strains in the mouse. This was different to the proportion arising from latent infection 
of the mouse with KOS(M) where the smaller transcript accounted for less than 10% of 
the total LAT (Wagner et al., 1988). Evidently both the strain of the vims and the host 
have a role in the processing or the stability of these transcripts which must ultimately 
I be a reflection of DNA sequence variations and host factors. It implies that the relative 
proportion of the spliced LAT is not a determinant of latency per se. The spliced
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species was not present in acute infection indicating that splicing occurs after the latent 
state has been established in mouse or rabbit neurones. Using oligonucleotide probes 
and confirming the findings with mung bean nuclease protection assays the splice 
acceptor site was accurately identified. The excision of the intron located between 
bases 297 and 1033 installs ORF 2 within 250 bases of the transcriptional start site and 
brings the translational leader length into the same range as other HSV-1 mRNAs.
Direct characterisation of the LATS using a combination of cDNA and PCR cloning 
demonstrated an intron spliced from the 2.0kb LAT to produce at least one of the 
smaller LATs (Spivack et al., 1991). The 5' end of this intron has a novel GC rather 
than the usual GT and it was proposed that this structure within the 2.0kb LAT may be 
part of a neuronal specific control mechanism yielding the transcripts present in sensory 
neurones during latent infection and reactivation but absent during the viral replication 
cycle.
A number of suggestions have been advanced for a role for the LATs (Stevens et 
al., 1987). Firstly, the RNA may act as a messenger for a protein that is involved in 
the early stages of the productive cycle but because it is restricted to the nucleus 
translation is prevented and the productive cycle is aborted. Secondly, the protein 
product may be required to maintain the latent state and, thirdly, the RNA acts as an 
antisense molecule to regulate the expression of the IE110 gene by reducing or even 
eliminating the pool of Vmwl 10 mRNA.
Although the LATs have ORFs which may suggest a protein product none encoded 
by these ORFs have been reported in vivo. The LATs have 2 ORFs, denoted ORF 1 
and ORF 2, common to all 3 sequences of strain F, 17syn+ and KOS (Wechsler et al.,
1989). The larger of the two, ORF 1, has a code highly conserved among HSV-1 
strains (Wagner et a l, 1988a) which some have argued is suggestive of a protein 
product. It has the coding potential for 305 aa.
If the larger transcript hypothesis is accepted then the LATs will have conventional 
promoter regions with the translational leader of appropriate length following splicing 
of the 2.0kb LAT to the 1.5kb LAT. This again is suggestive of a protein product and 
indeed if, as proposed, the polyadenylation site is 8.5kb from the cap site many more 
candidate proteins become possible.
Antibodies have been raised to several polypeptides corresponding to different 
portions of the ORF 1 but no viral protein has been identified (Wechsler et al., 1989).
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In another report an antiserum raised in rabbits to a 14aa peptide synthesised from the 
ORF 1 of the LAT failed to detect any antigens by immunohistochemistry of acutely or 
latently infected ganglia (Wagner et al., 1988a). Both of these reports refer to 
unpublished observations. Nevertheless, there have been publications of protein 
products arising from the LATs. The presence of the IE viral protein Vmwl75 in the 
trigeminal ganglia of latently infected rabbits detected by an indirect 
immunofluorescence assay using a monospecific antibody (Green et al., 1981) has been 
difficult to reproduce. Moreover rabbits are subject to frequent spontaneous 
reactivation which clouds the interpretation. Alternatively, there may be a species 
dependent translation of LATs since the Vmwl75 mRNA was undetected in latently 
infected mouse ganglia (Deatly et al., 1987). An antiserum has been raised in rabbits 
against a bacterially expressed fusion protein containing part of a LAT encoded 
polypeptide (Doerig et al., 1991b). This chimeric protein was produced from the 
plasmid pATH LAT 2 encoding a chimeric gene, part of which has the carboxy- 
terminal portion of the LAT ORF 1. Antiserum was also raised to the protein product 
of another chimeric gene in the plasmid pATH ICPO which possesses the carboxy- 
terminal part of the third exon of the IE protein VmwllO. Apart from the virally 
encoded aa these two proteins are otherwise identical. Using immunocytochemical 
techniques an antigen recognised by the anti-LAT 2 antiserum was demonstrated in 
primary neurones latently infected in vitro. This antigen, LAA, was not detected by 
the same techniques in mock infected neuronal cultures, neuronal cultures infected with 
the LAT deletion mutant d/1403 or productively infected Vero cells. The mutant, 
d/1403, has a Sal I - Xho I deletion in both copies of the LAT gene and was able to 
establish latent infection in vitro with 100% reactivation following NGF deprivation. 
On the other hand the anti-VmwllO antiserum whilst not reacting to the latently or 
mock infected cultures did to the productively infected Vero cells. Furthermore, 
analysis of the product in Western immunoblots demonstrated a protein in whole cell 
extracts from latently infected neurones recognised by the anti-LAT 2 antiserum with a 
mass of 80kd. This was absent in mock infected cultures or in productively infected 
Vero cells. A 45kd protein of varying intensity was also identified and it was 
suggested to be a degradation product. Another difficulty was the large discrepancy 
between the experimental finding of an 80kd protein and the predicted 33kd protein. 
This may be explicable if larger ORFs are generated by RNA splicing.
There are a number of observations which mitigate against the LATs producing a 
protein product during latency. Firstly, there has been no unequivocal demonstration 
of such a product in vivo. Secondly, the RNA is located within the nucleus rendering it 
untranslatable. Thirdly, no convincing evidence of any polyadenylated species has
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been found (Wagner et al., 1988b) despite earlier reports (Puga and Notkins, 1987; 
Wagner et al., 1988a) and, fourthly, there is no polyadenylation signal within 900bp of 
the 3' end of the major transcript (Perry et al., 1986). This last observation may be 
undermined by the identification of related transcripts in latently infected ganglia. 
These have been identified by in situ hybridisation (Dobson et al,. 1989; Mitchell et 
al., 1990) or Northern blotting (Zwaagstra et al., 1990) and shown to extend 
downstream of the major LAT 3f end to a poly A signal 8.5kb from the LAT TATA 
box. Since RNAs from this region were shown to be polyadenylated in productively 
infected cells (Dobson et al., 1989) there is reason to believe that this may well be the 
case in neurones too. An alternative possibility would be a splicing event to generate 
an ORF with a polyadenylated tail.
The experimental data need not only to be explained but also confirmed before a 
role for a LAT protein product in either the maintenance of latency or reactivation can 
be entertained. It has been hypothesised that the LAA could enhance reactivation. 
This might be the reason for the delayed reactivation of some LAT mutants in explant 
assays (Clements and Stow, 1989; Leib et al., 1989a; 1989b; Steiner et al., 1989) or 
the reduced efficiency of reactivation in vivo (Hill et a l , 1990; Trousdale et al., 1991). 
Other LAT mutants have the same reactivation kinetics as LAT+ viruses (Ho and 
Mocarski, 1989; Block et al., 1990) which could be because there are only minor or no 
alterations to the ORF 1. If the antigen is present during latency it would presumably 
need to be inactive until triggered by other events of the reactivation process.
The suggestion that the LATs might suppress expression of IE110 transcripts to 
which it is partially complementary by an antisense mechanism is attractive because 
IE110 gene expression is inextricably involved with the initial events surrounding 
infection (Stow and Stow, 1986) and also appears to have a role in reactivation (Leib et 
al., 1989b). A deletion mutant within the gene encoding the transcriptional activator 
VmwllO was shown to replicate poorly at low moi (Stow and Stow, 1986). Others 
have shown that although deletion mutants of VmwllO can establish latency they fail to 
reactivate efficiently or not at all from murine trigeminal ganglia (Leib et al., 1989b). 
The relative abundance and the nuclear localisation of the LATs is also in favour of 
such a mechanism but a major difficulty with the suggestion is that the sense transcript 
(VmwllO mRNA) has never been detected during latency. It may be that any sporadic 
expression of the sense transcript during latency is immediately so overwhelmed by the 
antisense RNA that it is beyond the current methods of detection. Experiments in 
which plasmid constructs expressing LAT, VmwllO and the reporter gene luciferase 
driven by the HSV-1 thymidine kinase promoter were co-transfected into rabbit skin
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cells showed LAT to inhibit transactivation by VmwllO (Farrell et al., 1991). A 
number of mechanisms as to how this might occur were suggested. Firstly, the LAT 
sequesters the IE110 transcript in the nucleus preventing translation, secondly, the 
RNA duplex formed by LAT and the IE110 mRNA may lead to modification of the 
IE110 transcript to render it untranslatable or its protein product non-functional or, 
thirdly, the duplex is a target for degradation by RNA nucleases (Farrell et al., 1991).
The hypothesis that LATs were capable of preventing productive infection by the 
inhibition of VmwllO expression through an antisense mechanism has been weakened 
by the evidence from a number of LAT mutants being able to establish latent infection 
in animal models. The LAT mutant TB1 is able to establish latency and reactivate with 
the same efficiency as the parental virus (Block et al., 1990). There were no detectable 
HSV-1 transcripts in mouse ganglia latently infected with this mutant and although a 
0.7 - 0.8kb RNA was apparent in productively infected CV-1 cells it did not 
accumulate in vivo (Block et al., 1990). The authors of the report argue that as 
disruption of the LATs does not transcriptionally derepress other viral genes a 
functional role based on an antisense mechanism seems unlikely. They admit that 
neither a readthrough transcript including sequences downstream of the insert nor the 
possibility of the insert conferring instability on the transcript in vivo could be 
excluded. The LAT mutant, 1704, can establish latent infection and be maintained 
without detectable levels of LATs for more than 6 weeks in trigeminal ganglia (Steiner 
et al., 1989) as measured by the ability to reactivate the virus by explantation. It is 
difficult to envisage how the null mutants d/LAT1.8 (Leib et al., 1989a) and d/1403 
(Clements and Stow, 1989) can establish a latent infection if VmwllO antisense 
repression is the sole means of establishing and maintaining the latent state.
1.3. Potential factors contributing to the latent state
1.3.1. Viral replication
The role of replication in establishing latency is difficult to assess. Results based on 
inhibited replication are difficult to interpret because ts mutants (Watson et al., 1980) 
may leak and immune serum (Klein, 1980) or antiviral drugs (Klein et al., 1979) may 
not be completely effective in preventing viral replication. Using deletion and 
nonsense mutations in the Vmw63 or Vmwl75 genes, three non-replicating viruses 
were unable to reactivate by co-cultivation of explanted ganglia (Leib et al., 1989b).
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Furthermore, one of these, the Vmwl75 mutant, could not be reactivated using 
superinfection of dissociated ganglionic neurones with a replication incompetent virus 
either and there was no detectable viral DNA in the ganglia (Leib et al., 1989b). Thus 
the absence of replication at the inoculation site rendered the virus unable to establish 
reactivatable latency. However, since the input virus would be unable to replicate, the 
DNA of a latent infection might be below the limits of detection. The findings could 
also be explained if Vmw63 and 175 have a role later in latency. Findings based on the 
ability of the mutant ini 814 to establish latent infection in mouse trigeminal ganglia 
without detectable replication in the eye (Steiner et al., 1990) support the hypothesis 
that replication during the initial infection is not a prerequisite for a latent infection. 
This is in accord with the results of others who were able to detect HSV DNA by a 
polymerase chain reaction assay in mouse ganglia infected by corneal inoculation 30 
days or more previously with replication incompetent mutants, including those with 
mutations in the IE175 gene, of HSV-1 (Katz et al., 1990). Another mutant which was 
unable to replicate due a deletion in the IE175 gene was shown to establish latency and 
stably express a cloned reporter gene in mouse ganglia following inoculation in the 
footpad (Dobson et al., 1990). Similarly, inhibition of the early stages of replication 
did not prevent a latent infection being established in vitro (Russell et al., 1987). Thus 
neither productive infection nor viral DNA replication is necessary for the viral DNA 
to be established and maintained in the ganglia. Replication at the site of inoculation 
merely increases the number of genomes available to enter the latent state.
Ecob-Prince and others (1993a) identified sensory neurones harbouring latent virus 
in vivo by in situ hybridisation. They were able to show that equal pfu of ini 814, the 
rescued revertant and the wt virus varied in their ability to establish latency and this 
was determined by the number of particles in the inoculum. Thus whereas only 3% of 
the neurones in the DRG were positive for LATs following infection with wt virus this 
could be increased to about 20% using more particles of the less neurovirulent mutant 
ini 814. Increasing the number of particles of wt virus killed the host. As in the 
observations above these results also show that even though a virus has limited ability 
to replicate or is unable to form plaques this does not prevent it from establishing 
latency.
1.3.2. Failure of IE gene expression
The virion structural protein Vmw65 (Heine et al., 1974) which is also a 
transactivator of the viral IE promoters in newly infected cells, has three essential 
regulatory domains. The 80aa C-terminal portion is a powerful activator domain
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(Sadowski et al., 1988) while one internal domain contacts the DNA and one or more 
accessory cellular proteins, and another directs specific interaction with helix 2 of the 
DNA recognition motif within the homeobox domain of Oct-1 (Stem and Herr, 1991). 
A stable DNA bound protein:protein complex, the IEC, is formed which targets the 
response elements within viral promoters and initiates the transcription of IE genes 
within 20 minutes of infection (Mosca et al., 1985) without the need for viral protein 
synthesis. There are two distinct types of Vmw65 response elements (apRhys et al., 
1989) the most familiar being the cis-acting TAATGARAT (R=purine) sequence 
(Preston C.M. et al., 1984; Whitton and Clements, 1984; Bzik and Preston, 1986) in 
the 5' regulatory region. A single copy of either from the IE175 and IE110 promoter 
is sufficient to confer responsiveness to Vmw65 (apRhys et al., 1989). As the 
structural and activation properties of Vmw65 are determined by different domains 
within the protein it was possible to construct a mutant which only affects the 
transinducing activity (Ace et al., 1988). The mutant, in i814, has a 12bp insertion in 
the gene encoding Vmw65 which abolishes its ability to transinduce IE promoters as 
shown by superinfection of cells transfected with a plasmid containing CAT controlled 
by the IE175 promoter (Ace et al., 1989). The role of the protein as a major structural 
component in virion assembly is apparently unaffected by the mutation. The mutation 
also abolished the ability of Vmw65 to complex with cell proteins and the specific 
regulatory element TAATGAGAT of IE68/12 (Ace et al., 1989). The migration of the 
viral genome to the nucleus was unimpaired but the absolute level of the IE mRNA was 
reduced by up to 4-fold in the case of IE 110, equivalent to the effect on the rate of 
synthesis of the protein (Ace et al., 1989). Although m l814 was able to infect cells 
normally at a high moi its plaque forming ability was reduced and it had a much higher 
pipfu. ratio than wt virus on both BHK and HFL cells. On the latter cell type the ratio 
was 11 for the wt virus and 1.7 x 10^ for the mutant. The defect could be partially 
overcome by prior transfection of a plasmid containing the IE110 gene or by prior 
infection with UV inactivated HSV tsK, which supplies functional Vmw65 in trans. 
Thus although the functional role of Vmw65 is redundant at a moi of 100 particles per 
cell, its transinducing ability is critical for successful productive infection at a low moi 
of 1 particle per cell. Even in the absence of Vmw65 there was a basal level of 
transcription of IE genes which suggests that the primary determinant of IE gene 
expression is not the transactivator itself. The requirement for Vmw65 at a low moi, as 
may occur in a natural infection, suggests that there is a threshold level of IE gene 
products required to effect a productive infection and that this protein has a place in 
guaranteeing it. It is hypothesised that latency is the ensuing outcome if there is a 
block to transcriptional activity early in the infection. Using ini 814 in a tissue culture 
model it was shown that at a moi of up to 5 particles per cell the viral genome was
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maintained at a low copy number in a non-linear configuration (Harris and Preston, 
1991). Moreover, the defect could not be complemented by Vmw65 once latency had 
been established but the silent genome remained sensitive to transactivation and hence 
reactivation by VmwllO. The fact that in i814 established latency at 42°C in tissue 
culture as efficiently as wt virus on the basis of particles (Harris and Preston, 1991) 
implies that the insertion does not affect entry or uncoating. The inference is that the 
reduction of IE transcription by 5 - 10 fold, characteristic of this mutant, is critical for 
the switch from the lytic to the latent pathway. Using the same mutant in the mouse 
eye model (Steiner et al., 1990), latency was shown to be established shortly after the 
arrival of virus in the trigeminal ganglia, some 24 to 48 hours post infection. It was as 
efficient as the parent or the rescued revertant on the basis of equal pfii but not 
particles. The efficiency of reactivation by explantation was similarly demonstrated. A 
cell line of stably transformed mouse L cells constitutively expressing a mutated 
Vmw65 which lacks the acidic activation domain and hence its transactivating property 
(Friedman et al., 1988) has a much diminished ability to support HSV-1 replication and 
this is thought to be due to reduced EE gene expression by dominant interference from 
the endogenous mutated Vmw65. It appears that the mutant protein competes with the 
incoming Vmw65 for important cellular factors and transactivation is inhibited. The 
phenotype of ini 814 in tisssue culture can be dramatically reversed by a short exposure 
to HMBA early after infection (McFarlane et al., 1992). There was an increased 
accumulation of IE mRNA following the exposure indicating a direct stimulation of IE 
transcription and presumably a primary effect on gene regulation again emphasising the 
importance of IE gene expression in determining the outcome of infection. The results 
of the studies with ini 814 in vitro (Harris and Preston, 1991) and in vivo (Steiner et 
al., 1990), are all in accord with the view that a failure of IE gene transcription is the 
normal route to latency (Kemp et al. , 1990).
One hypothesis that could explain failure of IE gene transcription is absence of the 
viral transactivating factor Vmw65 (Roizman and Sears, 1987). Evidence has been 
reported which does not support this hypothesis (Sears et al. , 1991). The establishment 
of latency could not be precluded nor could latency be terminated by supplying Vmw65 
in trans from a recombinant virus.
The replication of HSV is restricted in mouse neuroblastoma C l300 cells (Vahlne 
and Lycke, 1977). Early investigators found evidence for an inhibitor of replication 
which was not due to the induction of EFN (Vahlne and Lycke, 1978). The restriction 
could be overcome by pretreatment of the cells with sodium butyrate which was 
accompanied by an increase in the transcription of viral IE genes following infection
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(Ash, 1986; Kemp and Latch man, 1989). This finding was the first demonstration that 
a block to HSV IE gene transcription exists in neuronal cells and suggested that the 
failure of the lytic cycle was a consequence of failed IE gene expression. Subsequently 
it was shown, using a reporter gene driven by an IE promoter, that the transcriptional 
repression is mediated by the octamer motif in IE promoters (Kemp et al., 1990). A 
factor specific to neurones which binds to the TAATGARAT elements and thereby 
attenuates the activity of IE viral promoters was identified in the ND series of cell lines 
from immortalised primary rat DRG neurones (Wheatley et al., 1991). The cellular 
transcription factor Oct-1 (Fletcher et al., 1987) binds to ATGCAAAT in cellular gene 
promoters (Parslow et al., 1984) and to TAATGARAT in viral IE gene promoters 
(O'Hare and Goding, 1988; Preston et al., 1988). Plasmids consisting of promoters 
driving the CAT gene are expressed very weakly in non-permissive ND cells (Kemp et 
al., 1990) but their activity is greatly enhanced by the co-transfection of plasmids 
containing isolated TAATGARAT elements of the viral IE or the octamer motifs of 
cellular gene promoters (Kemp et al., 1990; Wheatley et al., 1991). Furthermore, 
transfection of these elements increased the permissivity of neuronal cells for HSV 
infection (Kemp et al., 1990; Wheatley et al., 1991). These findings strongly 
suggested the presence of an inhibitor that is titrated away by the addition of excess 
octamer or TAATGARAT motifs. The ND cell line and DRG were shown to contain 
Oct-2 mRNA (Lillycrop et al., 1991) which has been previously demonstrated to be 
present in embryonic sensory ganglia and adult neuronal tissues of the rat (He et al.,
1989) and brain extracts of the mouse (Scholer et al., 1989). An additional 
octamer/TAATGARAT-binding protein absent from permissive cells was identified as 
the lymphocyte- and neurone-specific octamer-binding protein Oct-2 (Lillycrop et al., 
1991). Down regulation of IE expression could be achieved by transfection of 
plasmids that express Oct-2 (Lillycrop et al., 1991) confirming its properties as a 
repressor in neuronal cells. Oct-2 acts as an activator in B lymphocytes (Muller et al.,
1988) suggesting that the neurone must either modify the protein or it is involved with 
another factor to be rendered a repressor. Thus Oct-2 has the potential to bind to the 
TAATGARAT to form a complex that would prevent the binding of either Oct-1 or the 
IEC to the IE promoters thereby reducing IE transcription, aborting the lytic cycle and 
switching the infection into latency. The RNA encoding Oct-2 is alternatively spliced 
in both B cells (Wirth et a l , 1991) and neuronal cells (Lillycrop and Latchman, 1992) 
to yield multiple protein isoforms when translated. The isoforms Oct 2.4 and 2.5 are 
the most abundant in neurones and repress the promoters containing the 
octamer/TAATGARAT motifs. Since the isoforms 2.1, 2.2 and 2.3 are activators in 
non-neuronal cells but repressors in neurones it is hypothesised that the conversion
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from activator to repressor is mediated by the high levels of the inhibitory 2.4 and 2.5 
isoforms (Lillycrop and Latchman, 1992).
The studies with ini 814 are strongly supportive of the hypothesis that IE 
transcription is the key in determining the outcome of an infection. The existence of 
repressors such as Oct-2, with the potential to repress IE transcription in neurones, is 
also suggestive, as are the results of the experiments of IFN on HSV replication whose 
effect is directed at the same point in the viral life cycle (section 1.4.4).
1.3.3. Nerve growth factor
NGF is required by sympathetic and sensory neurones in vitro and in vivo to 
maintain normal function and also, depending on their age and cell type, to survive 
(Thoenen and Barde, 1980). The manifold properties of NGF are probably mediated 
ultimately through its effects on transcriptional regulation (Lindsay and Harmer, 1989; 
Chao, 1992). A role for NGF in the latent state of HSV has been suggested on the 
basis of two observations. Firstly, that latency is only clearly apparent in NGF 
dependent neurones and, secondly, that axotomy or central rhizotomy, which 
diminishes or abolishes NGF retrograde transport is a very powerful stimulus to 
reactivation. Wilcox and Johnson were able to show that 24 hours after NGF 
deprivation of latently infected rat sympathetic neurones HSV-1 or HSV-2 antigens 
were readily detected in virtually all of the cells. By 48 - 72 hours the cytopathic effect 
was evident and infectious virus could be recovered (Wilcox and Johnson, 1988). 
During the latent phase the cells had normal morphological features and no infectious 
virus either in the culture supernatants or in association with the cells after lysis was 
apparent. No immunohistochemical viral specific antigens were detected. This 
observation that NGF was required to maintain latency in cultures of rat sympathetic 
neurones was also seen in cultures of sensory neurones from the DRG of rats, monkeys 
and humans (Wilcox et al., 1990). Upon depleting NGF by addition of anti-NGF 
serum and then replacing it with medium containing excess NGF they were able to 
show that interruption of the neuronal supply for only lh led to reactivation of the 
virus, indicating that the latent virus was very sensitive to changes in the concentration 
or binding of NGF. The sensitivity was species specific. A species specific 
monoclonal antibody, Mab-20.4, which blocks NGF binding to the human receptor was 
able to reactivate latent HSV from human but not rat sensory neurones. Moreover, 
Mab-192 which despite binding to the rat sensory neurone receptor does not prevent 
NGF binding to it as well was unable to produce reactivation. It appears therefore, that 
the effects of NGF on HSV latency are mediated by NGF binding to the NGF receptor
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and that the maintenance of latency is susceptible to cellular functions controlled by 
NGF. When NGF binds to its receptor it is internalised and both factor and receptor 
are transported to the neuronal cell body. It is possible to interfere chemically with the 
steps in this process for example by the addition of 6-hydroxydopamine, which destroys 
sympathetic nerve terminals or colchicine, which prevents retrograde transport. Either 
of these treatments was able to effect reactivation of latent HSV from cultured 
sympathetic neurones. A brief period lasting only 1 hour of protein or RNA synthesis 
inhibition using cycloheximide or 5,6,dichloro-l-D-furanosylbenzimidazole 
respectively also resulted in reactivation in 100% of the cultures which suggests that a 
short lived factor may exist in neurones either to maintain the status quo or to repress 
reactivation. This supports other studies (Tenser et al., 1988) where damage inflicted 
on the neuronal target or to the terminals reactivated virus, suggesting that the tissue 
actively synthesises a factor necessary to maintain latency. To test whether deprivation 
of NGF is only a means of inflicting a more general injury and thereby perturbing 
maintenance to effect reactivation, the cultures were exposed to UV irradiation from 
doses causing no morphological damage to those which killed the cells. Since no 
reactivation occurred at any dose it is clear that not all forms of cell injury will waken 
the latent virus. The effect of NGF deprivation on the viability of the neurone is 
reversible for 18 hours. This is in contrast to the effect on the latent virus which 
cannot be reversed after 1 hour of deprivation, suggesting that the virus is able to come 
out of latency and replicate by responding early to a warning signal that the cell’s 
viability might be under threat. The nature of the NGF signal which maintains latency 
or suppresses reactivation has not been clarified.
In mobility shift assays using nuclear extracts from adult rat DRG neurones it was 
shown that Oct-2 protein levels were increased by 3 - 4 fold when the cells were grown 
in the presence of NGF (Wood et al., 1992). There was a parallel increase in the Oct- 
2 mRNA but the Oct-1 mRNA was unaffected. This differential up-regulation by NGF 
provides a mechanism for the repression of the viral IE genes during the establishment 
and maintenance of latency consistent with the hypothesis that Oct-2 specifically 
inhibits IE gene expression in neurones. Conversely, the loss of the supply of NGF by 
a failure of retrograde transport as would occur in axonal damage would lead to a 
reduction in the levels of the inhibitory Oct-2 and the viral genome would become 
susceptible to activation by an ensuing rise in IE gene products such as VmwllO (Leib 
etal., 1989b).
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A number of mutants have been used to investigate the possible role of the LATs 
in latency and these are shown in figure 1.8. The mutant XI0-13 (Javier et al., 1988) 
is an HSV-1 x HSV-2 recombinant with predominantly HSV-1 genetic material. It has 
a sequence deletion in the LAT which includes the characterised LAT promoter 700bp 
upstream of the 5' end (Dobson et al., 1988; Wechsler et al., 1989). It does not 
express any LATs or other viral transcripts detectable by in situ hybridisation or 
Northern blotting yet is able to establish latent infection following footpad inoculation 
of mice and be maintained in the latent state (Javier et al., 1988). Since both mutant 
and wt virus could be recovered with equal frequency from explanted lumbar ganglia it 
was deduced that expression of LATs is not required for establishment of or 
reactivation from the latent state in mouse neurones. However, although reactivation in 
vitro was unaffected (Javier et al., 1988) XI0-13 has been shown to reactivate poorly 
in vivo (Hill et al., 1990). Latency was established in the rabbit eye model but the 
virus could not be efficiently reactivated after iontophoresis of epinephrine onto the 
cornea (Hill et al., 1990). The deletion was restored by marker rescue to yield virus 
XC-20 which expresses LATs and reactivates at a significantly higher rate, comparable 
to that of the wt virus. Both XI0-13 and XC-20 were able to establish latency in 
equivalent numbers of neurones. It was concluded that latent phase transcription of 
HSV-1 facilitates ganglionic reactivation and subsequent ocular shedding of the 
reactivated virus. There was no difference between the two viruses in the low level of 
spontaneous reactivation. There appear to be basic physiological differences between 
spontaneous and induced reactivation in that intact comeal nerves need to be present to 
achieve epinephrine induced reactivation but not for indirect reactivation elicited by 
systemic disturbances such as intravenous cyclophosphamide or dexamethasone. It 
could be that the LATs are important for direct activation in vivo such as caused by 
sunlight or trauma whereas they have no importance in indirect activation produced by 
more generalised stimuli such as immunosuppression or pyrexia. It is also feasible that 
different processes operate in the lumbosacral ganglia to those in the trigeminal ganglia. 
The difference in the kinetics of reactivation was not apparent when rabbit trigeminal 
ganglia (Hill et al., 1990) or murine lumbosacral ganglia (Javier et al., 1988) were co­
cultivated. Thus reactivation in vivo might well be an entirely different process to 
explant reactivation in vitro with a role for the LATs in the former but not the latter.
The interpretation of the results of the experiments using the mutant XI0-13 does 
not account for the possibility of the HSV-2 sequences compensating for the LAT 
deletion. The recombinant has not been sufficiently well characterised so that even
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though the deletion does leave the body of the LAT intact and expression is 
undoubtedly reduced the conclusions can only be suggestive.
The mutant TB1 is derived from HSV-1 strain HFEM and has 400bp of X DNA in 
place of a 168bp deletion within the transcribed portion of the LAT gene (Block et al.,
1990). The disruption occurs between bases +839 and +1007 with respect to the 
RNA start site of the 1.5 - 2.0kb LATs. A 0.7 - 0.8kb RNA was expressed during 
productive infection in tissue culture but no HSV-1 transcripts were detected in latently 
infected mouse ganglia or in tissue culture. Nevertheless, the mutant was able to 
establish latent infection and reactivate as efficiently as the parental or revertant strains 
from explanted trigeminal ganglia latently infected following corneal inoculation of 
mice (Block et al., 1990). As the mutant is unable to produce full length LATs they 
cannot be essential for the establishment of or reactivation from latency as determined 
by explant cultivation although the smaller 0.7 - 0.8kb product present during lytic 
infection in vitro but not detectable in vivo may be functional (Block et al., 1990). 
Therefore if the LATs have a biological function it must include the region between the 
conventional promoter (Dobson et al., 1989) and the disruption in TB1. This 
encompasses a stretch of some 1600 nucleotides and would implicate the first 838bp of 
the LATs in the process of reactivation. The results do not preclude the possibility of 
sequences downstream of the insertion site being responsible for reactivation. 
Furthermore, as the mutant has the coding potential for the putative larger transcript it 
might be produced at low levels with the possibility of the derived transcripts being 
present in undetectable yet functional amounts. The absence of the 2.0 and 1.5kb 
LATs in latent infection with TB1 could still be explicable on the grounds of them 
being processing products or introns from a functionally important larger transcript 
(Dobson et al., 1989; Mitchell et al., 1990).
The LAT defective HSV-1 mutant, RH142, has both copies of the LAT disrupted 
by the insertion of the E. coli lacZgene under LAT promoter control (Ho et al., 1989). 
LATs were not detectable in either latently or productively infected cells although /?- 
galactosidase expression was readily detectable in sensory neurones of latently infected 
mice. This mutant was able to grow in cultured cells as well as become established and 
maintained in the latent state as determined by explant reactivation, in the trigeminal 
ganglia of mice (Ho et al., 1989). The reactivation kinetics and efficiency were the 
same as those of the parent. This again indicates that LATs are dispensible for these 
processes to occur.
49
Introduction
The LAT defective HSV-1 mutant, 1704, has a 3758bp deletion in IR l and the 
adjacent unique region (Junejo et al., 1991) thus removing most of the IR l copy of the 
LATs coding region. In addition it has a 942bp deletion immediately upstream of the 
coding region of the T R l copy (Junejo et a l , 1991) removing most of the proposed 
promoter (Wechsler et a l , 1988; 1989) but not extending into the 5' end of the LATs. 
The deletions do not extend into the IE110 gene. The virus was predicted to be a null 
mutant incapable of producing any putative large or derived transcripts Thus as 
expected, none of the recognised LATs were detected in the latent state in mice by 
Northern blotting or in situ hybridisation implying that the 942bp deletion may contain 
the important regulatory elements for the transcripts. The mutant was able to replicate 
in trigeminal ganglia with kinetics similar to those of the parent virus (17+ ) and to 
establish latent infection as determined by reactivation from explants (Steiner et a l ,  
1989). Since LATs were not detected it was concluded that they are not essential, at 
least at detectable levels, for the establishment of latency. However, 1704 is slower to 
reactivate from latently infected explants than the parental strain HSV 17+ (Steiner et 
a l,  1989) in that 100% of explanted trigeminal ganglia reactivated 17+ within 7 days 
but it was 31 days before 89% of the ganglia reactivated 1704. This was the first 
demonstration of delayed reactivation with a defined mutant and suggested a role for 
LATs in this process. A role based on an antisense mechanism was considered unlikely 
since if this were the case a mutant expressing no LATs would be expected to reactivate 
more rapidly rather than more slowly as was observed. The potential value of 
accumulated transcripts in favouring reactivation by preparing the genome in a state of 
readiness for the event was considered more likely. Other explanations for the 
observations such as the deletion resulting in latency being established in fewer 
neurones or that there are other unidentified genes which play a part in reactivation and 
are affected by the deletions were not excluded.
The KOS-derived LAT mutant dlLAT 1.8 is also a null mutant expressing no LATs 
as determined by in situ hybridisation (Leib et a l,  1989a). The mutation, affecting 
both copies, removes the putative promoter region (Wechsler et a l ,  1988), the 
transcriptional start site and 1015bp of the DNA sequence specifying LATs (Leib et 
a l, 1989a). The mutation completely removes both copies of the LATs (Leib et a l ,  
1989). It is replication competent and capable of establishing latent infection in the 
mouse ocular model (Leib et a l,  1989a). The levels of viral DNA present in latently 
infected tissue were comparable to those in wt virus infection. Despite being 
replication competent in the mouse ocular model it reactivated from explanted ganglia 
with lower efficiency (49%) than the LAT+ parent (94%) or the rescued virus (85%)
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FIGURE 1.8: LOCATION OF VARIOUS MUTATIONS IN THE LAT REGION OF 
VIRUSES USED IN STUDIES OF LAT FUNCTION
The HSV-1 prototype genome arrangement is shown with Bam HI B and E enlarged. 
The five mutants described in the text are illustrated. X10-13 is an HSV-1 x HSV-2 
recombinant predominantly HSV-1 except between 0.396 - 0.404 map units which was 
derived from HSV-2 and in addition a spontaneous deletion of 1.2kb within both long 
repeats at sites between 0.019 - 0.076 map units and 0.743 - 0.808 map units (Javier et 
al., 1988). 1704 is an HSV-1 variant deleted in T R l and IR]7U l (MacLean and 
Brown, 1987; Junejo et al., 1991). The deletions are 942bp and 3758bp respectively. 
dZLAT1.8 has a 1.8kb deletion which removes the putative LAT promoter and 1015bp 
of the sequences specifying LAT (Leib et al., 1989a). The mutant RH142 has the lacZ 
gene fused to putative LAT promoter-regulatory sequences 136bp downstream of the 
transcription start site in both copies of the LAT gene following a deletion from +137 
to +509 relative to the putative start site (Ho and Mocarski, 1989). TB1 is derived 
from HFEM, which has a 4. lkb deletion within the Bam HI B fragment and therefore 
only one complete copy of LATs and contains an additional 440bp segment of 
bacteriophage X DNA in place of a 168bp deletion in the transcribed portion of the 
remaining LAT gene (Block et al., 1990).
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again suggesting a role for LATs in this process (Leib et al., 1989a). The absence of 
ORF 1 in this mutant as well as in 1704 is not the explanation for their impaired 
reactivation kinetics since the disruption in TB1 also removes the start of ORF 1 and it 
reactivates normally. The levels of viral DNA present in latently infected tissue were 
comparable to those after wt infection although a difference in structure or modification 
might account for the altered biological activity. There was no change in 
neurovirulence in terms of mortality but microscopic examination of acutely infected 
tissue revealed more extensive cpe suggesting that higher titres were reached early in 
infection, presumably because the genes are less efficiently repressed as latency is 
established. The increased viral damage may result in fewer viable latent neurones and 
thus explain the reduced frequency of reactivation. The results indicate that LATs are 
not essential for establishment of or reactivation from latency but they may have a role 
in the efficiency of the latter process. This explanation might also account for the 
delayed expression of lytic phase transcription in explanted murine ganglia infected 
with LAT-  viruses compared with wt virus controls (Sederati et al., 1989).
The possibility of reactivation being delayed in some cases as a result of fewer 
neurones becoming latently infected has been addressed experimentally (Ecob-Prince et 
al., 1993b). In this study reactivation in vivo following neurectomy was determined by 
the induction of VmwllO mRNA although viral antigens were undetectable and the 
release of infectious virus was not investigated. None of the neurones which expressed 
VmwllO mRNA expressed LATs unlike lytically infected tissue where both RNAs 
could be detected in a single cell. This raises the possibilities of the down-regulation of 
LATs in reactivation (Rock et al., 1992) due to the expression of an IE gene such as 
IE175 (Batchelor and O’Hare, 1990), reactivation occurring from latently infected cells 
in which LATs have become undetectable or reactivation from latently infected cells in 
which LATs have never been expressed.
The observations made with the various LAT mutants argue against a role for the 
LATs in the establishment or maintenance of latency although there has been one report 
which suggests there may be a site dependent function for the LATs in establishing 
latency (Sawtell and Thompson, 1992). Direct comparison of the relative number of 
latent infections established by LAT+ and LAT-  mutants in which the LAT promoter 
drives the E. coli lacZgene during latency showed that the frequency of reactivation by 
hyperthermia was dependent on the anatomical site. The reactivation frequency of 
LAT-  mutants was reduced by 80% in the trigeminal ganglia but unaffected in the 
lumbosacral ganglia of mice compared with wt virus frequencies. The likely 
explanation is a reduction in establishment of latency since the LAT-  mutants were
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shown to establish about 80% fewer latent infections in trigeminal ganglia compared 
with the LAT+ mutants but with the same or greater frequency of latent infections in 
the lumbosacral ganglia. It was concluded that the LATs promote the establishment of 
latency in the trigeminal ganglia but not in the lumbosacral ganglia of mice (Sawtell 
and Thompson, 1992). The in vitro findings in studies of reactivation are inconclusive. 
The mutants X10-13, TB1 and RH142 have wt virus reactivation profiles whereas the 
other LAT mutants 1704 and dlLAT 1.8 do not. The lack of correlation of LAT+ 
neurones with reactivation (Ecob-Prince et al. , 1993) also suggests that these transcripts 
have no role in this phenomenon. Thus despite the transcriptional activity of the latent 
genome the question as to whether the products have any part at all to play in the latent 
state still remains unanswered.
1.3.5. VmwllO
VmwllO is one of the first proteins synthesised in a productive infection and is a 
potent transcriptional activator of all three classes of genes, a property first 
demonstrated in transfection assays (Everett, 1984). It can act alone or with Vmwl75 
to stimulate gene expression. O'Hare and Hayward proposed that Vmwl75 and 
VmwllO together may mediate a switch between lytic and latent infection (O'Hare and 
Hayward, 1985). They studied the trans-acting regulatory components of HSV in a 
transient assay system by analysis of the expression of recombinant constructs. They 
speculated that if the inhibitory action of Vmwl75 and the stimulatory action of 
VmwllO on the Vmwl75 regulatory region also operated on the VmwllO regulatory 
region then a dual action could effect a balanced control of IE expression. An 
alteration in the balance could favour latency. In addition reactivation could be 
effected by an interruption of the Vmwl75 repressor function.
The mutant d/1403 has a 2kb deletion within the gene encoding VmwllO in 
TRj^and IRl  (Stow and Stow, 1986) and also includes part of the LATs. It is predicted 
to produce a polypeptide consisting of the original N-terminal 105aa and 56aa from a 
different reading frame. It has reduced virulence but is still able to become latent in 
sensory ganglia following footpad inoculation and reactivate from explants albeit much 
more slowly than the wt or the marker rescued virus (Clements and Stow, 1989). Thus 
the presence of functional Vmwl 10 is not an absolute requirement for reactivation in 
murine ganglia. Comparison of the reactivation kinetics of d/1403 with the wt virus 
may not be valid. Lacking VmwllO it will probably enter the replication cycle more 
slowly and spread less efficiently through the ganglia. The result may well be fewer 
neurones ultimately becoming latently infected which could account for the altered
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reactivation kinetics. Other investigators found that three different deletion mutants of 
VmwllO, including dll403, varied in their ability to establish and reactivate from the 
latent state (Leib et al., 1989b). Two of the mutants, d/x0.7 and dh3 .\, established 
latency but did not reactivate from standard explant cultures (Leib et al., 1989b). This 
was not due to poor growth since addition of DMSO to explanted ganglia increased the 
reactivation of dh3.1 but did not improve its growth characteristics (Leib et al., 
1989b). VmwllO is important for growth in cell culture at low moi (Stow and Stow, 
1986). Deletion mutants replicate poorly in tissue culture at low moi but have wt virus 
patterns of gene expression at high moi. As VmwllO is important at low moi this 
might be the reason for the latency incompetence of these viruses since the reactivation 
process may in effect be equivalent to an infection at low multiplicity. All three 
deletions also differ in relation to the LATs and the authors were tempted to speculate 
that in the absence of VmwllO, the more LAT sequences removed the more the virus 
became latency competent.
In vitro experiments with adenovirus recombinants expressing VmwllO have shown 
that this gene product alone is sufficient to reactivate latent HSV-2 (Harris et al.,
1989). The transactivation domain of VmwllO appears to be the same domain 
required for reactivation (Zhu et al., 1990). These findings confirm the results of 
earlier investigations into the properties of ts insertion or deletion mutants of HSV in 
vitro (Russell et al., 1987). The VmwllO deletion mutant, d/1403, was unable to 
reactivate latent HSV-2 unlike tsK or M411 which fail to produce functional Vmwl75. 
Similarly latent ini 814 in vitro can be reactivated by superinfection with wt HSV-1 but 
not with d/1403 showing that it too requires VmwllO to effect reactivation (Harris and 
Preston, 1991). VmwllO appears to be a generalised transactivator not specific for 
promoter sequences. Spontaneous reactivation of latent virus may depend on activation 
of either this transactivator, if it has been modified during the establishment and 
maintenance of the latent state, or of cellular factors that mimic generalised 
transactivators.
Oct-2 may also have a role in reactivation since reduced levels of inhibitory Oct-2 
might allow reactivation to take place. The effect of NGF which is required to 
maintain Oct-2 might be an important mediator of the reactivation stimulus (Wood et 
al., 1992).
The possibility that IE proteins might affect gene expression very early in infection 
exists since Vmwl75 has been shown to be present in certain virus related particles 
known as L-particles (Szilagyi and Cunningham, 1991)
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1.3.6. Host factors
Reactivation of latent virus by co-cultivation or homogenisation of tissue from the 
mouse PNS is readily achieved unlike mouse CNS tissue in which it is very difficult or 
impossible (Deatly et al., 1988). In situ hybridisation experiments demonstrated that 
HSV-1 transcripts from the same region of the genome are present in both of these 
tissues when latently infected (Deatly et al., 1988) which suggests that the difference in 
reactivation cannot be attributed to a different transcription pattern between the two 
during latency. It may be that subtle differences in the structure or in modifications of 
the latent DNA occur between the CNS and PNS such that host differences become 
important determinants of reactivation in explanted material.
DMSO can induce the reactivation of the VmwllO deletion mutant dh3.1 (Leib et 
al., 1989b), can induce recurrent disease in latently infected mice (Harbour et al., 
1983) and increases the frequency of reactivation of HSV-1 from latently infected 
ganglia (Whitby et al., 1987). DMSO has effects on cellular processes (de la Torre, 
1983) so it is suggested that an alteration in the host mediated by DMSO leads to 
reactivation. The related compound HMBA also enhances the reactivation of latent 
HSV in explanted ganglia but not replication in tissue culture (Bernstein and Kappes, 
1988). It has however been shown to reverse the phenotype of ini 814 in tissue culture 
(McFarlane et al., 1992), due to increased IE mRNA accumulation. Since this effect 
was apparent in the presence of cycloheximide it must involve pre-existing cellular or 
viral components. It is interesting to speculate that stimulation of IE mRNA production 
has a part to play in the mechanism of reactivation from latency in vivo.
1.4. Interferon
1.4.1. Classification
Interferon was discovered in 1957 (Isaacs and Lindenmann, 1957) as a factor which 
is produced in virally infected cells and capable of converting other cells into a virus 
resistant state. It has subsequently been shown that it is not a single entity but a potent 
and multifunctional family of many members which can rightly be described as 
cytokines. These are small proteins which are able to influence gene expression and 
cell physiology. Cytokines are synthesised in response to a number of stimuli and, 
following secretion, interact with receptors on other cells to regulate cellular
55
Introduction
proliferation and differentiation. Those which are produced in and regulate the 
immune system form a subdivision known as lymphokines. Human IFNs have been 
grouped into two types and four antigenically distinct classes (Samuel, 1991; Sen and 
Lengyel, 1992). Type I IFNs include the members of the a , j8 and <*) classes and type 
II the 7 class. The a  interferons originate from leucocytes and the class is composed of 
at least 22 subtypes, each subtype having 70% of their 165 or 166 amino acids in 
common (Finter, 1991). There is only one member in each of the (3 and to (formerly 
designated as ot-2) IFN classes and these originate from fibroblasts. The fourth class, 7 
IFN, also has only one human member and is very different to all the other IFNs. 
Since it originates from lymphocytes it is more accurately described as a T cell 
lymphokine.
IFNs are host specific and have a wide range of modulatory effects including those 
on the immune system and on the proliferative activity of cells as well as on viral 
replication. They have a powerful part to play in the immediate response to invasion 
by viruses, being found in the blood and the tissues during the acute phase of infection.
The antiviral defence may be the main function of IFNs a  and (3 since they are 
induced by viruses and by naturally occuring as well as synthetic dsRNA (Field et al. , 
1970). RNA viruses are more potent inducers of IFN than DNA viruses. It has been 
suggested that dsRNA might be an intermediate product in viral replication boosting 
interferon production even further during infection of the host cell. Other biological 
stimuli which enhance IFN-a or -/3 biosynthesis include bacteria, mycoplasma, 
protozoa, certain cytokines and growth factors. IFN-y on the other hand is induced by 
antigenic stimulation of sensitised lymphocytes.
Human IFN-a, -(3 and -<*> genes form a cluster on the short arm of chromosome 9 
and all lack introns. Human IFN-a usually consists of a 166 aa primary protein 
following maturation in which a 23aa signal sequence is cleaved off the precursor 
protein. Unlike IFN-0 or -7 it is not glycosylated (Weissmann and Weber, 1986).
It is probable that all cell types are capable of IFN production although only when 
induced. Viral infection activates factors which bind to the virus responsive regions of 
the human IFN-/3 (Goodboum et al., 1985) and IFN-a promoters (Ryals et al., 1985). 
The former has regulatory elements known as PRDI, PRDII and NRDI sequences 
(Goodboum and Maniatis, 1988) whereas the latter has only PRDI-like elements in 
common (MacDonald et al., 1990). The exact sequence of the PRD confers specificity 
of induction to a particular virus or a transcriptional activator such as IRF-1 but the
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genes may require other activators which bind to the GAAATG sequence in the 
promoter (MacDonald et al., 1990). The earliest intermediates in IFN induction are 
IFN mRNAs (Wagner and Huang, 1965) which can be extracted from induced cells and 
translated in cell free systems (Reynolds et al., 1975). The synthesis of IFN is shut off 
after induction (Sehgal and Gupta, 1980) and translatable IFN mRNAs are rapidly and 
selectively degraded (Sehgal et al., 1978). Transcriptional and posttranscriptional 
controls regulate IFN production (Taylor and Grossberg, 1990).
1.4.2. Interferon induced proteins
IFNs secreted from producing cells bind to cell surface receptors (Aguet and 
Mogensen, 1983) and trigger multiple pathways of signal transduction which can be 
distinguished by their susceptibility to various inhibitors. IFN-a and -/3 bind to the 
same receptor (Aguet and Blanchard, 1981). The bound IFN is not internalised but 
eventually released from the receptor intact (Aguet, 1980). The rate of transcription of 
IFN activatable genes increases within minutes of the cells coming into contact with 
IFN (Friedman et al., 1984). It peaks within a few hours and some genes may 
continue to be transcribed at the same rate whereas others may decline even in the 
presence of IFN (Gupta et al., 1974; Friedman et al., 1984). The relative transcription 
rates depend on the concentration of IFN (Friedman and Stark, 1985). A consensus ex­
acting DNA sequence, the ISRE, conferring inducibility by IFNa//3 (Levy et al., 1986; 
1988) is present in all 5' flanking regions of IFNa/jS inducible genes examined to date. 
ISGF3 is required for the transcriptional activation of the ISRE-containing genes 
(Kessler et al., 1988) and is present in the cytoplasm as two inactive protein subunits 
Levy et al., 1989). The a  subunit of ISGF3 is activated following the interaction of 
IFN with the receptor at the cell surface. The mediator is unknown. The activated a 
subunit combines with the y  subunit to form active ISGF3 (Levy et al., 1989) which is 
translocated to the nucleus (Levy et al., 1989) and binds to the consensus DNA site 
(Dale etal., 1989).
There are at least 20 well characterised IFN inducible proteins (Staeheli, 1990) but 
many others occur at low abundance and it is likely that some have not yet been 
identified. Continued exposure to IFN may be required to ensure that the full repertoire 
of proteins is produced. Two IFN inducible proteins that may play a part in the 
antiviral activity of IFN have been extensively studied. The first, oligo 2 ',5 'adenylate 
synthetase becomes active in the presence of dsRNA (Zilberstein et al., 1978). It 
converts ATP to 2'-5'(A)n where n extends from 1 to about 15 (Dougherty et al., 
1980). This product activates latent RNase L which degrades mRNA (Baglioni et al.,
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1978). The second is a dsRNA activatable protein kinase (Zilberstein et al.f 1978). It 
phosphorylates the a  subunit of the peptide initiation factor eIF-2 (Zilberstein et al., 
1978) and as a result initiation of mRNA translation is inhibited (De Beneditti and 
Baglioni, 1984). Another well characterised IFN induced protein is the Mx protein 
(Staeheli et al., 1984; Staeheli and Haller, 1985). IFN-a induces class IMHC antigens 
which is not dependent on the presence of dsRNA (Fellous et al., 1982). It does not 
significantly induce class 2 antigens unlike IFN-7 which induces both of these classes 
(Collins et al. , 1984).
IFN induces the synthesis of other proteins but these are largely of unknown 
function (Staeheli, 1990).
1.4.3. Interferon and the antiviral state
The antiviral properties of IFN are well documented. Injected IFN is able to 
protect from some viral diseases (Stewart, 1979) and mice treated with antiserum to 
mouse IFNs are killed by amounts of virus several hundred fold less than controls 
(Gresser et al., 1976a; 1976b). Viral replication can be impaired at concentrations as 
low as 3 x 10“ 14M (Kawakita et al., 1978). The antiviral state is non-specific and a 
number of mechanisms may operate at various stages in the replication cycle of a virus 
including penetration, uncoating (a general term applied to all events that set the stage 
for the parental viral genome to express its functions), transcription, translation and 
assembly of progeny viruses. It seems likely that several steps are affected and that 
some viruses will be more susceptible at certain stages than others.
The dependence of oligo 2 ',5 'adenylate synthetase and the protein kinase on the 
presence of dsRNA has led many to postulate the existence of dsRNA intermediates in 
viral replication. The activation of these pathways could therefore lead to the 
destruction of viral mRNA or inhibition of its translation. It has been reported that 
oligo 2’,5'adenylate synthetase is induced in mouse trigeminal ganglia during the acute 
phase of infection with HSV together with interferon activity and that both activities 
disappear once latent infection is established (Sokawa et al., 1980). Another 
investigation (Lewis, 1988) in which clones of an IFN resistant murine cell line were 
infected with vesicular stomatitis, Mengo virus and reovirus, found that the effect of 
IFN on the oligo 2 ',5 'adenylate synthetase and eIF-2 kinase pathways did not correlate 
with their antiviral properties. In particular, one clone had greatly elevated levels of 
oligo 2',5 'adenylate synthetase but no antiviral state and another had an activated 
antiviral state but no elevation of oligo 2 ',5 'adenylate synthetase activity. Thus these
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two enzyme systems alone are not sufficient to explain the antiviral properties of IFN 
and other mechanisms are likely to contribute. This is also suggested by the finding 
that certain strains of HeLa cells constitutively express high levels of oligo 
2’,5 'adenylate synthetase but require IFN treatment to acquire the antiviral state (Meurs 
et al., 1981). It has been proposed that the in vivo levels of 2'5'(A)n can be 
determined by agents other than oligo 2 ',5 'adenylate synthetase. The present 
experimental evidence appears to show that functional oligo 2’,5 'adenylate synthetase is 
not an absolute requirement for the antiviral state to be established by IFN. On the 
other hand, a functional eIF-2 system does appear to correlate with the antiviral activity 
of some virus cell systems (Whitaker-Dowling and Youngner, 1986). The mechanisms 
dependent on dsRNA activated pathways may be more important for RNA viruses than 
DNA viruses and some viruses may be able to overcome some of the effects of 
interferon. This might be relevant to HSV infection during which inhibitors of RNase L 
are formed which would impair the effect of the oligo 2',5 'adenylate synthetase 
pathway (Cayley et al., 1984). This could also account for the relatively high doses of 
IFN required to inhibit the growth of herpes simplex compared with other viruses 
(Cayley et al. , 1984).
The Mx protein in the mouse which is induced by IFN-a and -/3 is able to establish 
the antiviral state against influenza virus (Staeheli et al., 1984). A human counterpart 
induced by IFN-a has been described (Staeheli and Haller, 1985).
The induction of MHC antigens (Heron et al., 1978) may contribute to the antiviral 
response by enhancing the lytic effect of cytotoxic T lymphocytes which is virus 
specific and histocompatability antigen restricted (Hood et al., 1983; Schwartz, 1985). 
The antigenic threshold might be breached by the IFN induction and since MHC 
antigens present viral antigens to T cells this would elicit an efficient T cell response 
and an important host defense mechanism to virus infection.
1.4.4. Interferon and herpes simplex virus replication
Studies using cultured fresh human monocytes (Linnavuori and Hovi, 1983) found 
that replication following infection with HSV was either aborted or highly restricted at 
a high moi of 1 pfu per cell but not at a low moi of 10“ ^ pfu per cell. IFN production 
was evident in those cells infected at the high moi but not in those infected at the low 
moi. Furthermore, the productively infected monocytes differentiated into 
macrophages, a process prohibited by infection at a high moi of HSV and also by 
exogenous IFN. Antisera to IFN-a/jS enhanced the rate of replication and production
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of HSV. These results suggest that IFN induced in monocytes by HSV prevents 
replication of the virus either directly or by inhibiting differentiation into macrophages 
or both. Extensive cell death was not evident at the higher moi from which it could be 
inferred that IFN reduced the cytopathic effect
Early studies of HSV-1 products in infected mouse L-cells had found that IFN 
inhibits HSV replication at an early stage in the viral life cycle. This was evident from 
the decreased levels of the early proteins, thymidine kinase and DNA polymerase, of 
the replicating virus (Panet and Falk, 1983). Later, the expression of early genes was 
shown to be inhibited suggesting that the inhibition occurred prior to or during early 
protein synthesis (Domke et al., 1985). These findings were confirmed in human 
macrophages and in addition reduced immunofluorescence of the IE protein, Vmwl75, 
was observed (Domke-Opitz et al., 1986). Reduced translation of IE proteins in IFN 
treated mouse macrophages has also been shown by other investigators although the 
synthesis of Vmwl75 mRNA was only moderately inhibited (Straub et al., 1986). 
These results indicated that IFN primarily acts at the translational level. Some studies 
have suggested different mechanisms to explain the effects of IFN. Munoz and 
Carrasco were unable to show any gross inhibition of viral protein synthesis by IFN but 
rather the production of defective virions (Munoz and Carrasco, 1984) while others 
found IFN blocked the late stages of morphogenesis with reduced or delayed synthesis 
of glycoproteins D and B (Chatteijee et al., 1985). In the latter experiments cloned 
IFN was used and at a dose of only 100 units per ml which might explain the different 
results to those of their predecessors. Pretreatment of cultured mouse splenic 
macrophages with murine IFN-c*/0 for 18 hours led to a stable inhibition of HSV-1 
replication for more than 50 hours (Mittnacht et al., 1988). There was no difference 
between IFN pretreated cultures and controls in the quantity of viral DNA present in 
nuclei shortly after infection indicating that there was no inhibition in the uptake of the 
virus or transport to the nucleus and no breakdown of the viral genome. The analysis 
of viral DNA, RNA and protein synthesis in these cultures identified the expression of 
the IE genes as the major target of IFN mediated inhibition. Immunofluorescence 
studies using a monoclonal antibody specific for Vmwl75 showed a marked decrease in 
the nuclear fluorescence of the viral antigen indicative of an inhibition early in the 
replicative cycle, and the analysis of nuclear run off transcripts demonstrated a 
significant decrease in IE transcription rates following the pretreatment (Mittnacht et 
al., 1988). Using probes specific for the Vmwl75 gene and examining the transcripts 
on Northern blots the inhibition appeared to be to the onset of transcription. It was 
suggested that this inhibition per se is responsible for the depression of early gene 
expression which had been observed previously (Domke et al., 1985). In contrast, the
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cellular actin gene and overall transcriptional activity was comparable in controls and 
pretreated cultures at all times (Mittnacht et al., 1988). A similar finding with another 
DNA virus, SV40, has also been reported where the block mediated by IFN was 
specific for the onset of but not ongoing transcription (Brennan and Stark, 1983). 
Possible explanations as to how IFN might achieve this effect on IE genes include 
blocked uncoating of the viral genome rendering it inaccessible to transcription, direct 
inhibition of the IEC or a direct negative effect on IE gene transcription by an IFN 
induced cellular activity. In an attempt to narrow down these possibilities the effect of 
IFN-o: pretreatment on HSV-1 infection of human HEp-2 cells was investigated 
(Oberman and Panet, 1989). They were able to confirm the earlier findings and 
hypothesised that an uncoated viral genome would be more sensitive to DNase 
digestion than the input DNA. This hypothesis is based on the supposition that the 
parental viral nucleoprotein undergoes a structural change at the initiation of 
transcription and that this change is reflected in an increased sensitivity to digestion by 
pancreatic DNase I. They found that virion DNA in the absence of nuclei was 
completely resistant to DNase I but at 1 hour post infection had become extremely 
sensitive. This was interpreted as evidence that the genome had become uncoated. 
Since IFN had no effect on this sensitivity they argue that its mode of action is not 
related to the uncoating of the viral genome but is primarily at the initiation of IE gene 
transcription. This limits the site of IFN action even further. Outstanding possibilities 
which remain include the involvement of cellular anti-HSV factors induced in IFN 
treated cells to reduce IE gene mRNA production or the effect of IFN on Vmw65 
which has a particular role in transactivating IE genes. A role at this point in the viral 
replication cycle would satisfactorily explain why pretreatment with IFN is required for 
it to be effective and why a higher moi is able to overcome it.
The specific effect of IFN on the transactivation event has been explored further 
(De Stasio and Taylor, 1990). Both human recombinant IFN-a and IFN-7 were shown 
to inhibit viral replication at an early stage in human cell lines as evident by reduced IE 
mRNA accumulation (De Stasio and Taylor, 1990). Northern blotting demonstrated 
that the inhibition involved IE genes and when the IE response element was linked to a 
reporter gene as for example in pi 10CAT, IFN inhibited the transactivation. The 
transcription of an unrelated gene in the presence of Vmw65 was unaffected by IFN 
treatment. There was no abnormal degradation of mRNA by IFN treatment. The site 
of IFN action thus has been narrowed down to a direct effect either on the 
transactivator Vmw65 or on the IEC, the interaction of the transactivator with the IEC 
or a modification of the IEC following its assembly. The effect of IFN-a treatment on 
the level of Oct-1 activity in a transformed human B lymphoblastoid cell line (Daudi
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cells) has also been investigated (Dent et al., 1991). Oct-1 is a ubiquitous DNA- 
binding protein which plays an essential part in gene expression (Affolter et al., 1990). 
IFN-a treatment reduced the levels of this protein and specifically inhibited gene 
expression from octamer containing promoters. Mobility shift assays demonstrated that 
treatment for 48 hours but not 24 hours decreased the level of die Oct-1 protein-DNA 
complex. The authors argue that down-regulation of Oct-1 may be responsible for the 
failure of IE transcription following IFN-a treatment with the consequent abortion of 
the viral lytic cycle.
It has not yet been possible to distinguish experimentally between the various 
hypotheses for the effect of IFN on the early events in the viral life cycle.
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2. MATERIALS
2.1. Virus stocks
The HSV-1 viruses used were all derived from the parent HSV-1 strain 17 (Brown et 
al., 1973) and supplied by C.M. Preston. The mutant ml814 has a 12bp insertion in 
the gene encoding Vmw65 (Ace et a l , 1989) and 1814R is the rescued revertant (Ace 
et al., 1989). The mutant ini 820, constructed by C.M. Preston, is derived from 
m l814 with the VmwllO promoter replaced by the MoMuLV enhancer. The mutant 
ml 863 has the E. coli lacZgene under the control of the CMV enhancer inserted in the 
TK gene of 1814R and ml 883 is derived from the same insertion in the TK gene of 
ml 820. The mutant ml 835 has the E.coli lacZ gene under the SV40 promoter 
replacing the LAT promoter in m l814. Insertion of the E.coli lacZ gene under the 
control of the VmwllO promoter into the TK gene of m l820 yielded the mutant 
ml 884. The mutant dR403 has a 2kb deletion within both the T R l and IR l copies of 
the gene encoding VmwllO (Stow and Stow, 1986) and tsK has a temperature- 
sensitive mutation in the Vmwl75 gene in which a single C:G bp in the wt gene is 
replaced by T:A in the mutant gene (Davison etal., 1984).
2.2. Tissue culture cells
Two cell types were used. BHK-21 clone 13 (BHK) cells were as described by earlier 
investigators (MacPherson and Stoker, 1962) and HFL cells were Flow 2002 cells, 
provided by Flow laboratories.
2.3. Tissue culture media
EF10 Eagles BHK 21 Glasgow MEM without L-glutamine, tryptose
phosphate broth and sodium bicarbonate (Gibco BRL) 
supplemented with 0.25% NaHCC>3, 100 iu/ml penicillin, 100
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ETC10
EHu2
EHu5
Trypsin
Versene
2.4. Solutions
alkaline transfer 
solution
neutralising
solution
PBSA
PBSB
PBSC
PBS
20 x SSC
f i g / ml streptomycin, 4mM L-glutamine and 10% foetal calf 
serum (Gibco BRL).
Eagles BHK 21 Glasgow MEM without L-glutamine, tryptose 
phosphate broth and sodium bicarbonate (Gibco BRL) 
supplemented with 0.25% NaHCC>3, 100 iu/ml penicillin, 100 
f i g / ml streptomycin, 4mM L-glutamine, 10% newborn calf 
serum (Gibco BRL) and 10% tryptose phosphate broth.
EF10 with 2% human serum instead of 10% foetal calf serum
EF10 with 5% human serum instead of 10% foetal calf serum
0.25% (w/v) trypsin (Difco) in Tris-saline
0.6M EDTA in PBSA containing 0.0015% (w/v) phenol red
0.4M NaOH, 0.6M NaCl 
0.5M Tris HC1 pH 7.0, 1M NaCl
170mM NaCl, 3.4mM KC1, ImM Na2HPC>4, 2mM KH2P 04 
and buffered to pH 7.2
6.8mM CaCl2
4.9mM MgCl2
8 parts PBSA : 1 part PBSB : 1 part PBSC 
3M NaCl, 0.3M sodium citrate. Filtered.
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20 x SSPE 3.6M NaCl, 0.2M Na2HP0 4-NaH2P0 4 buffer pH 7.4, 20mM 
EDTA
TBS 140mM NaCl, lOmM KC1, lOmM Tris HC1 and ImM MgCl2 
pH 7.0
Sucrose solutions all sucrose solutions were treated with 250/lcI of DEP to destroy 
endogenous nucleases and then autoclaved to inactivate the
2.5. Reagents
The reagents used were of the highest purity and obtained from the following suppliers:
BDH Chemicals, Beecham Research Laboratories, Bethesda Research Laboratories, 
Bio-Rad Laboratories, Fluka, Kochlight Limited, May and Baker, Melford 
Laboratories, Merck, Sharp and Dohme International, Pharmacia Chemicals and Sigma 
Chemical Company Limited.
2.6. Radiochemicals
These were all supplied by Amersham International pic. Specific Activities were 40 - 
60 Ci/mmol for [methyl-^HJthymidine and 3000 Ci/mmol for [a-32p]dNTPs.
DEP.
2.7. Commonly used buffers
L buffer 0 .1M EDTA pH8.0, lOmM Tris HC1 pH 7.6 and 20mM NaCl
lysis buffer lOmM Tris HC1 pH 7.5, 2mM MgCl2, lOmM NaCl and 0.5% 
Nonidet P40
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TE lOmM Tris HC1, ImM EDTA pH 7.5
Materials
TNE lOmM Tris HC1 pH 7.5, ImM EDTA pH 7.5 and lOmM NaCl
2.8. Electrophoresis buffers
EEB 5mM sodium acetate, ImM EDTA, 40mM Tris HC1 pH 7.8
TBE 90mM Tris, ImM EDTA, 90mM boric acid pH 8.3
5 x TBE loading A few grains of bromophenol blue powder added to a 1:2
buffer dilution of 10 x TBE in glycerol
2.9. Hybridisation mixtures
50 x Denhardt's 
solution
1 % (w/v) ficoll, 1 % (w/v) BSA fraction V, 1 % (w/v) 
polyvinylpyrollidone
DNA/RNA
prehybridisation
mixture
50% formamide (deionised using 'Amberlite' MB-1 monobed 
mixed resin immediately before use), 5 x SSPE, 5 x 
Denhardt's solution, 100^ig/ml of sonicated and denatured calf 
thymus DNA. pH adjusted to 7.5 with 1M HC1 as measured 
by indicator paper
DNA/RNA
hybridisation
mixture
50% deionised formamide, 5 x SSPE, 1 x Denhardt's solution, 
lOO i^g/ml of sonicated and denatured calf thymus DNA. pH 
adjusted to 7.5 with 1M HC1 as measured by indicator paper
DNA/DNA
hybridisation
mixture
7% SDS, 0.5M Na2HP0 4/NaH2P0 4 buffer pH 7.4
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2.10. Reaction mixtures
histochemical 
reaction mixture 
(stain) for /3- 
galactosidase 
activity
1 mg/ml 5-Br-4-Cl-3-indolyl-/3-D-galactopyranoside (X-gal), 
5mM potassium ferricyanide, 5mm potassium ferrocyanide, 
2mM MgCl2 and 0.02% Nonidet P40. The X-gal was 
dissolved in dimethylsulphoxide (DMSO) at 40mg/ml and then 
diluted into the reaction mixture
micrococcal 
nuclease reaction 
mixture
0.25M DEP treated sucrose, O.lmM PMSF, 20mM PIPES pH
7.0, ImM MgCl2, ImM CaCl2, 10mM NaCl and 5mM 2- 
mercaptoethanol added immediately before use. The PMSF 
was made as a fresh 50mM stock solution in methanol and 
diluted to 0.5mM in distilled water immediately prior to use
oligolabelling 
reaction mixture
250mM Tris HC1 and 25mM MgCl2 buffered to pH 8.0, 
50mM (3-mercaptoethanol, 1M HEPES pH 6.6 and 27 OD 
units/ml of a random mixture of hexamer oligonucleotides
proteinase K 
reaction mixture
20mM Tris HC1 pH 7.5, 2.5mM EDTA pH 7.5, 0.5% SDS 
and proteinase K at either 100/xg/ml or 250/xg/ml
TK reaction 
mixture
50mM Na2HP04/NaH2P04 buffer pH 6.0, lOmM MgCl2, 
5mM ATP, lOOj-iM dl'TP and 10/iCi [methyl-^H]thymidine
2.11. Enzymes
Klenow fragment DNA polymerase and proteinase K were supplied by Boehringer 
Mannheim GmbH and micrococcal nuclease by Pharmacia LKB Biotechnology. 
Restriction enzymes were supplied by Boehringer Mannheim GmbH or New England 
Biolabs, Inc.
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2.12. Other materials
Bradford reagent 0.01% coomassie brilliant blue G, 0.0003% w/v SDS, 4.75% 
v/v ethanol and 8.5% w/v phosphoric acid.
BSA
IFN-a
provided by C.M. Preston
Human Lymphoblastoid Interferon; Hu IFN-a-Ly supplied by 
Sigma Chemical Company, Ltd. Dissolved at 10^ iu/ml in 
sterile water and stored in aliquots at — 70°C. One unit of 
IFN-a protects 50% of indicator cells from viral 
cytopathology.
Carmalum stain
(Kirkpatrick's
modification)
This was provided by the pathology department at the Institute 
of Neurological Sciences, Glasgow where it was made 
according to the following recipe: 25g carmine was added to 
25ml glacial acetic acid and 600ml distilled water. After 
standing for 20min, the mixture was boiled for lh, and 25g 
aluminium potassium sulphate added after cooling. 400ml of 
distilled water was added and the mixture reboiled, cooled and 
filtered. One crystal of thymol was added. Stored at 4°C
Giemsa 1.5% (v/v) suspension of Giemsa stain in glycerol obtained 
from BDH Laboratory supplies heated to 56° C for 2h and 
diluted with an equal volume of methanol.
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3. METHODS
3.1. Cell culture
HFL cells were grown in EF10 in 175cm2 plastic culture flasks at 37°C in an 
atmosphere of 5% CO2 and 95% air. The monolayers were harvested by washing once 
with 10ml of versene, once with a 10ml 1:1 mix of versene: trypsin and suspension in 
10ml of fresh EF10. The homogeneous cell suspension was used to seed subsequent 
monolayers. For further passage, the cell suspension was subcultured at 1:5 dilution 
into flasks each containing 50ml of EF10. To seed monolayers on tissue culture plates, 
10ml of the cell suspension was diluted to 50ml in EF10 and 2ml, 5ml or 15ml pipetted 
onto 35mm, 50mm or 90mm diameter tissue culture plates respectively and incubated 
at 37 °C in an atmosphere of 5% CO2 and 95% air. Monolayers were usually 
confluent within 24h.
A confluent monolayer of HFL cells in a 175cm^ flask has about 1.5 x 10^ cells 
and on a 35mm, 50mm or 90mm diameter plastic tissue culture dish approximately 
106, 2 x 10^ and 7 x 10^ cells respectively.
3.2. Preparation of a herpes simplex virus stock
BHK cells from a seed stock of 10^ cells per ml were grown in 850cm^ plastic 
roller bottles. Each of four bottles received 8 x 10^ cells in 150ml of ETC10 and were 
incubated at 37°C overnight until at least 50% confluent. The medium was replaced 
with 50ml ETC10 containing approximately 2 x 10^ pfu of ini 820 seed stock and 
incubation was continued for a further 3 days at 31 °C when extensive cpe was 
apparent. The bottles were shaken to disperse the cells and the combined medium 
centrifuged at 2500rpm for 10 minutes in a GSA rotor in a Sorvall RC5B centrifuge. 
This procedure separated the virus preparation into cell released virus in the supernatant 
and virus still associated with the cells in the pellet. The supernatant was centrifuged at 
12000rpm in a GSA rotor for 2h at 4°C and the pellet resuspended in 10ml of the 
supernatant. The viral stock was dispensed into small aliquots and stored at -70° C. 
Only cell released virus was used.
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3.3. Titration of a herpes simplex virus stock
Methods
The virus stocks were titrated on confluent monolayers of both BHK and HFL cells 
grown on 35mm diameter tissue culture dishes. Serial 10-fold dilutions were made in 
ETC 10 for titration on BHK cells and in EF10 for titration on HFL cells. Monolayers 
in triplicate from which the medium had been withdrawn were inoculated with 200/d of 
each dilution. Following [ absorption at 37°C for lh, the infected monolayer was 
overlaid with EHu2 in the case of BHK cells and EHu5 in the case of HFL cells and 
incubation continued for 3 days. The medium was removed and the monolayer stained 
with Giemsa at room temperature for 20 minutes. The tissue culture dishes were rinsed 
under running water and the plaques counted using a microscope. The number of pfu 
per ml was determined.
3.4. The in vitro latent system
The system described below is a modification of that described by earlier 
investigators (Russell and Preston, 1986; Harris and Preston, 1991).
Typically, confluent HFL monolayers grown on 35mm, 50mm or 90mm diameter 
tissue culture plates were treated with IFN-a at 10^ units per ml in 2ml, 5ml and 15ml 
of EF10 respectively. Treatment was continued at 37°C for 18h and then the medium 
aspirated with a Pasteur pipette and the monolayer washed with fresh EF10 to remove 
all residual IFN-a. The cells were inoculated with virus usually at 120 particles per 
cell in a volume of 200/xl, 400/d or 1.2ml according to the size of the plate. The 
monolayers were incubated for lh at 37°C with rocking at 20 minute intervals to allow 
the virus to adsorb to and penetrate the cells. For the determination of plaque 
numbers, EHu5 was added to make up to the requisite volume and incubation at 37°C 
continued for 72h, medium was poured off, the plates stained with Giemsa for 20min 
and gently washed under running water. Plaques were counted under a dissecting 
microscope. For the analysis of DNA, EF10 containing ara-C at 50/xg/ml was added to 
make up to the requisite volume and incubation continued at 37 °C for 72h. Ara-C is 
included in the medium to prevent "non-latent" virus from replicating. It is an
analogue of deoxyribonucleotides and as ara-CTP acts as a competitive inhibitor of 
dCTP in the DNA polymerase reaction or as an incorporated analogue
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HFL cell monolayer
Pretreatment with IFN-a at 10^ units/ml for 18h
Aspiration of the medium 
Monolayer washed once with EF10 
Inoculation with virus at 120 particles per cell 
lh  adsorption at 37°
Addition of EHu5 (plaque counts) or EF10 with ara-C at 50jng/ml (DNA analysis) 
Incubation continued for up to 72h at 37 °C
Plaque Count DNA Analysis
Stain with Giemsa Effect of Superinfection Latent
Absorb lh, add EF10 with ara-C 
Incubate for desired period at 37 °(
Remove medium before 72h 
Apply superinfecting inoculum
Harvest at 72h
FIGURE 3.1: FLOW DIAGRAM OF PROCEDURE FOR THE IN  VITRO HSV-1
LATENCY MODEL
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into DNA impedes its synthesis (Cozzarelli, 1977). From the known p:pfu ratio of 1.4 
x 105 to 10^ and infecting at 120 particles per cell between 0.012% and 0.086% of the 
genomes will be potentially productive. This will not affect the molecular studies but if 
the virus were allowed to replicate and spread it would create a significant background 
problem. The cells were harvested. If the monolayer was to be superinfected, the 
incubation period was appropriately curtailed to permit the removal of the medium, 
application of the superinfecting inoculum,!absorption for lh  and then the incubation 
continued at 37°C in the presence of EF10 containing ara-C at 50/xg/ml. At 72h total 
incubation time the cells were harvested. The model system is shown as a flow 
diagram in figure 3.1.
3.5. Preparation of nucleic acids
3.5.1. Preparation of nuclear DNA
The monolayers were harvested at 72h by pouring off the medium carefully and 
washing once by addition and removal of ice cold PBS. For a 50mm diameter plate, 
lml of fresh ice cold PBS was added and the cells scraped into this using a silicone 
rubber policeman. The resulting cell suspension was transferred to a 1.5ml reaction 
vial using a Pasteur pipette and the cells collected by centrifugation at 6500rpm for 30s 
in a benchtop microfuge. The supernatant was discarded and the cell pellet 
resuspended in lml of ice cold lysis buffer. This was incubated at 4°C for 5min with 
intermittent mixing on a vortex mixer. The nuclei were pelleted by centrifugation at 
13000rpm for 2min in a benchtop microfuge and the supernatant discarded. The pellet 
was mixed on a vortex mixer and resuspended in 0.5ml of proteinase K reaction 
mixture containing 250/ng/ml proteinase K. Incubation was continued for 18h at 37°C. 
Sodium acetate, pH 7.0, was added to 0.3M and the nucleic acids purified by one 
extraction with phenol/chloroform (1:1 v/v) and one extraction with chloroform. The 
DNA was precipitated by addition of lml of ice cold ethanol. The mixture was 
inverted, centrifuged in a benchtop microfuge at 13000rpm for 2min and the pellet 
washed in 70% ethanol to remove any excess salt. Finally, it was allowed to dry 
overnight in air at room temperature and stored at —20°C.
When cells were harvested from 90mm diameter plates, the nuclear pellet was 
resuspended in 10ml of proteinase K reaction mixture in a 50ml polypropylene conical 
tube. The volumes used for purification were adjusted accordingly and the DNA
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precipitated by the addition of two volumes of ice cold ethanol. It was then collected by 
centrifugation at 2500rpm for 20min in a benchtop microfuge at 25 °C.
3.5.2. Preparation of cytoplasmic RNA
Monolayers of HFL cells were grown on 50mm diameter plates and variously 
treated with IFN-a and infected as described for the in vitro latency model above. The 
medium was poured off and the cells washed with ice cold PBS. lml of fresh ice cold 
PBS was added and the cells scraped into this using a silicone rubber policeman. The 
suspension was transferred into a 1.5ml reaction vial using a Pasteur pipette and 
centrifuged at 6500rpm in a benchtop microfuge for 30s. The supernatant was drawn 
off and the remaining pellet resuspended in 67/d of cold lOmM Tris HC1 pH 7.0 and 
ImM EDTA. Following the addition of 7.5/d of 5% Nonidet P40, the suspension was 
mixed on a vortex mixer and incubated on ice for 5min. A further 7.5/d of 5% 
Nonidet P40 was added, the sample mixed again and centrifuged at 6500rpm in a 
benchtop microfuge for 2min. The supernatant which contains cytoplasmic RNA was 
taken up as a 50/d aliquot into a 1.5ml sterile reaction vial containing 45/d of 20 x SSC 
and 30/d of formaldehyde. The solution was mixed and incubated, after clamping the 
vial in a metal holder, for 15min at 60°C and then stored at — 70°C. A 2.5/d aliquot, 
diluted to 250/d in sterile water, was taken for quantification.
3.6. Preparation of nuclear matrices
Nuclei, prepared by lysing cells from monolayers as described previously in section 
3.5.1 but washed and collected in TBS, were resuspended in lml of ice cold 10% DEP 
treated sucrose containing lOmM Tris HC1 pH 7.5 and centrifuged at 6500rpm for 
4min and the supernatant discarded. This procedure effectively removed the detergent 
NP40 and prohibited excessive clumping of the nuclei. The pellet was resuspended in 
300/ri of lOmM NaCl/25mM Tris HC1 pH 8.0 and mixed on a vortex mixer. It was 
mixed again following the addition of 3/d of 10% Triton X-100. Following the 
addition of 300/ri of 4M NaCl, the sample was kept on ice for 5min with intermittent 
gentle mixing by inversion. The sample, now viscous, was taken up in a Pasteur 
pipette and layered onto a 100/ri 40%w/v sucrose/25mM Tris HC1 pH 8.0 cushion in a 
1.5 ml reaction vial. The vial was inserted into an adapter and centrifuged in an SS34 
rotor at 18000rpm for 20min at 4°C. The nucleoids, which appeared as a greyish 
aggregate at the interface with the cushion, were removed in a volume of 100/ri by
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being drawn up into a pipette tip. The salt was eliminated by a repeat of this procedure 
after the nucleoids had been resuspended in lml of ice cold 25mM Tris HC1 pH 8. 
Matrix preparation was based on a previously published method (Cook et al., 1982).
3.7. Preparation of nucleosomal DNA '
Cells were harvested and lysed as described in section 3.5.1. The nuclei were 
resuspended in lml of ice cold 10% w/v sucrose, lOmM Tris HC1 pH7.5 and 2mM 
MgCl2 and centrifuged for 4min at 6500rpm in a benchtop microfuge. The supernatant 
was discarded and micrococcal nuclease reaction mixture added to the pellet. The 
nuclei were dispersed in the reaction mixture using a vortex mixer and kept on ice. At
Omin micrococcal nuclease was added and incubation at 37 °C commenced for the
predetermined time interval. The volume of reaction mixture was adjusted so that 
when the enzyme was added the total volume was 150/xl. The reaction was stopped by 
placing the sample on ice and adding EDTA to 12mM. The sample was made up to 
5QQfil by the addition of proteinase K reaction mixture with a final concentration of 
proteinase K at lOOjag/ml and incubated at 37 °C for 3h. DNA was extracted from the 
sample as described in section 3.5.1.
3.8. Preparation of latent viral genomes
HFL cells were grown on 90mm diameter tissue culture plates and treated in 
accordance with the in vitro latency model described in section 3.4. The cells were 
washed with 15ml PBS and collected in lml of PBS into a 1.5ml reaction vial. They
were pelleted by centrifugation at 6500rpm for 30s in a benchtop microfuge and the
supernatant discarded. The pellet was resuspended in ice cold L buffer to a 
concentration of 5 x 10^ cells per ml and warmed to 42°C. 1% low melting point 
agarose cooled to 42°C was mixed in an equal volume with the cells and quickly 
pipetted into the moulds of a block former. When set, the blocks were expelled into 
50ml polypropylene conical tubes containing 50 volumes of L buffer with 1 % SDS and 
proteinase K at lmg/ml. The blocks were incubated at 50°C for 2 days. At the end of 
the incubation period the blocks were washed three times in lOmM EDTA pH 8.0 and 
stored in 50 volumes of the same at 4°C. For digestion with Ase I the blocks were 
washed 10 times in lOmM EDTA to remove all traces of proteinase K, equilibrated in 
600/xl of restriction enzyme buffer for 15min and incubated with 200 units of enzyme
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for 4h at 37°C. Prior to electrophoresis all blocks were soaked twice for 30min in 50 
volumes of TE buffer.
3.9. Purification and characterisation of nucleic acids
3.9.1. Restriction enzyme digestion
DNA recovered from a 50mm diameter tissue culture plate was routinely digested 
in a volume of 100/ri of reaction mixture containing the appropriate buffer for the 
restriction enzyme as specified by the manufacturer. The material obtained from a 
90mm diameter plate was digested in a volume of 500/ri. The digestion was usually 
carried out overnight at 37°C. When complete and if not used immediately the digest 
was stored at — 20°C.
3.9.2. Phenol/chloroform extraction of DNA
To separate DNA from protein, the nucleic acid was extracted from samples by the 
addition of sodium acetate, pH 7.0, to 0.3M followed by an equal volume of a 1:1 
distilled phenol:chloroform mixture, mixed on a vortex mixer and centrifuged. 
Samples in a 1.5ml reaction vial were centrifuged in a benchtop microfuge at 
13000rpm for 2min whereas those in 50ml polypropylene conical tubes were 
centrifuged in a Beckman GPR centrifuge at 2000rpm for 20min. The aqueous phase 
was taken and extracted with an equal volume of chloroform to remove any residual 
phenol. The DNA in aqueous solution was precipitated by the addition of 2 - 3 
volumes of ice cold ethanol, agitated by hand and centrifuged at 13000rpm for 2min in 
a benchtop microfuge or at 2500rpm for 20min in a Beckman GPR centrifuge. The 
pellet was washed once with 70% ethanol to remove the excess salt and dried in air at 
room temperature. Subsequently, the pellet was either dissolved in distilled water 
containing 10/xg of ribonuclease A for 3h at room temperature and then stored at —20° 
C or subjected to a restriction enzyme digest as required.
3.9.3. Ultracentrifugation of DNA in a caesium chloride gradient
Separation of HSV DNA from cellular DNA in preparations of latently infected 
cells was achieved by ultracentrifugation of the preparation through a caesium chloride 
gradient of RI 1.4 at 25°C. The principle of this separation is the exploitation of the 
high G + C content of the viral DNA relative to the host cell genome. Latently
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infected cellular DNA derived from 90mm diameter plates was digested to completion 
with Bam HI in a reaction volume of 500/ri and mixed with a working solution of CsCl 
(1.465g/ml) to a volume of 5ml and a final RI of 1.4. adjusted by either the addition of 
water or CsCl solid. The mixture was transferred to a TV865B centrifuge tube, 
balanced with stock CsCl of RI 1.4 and the remaining space in the neck of the tube 
filled with liquid paraffin. The neck was sealed with a stopper, capped and crimped 
with a crimper. The samples were centrifuged in a TV865B vertical rotor at 40000rpm 
for 18h at 15°C in a Sorvall OTD50B ultracentrifuge. The gradient was collected in 
fractions of 10 drops into wells in a 24 well plate by piercing the bottom of the 
clamped tube with a 21 gauge needle. The RI of each fraction was determined and 
those between 1.4010 and 1.4030 were pooled. The pooled fractions were placed into 
dialysis membrane tubing (prepared by boiling in 5mM EDTA for 5min) and dialysed 
against TNE for 3h at 4°C. The buffer was changed once and the dialysis continued 
overnight. The volume of the sample was reduced to approximately lml by emptying 
the contents of the tubing into a 15ml conical tube, adding 2 volumes of butan-2-ol and 
centrifuging for 4min at 2000rpm. The upper phase was discarded and the residual 
butan-2-ol evaporated by incubating the open tube for 3h at 55 °C. The final material, 
in aliquots of 0.5ml, was transferred to 1.5ml reaction vials and the DNA precipitated 
by the addition of sodium acetate, pH 7.0, to 0.3M and 2 volumes of ice cold ethanol. 
After standing at — 20° C for 1 - 2h the sample was centrifuged at 13000rpm for 2min 
in a benchtop microfuge and the pellet washed in 70% ethanol and air dried at room 
temperature overnight. The dried pellet was dissolved in 40/ri of distilled water 
containing 1/ig of ribonuclease, left for 3h at room temperature and stored at —20°C.
3.9.4. Electroelution of DNA fragments
The requisite DNA was run in a 0.6% agarose minigel and the appropriate fragment 
excised when visualised under long wave UV light. It was eluted onto dialysis 
membrane (previously boiled in 5mM EDTA for 5min) in EEB using an electroelution 
chamber at 20mA per sample at 4°C for 1.5h. The volume of EEB in the well was 
reduced to 200/ri and the DNA was removed from the dialysis membrane by vigorous 
pipetting. The volume of the sample was made up to 400/d with distilled water and 
sodium acetate, pH 7.0, to 0.3M. The DNA was extracted with 400/ri of 1:1 v/v 
phenol: chloroform, 400/ri of chloroform and precipitated in 0.5ml of propan-2-ol. 
After standing at room temperature for 1 - 2h the DNA fragment was collected by 
centrifugation in a bench top microfuge for lOmin at 13000rpm. The pellet was 
washed in 0.5ml of 100% ethanol, dried and dissolved in 15/d deionised water. This 
stock solution was diluted 10-fold prior to use.
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3.9.5. Quantification of nucleic acids
Methods
The relative intensities of DNA bands for comparative purposes were measured by 
storage phosphor technology. Membranes to which radiolabelled DNA had been 
hybridised and prepared for autoradiography as described in section 3.13, were 
wrapped in clingfilm and exposed to a storage phosphor screen overnight. The screen 
was transferred to a Molecular Dynamics 400B Phosphorlmager™, scanned and the 
created image analysed using Molecular Dynamics ImageQuant software.
RNA was quantified by measuring the OD at 260nm in a Beckman Du-62 
spectrophotometer. Estimation was based on 1 mg/ml of RNA giving 25 OD units at 
260nm. DNA was quantified by measuring the OD of ini 820 DNA at 260nm.
3.10. Separation of DNA by gel electrophoresis
3.10.1. Minigels
Small amounts of DNA were analysed by electrophoresis in 50ml of either 0.6% or 
0.8% agarose in 1 x TBE and cast in a 100mm x 70mm x 7mm minigel kit. Loading 
buffer was added to the sample and 10/xl loaded into the well. Electrophoresis in 1 x 
TBE was conducted at 40mA. At 45min, ethidium bromide was added to the buffer at 
2/xg/ml to stain the gel. At lh the gel was visualised under UV illumination and 
photographed on Polaroid 667 film.
3.10.2. Large agarose gels
Horizontal slab gels were used for Southern transfer of DNA. Agarose, 0 .6 -1 % , 
in 300ml of 1 x TBE containing 0.5/xg/ml ethidium bromide was cast on the sand 
blasted face of a 260mm x 160mm x 7.5mm glass plate. Samples were loaded in 1 x 
loading buffer and the wells topped up with 1 x TBE. The tank was filled with 1 x 
TBE containing 0.5/xg of ethidium bromide to be level with but not over the surface of 
the gel. Electrophoresis was conducted at 8 - 18mA for 16 - 20h. The gel was 
visualised under UV illumination and photographed on Polaroid 667 film.
For the analysis of nucleosomal DNA, gels were cast as 2% agarose in a 3:1 ratio 
of 1.5% agarose and 0.5% NuSeive® GTG agarose. Otherwise the conditions were as 
above.
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Separation of high molecular weight latent DNA was performed in a Rotaphor® 
Type V electrophoresis chamber. Gels of between 0.7% and 1% agarose in 300ml of 
0.25 - 1 x TBE containing 0.5/ig of ethidium bromide were cast in the frame. Agarose 
blocks containing embedded DNA, prepared as described in section 3.8, were inserted 
into the wells and the ramp along the well line trimmed to lie flush with the surface of 
the gel. The electrophoresis was conducted in 0.25 x TBE under various permutations 
of temperature, switching interval, angle and voltage for up to 72h.
3.11. Hexanucleotide (random) primer extension
A modified method of random primer extension described by Feinberg and 
Vogelstein (1983) was used. Approximately lOng of DNA was made up to 21/ri in 
distilled water, heated in a dri-block at 100°C for lOmin, cooled on ice for 5min and 
centrifuged at 6500rpm in a benchtop microfuge for 20s. To this was added 2/d of
0.1% BSA, 10fil of oligolabelling reaction mixture, 2.5/ri each of 0.4mM dATP and 
dCTP, 5/il (50/iCi) each of [a-32P]-dGTP and [a-32P]-dTTP and 2/d (4 units) of 
labelling grade Klenow fragment DNA polymerase. Incubation was continued 
overnight at room temperature. The radiolabelled DNA fragment was purified by 
passage through a Sephadex® G-50 Medium column.
3.11.1. Determination of percentage incorporation
A 0.5/ri volume of the oligolabelling mixture was diluted to 10/ri in water and 3/d 
spotted onto Whatman No. 1 filter paper discs in duplicate. The discs were allowed to 
dry and one washed once in 10% w/v TCA, once in 5% w/v TCA and twice in 
ethanol. It was dried under a heat lamp. Both discs were placed in scintillation vials 
containing 10ml Ecoscint A and the radioactivity determined in a scintillation counter. 
Incorporation was measured as the percentage of radioactivity on the washed disc 
compared with the unwashed disc. At least 30% incorporation was found to be 
required for a successful outcome to hybridisation.
3.11.2. Purification of radiolabelled DNA fragments
A 10ml column was prepared from lg of Sephadex® G-50 Medium swollen in 
30ml distilled water for at least 3h. The oligolabeling reaction mixture containing the 
DNA fragment was mixed with 50/d of 1:1 phenol: chloroform and the aqueous phase
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applied to the column. The eluate was collected as fractions of 5 drops in 1.5ml 
reaction vials and those harbouring the peak of radioactivity pooled as a total volume of 
1.5ml. The sample was denatured by the addition of 33fi\ of 6M NaOH for lOmin at 
room temperature.
3.12. Southern transfer and hybridisation
3.12.1. Transfer of DNA from agarose gels to a membrane
The technique used is a modification of that described by Southern (1975). 
Following electrophoresis in agarose gels the DNA was transferred to GeneScreenP/us 
hybridisation membrane (Du Pont) by alkaline transfer as described by Chomczynski 
and Qasba (1984). After cutting off the wells and trimming, the gel was soaked in 
alkaline transfer solution for 30min. It was inverted and laid on two sheets of 
moistened Whatman 3MM paper, which acted as a wick by being placed at right angles 
to each other on a glass plate and supported in a tray. The GeneScreenPlus 
hybridisation membrane was cut to the size of the gel, immersed in transfer solution 
and laid on top of the gel. Any air bubbles between the gel and the membrane were 
expelled by rolling with a glass tube. Capillary transfer was achieved by sequentially 
layering two wet and four dry sheets of Whatman No 1 paper and a 5cm stack of 
absorbent paper towels, all cut to the size of the gel. A glass plate and a weight were 
placed on the top of the stack and the transfer effected over a period of 16 - 24h. The 
towels and filter papers were discarded and the membrane lifted away from the gel. 
The membrane was soaked for 15min in neutralising solution and allowed to dry at 
room temperature until just moist. The DNA was crosslinked to the membrane by 
exposure to 120000 microjoules/cm^ of ultra violet light irradiation in a Stratalinker 
UV Crosslinker 1800 and then dried at room temperature.
To effect the transfer of high molecular weight DNA, depurination was carried out 
by incubation of the gel in 0.25M HC1 for 15min prior to alkaline treatment.
3.12.2. Application of RNA to a membrane
Total cell RNA was diluted to 3.0, 1.0 and 0.3/zg in 50/d of 20 x SSC and applied 
to a Schleicher and Schull BA 85 nitrocellulose membrane using a dot - blot manifold. 
Prior to the application the membrane was soaked in distilled water followed by 20 x 
SSC and placed on top of a sheet of Whatman No. 1 filter paper soaked in 20 x SSC
79
Methods
and the two inserted into the manifold. 50/xl of the diluted sample was applied to each 
well. The blot was dried for 2h in air and then baked in a vacuum oven at 80°C for a 
further 2h.
3.12.3. DNA/DNA hybridisation
This was conducted either in a shaking water bath or a Hybaid hybridisation oven. 
For the shaking water bath method, the dry membrane was placed into a polythene bag 
and preincubated with 50ml of hybridisation buffer for 2h at 70°C. The denatured 
radiolabelled DNA fragment was added to 18.5ml of hybridisation buffer containing 33 
H1 of 6M HC1, to neutralise the denaturing NaOH, and warmed to 70°C. The whole 
was added to the membrane in the bag and incubation at 70° C continued with shaking 
for 24 - 72h.
The radioactive hybridisation solution was poured off, the membrane removed from 
the bag and washed once in 400ml of fresh hybridisation buffer and twice in 400ml 
solutions of 0.2 x SSC and 0.1% SDS. Each wash was at 70°C and for 45min. After 
washing, the membrane was rinsed under running water, dried in air at room 
temperature and put up for autoradiography.
For the hybridisation oven method, the membrane was rolled up with Hybaid 
support mesh sheeting and inserted into a 300mm x 35mm Hybaid hybridisation bottle. 
Incubation with 50ml of hybridisation buffer was performed for 2h at 70° C and then 
the buffer poured out. The denatured radiolabelled DNA fragment was added to 
18.5ml of hybridisation buffer containing 33^1 of 6M HC1 and warmed to 70°C. The 
whole was poured into the hybridisation bottle and incubation at 70° C continued for 
24 - 72h.
The radioactive hybridisation solution was poured off and the membrane washed 
once in 50ml of fresh hybridisation buffer and twice in 50ml of 0.2 x SSC / 0.1% 
SDS. Each wash was at 70°C and for 45min. After washing, the membrane was 
removed from the bottle, rinsed under running water, dried in air at room temperature 
and put up for autoradiography.
3.12.4. DNA/RNA hybridisation
This was conducted in a shaking water bath. The baked nitrocellulose membrane 
was placed into a polythene bag and preincubated with 15ml of prehybridisation buffer
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for 2h at 42°C. Denatured radiolabelled DNA was added to 8.5ml of hybridisation 
buffer containing 33/d of 6M HC1 and warmed to 42°C. The whole was added to the 
membrane in the bag and incubation at 42 °C continued with shaking for 24 - 72h.
The radioactive hybridisation solution was poured off, the membrane removed from 
the bag and washed twice in 500ml of 2 x SSC / 0.1 % SDS at room temperature for 
15min, twice in 500ml of 0.1 x SSC / 0.1% SDS at room temperature for 15min and 
twice in 500ml of 0.1 x SSC / 0.1% SDS at 70°C for 15min. After washing, the 
membrane was rinsed under running water, dried in air at room temperature and put up 
for autoradiography.
3.13. Autoradiography
The dried membrane holding the radiolabelled hybridised DNA was placed on a 
glass plate and enclosed in polythene sheeting. It was put into a cassette with Kodak X- 
OMAT S film in front and an image intensifying screen on top. The sheeting and the 
intensifying screen were wiped with Kodak intensifying screen cleaner and antistatic 
solution before the cassette was made light proof and put at —70°C. The film was 
developed in a Kodak X-OMAT Processor Model ME-3.
3.14. Estimation of protein concentration
Protein concentration was measured using the method described by Bradford 
(1976). lml of Bradford reagent was added to 25/d of the sample in a plastic cuvette. 
The cuvette, covered with Nesco film, was inverted several times and stood at room 
temperature for 15min. The absorbance at 595nm was measured in a 
spectrophotometer and compared with a standard curve constructed from absorbance at 
the same wavelength of concentrations ranging from 0 - 120/xg of BSA.
3.15. Determination of thymidine kinase activity
The supernatant recovered following lysis and centrifugation of the cells as 
described in section 3.5.1. was assayed for thymidine kinase activity. Up to 12/d of
81
Methods
the sample was incubated at 30°C for 3h in TK reaction mixture to a total volume of 50 
fi 1. The reaction was stopped by the addition of 10/ri of lOOmM EDTA pH 7.5 and 
ImM thymidine and heated in a dri-block at 100°C for 5min. The sample was cooled 
on ice for 5min and centrifuged at 13000rpm for 2min in a benchtop centrifuge. 50/xl 
of the supernatant was spotted onto Whatman DE81 discs and dried under a heat lamp. 
The discs were immersed twice in 40mM ammonium formate pH 4.0 and 10/zM 
thymidine at 37°C for lOmin and followed by two washes of 5min each in 100% 
ethanol. The discs were dried under a heat lamp, placed into scintillation vials with 
10ml of Ecoscint A and their radioactivity determined in a scintillation counter.
3.16. Staining monolayers for /S-galactosidase activity
Cells infected with viruses which are carrying the lacZ  gene can be stained for the 
activity of the gene product, /3-galactosidase. Brefeldin A, which prevents egress of 
the virus from the cell, was added to the medium at 3/ig/ml in all cases where 
potentially lytic virus would spread from cell to cell and destroy the monolayer.
The medium overlying cells grown on 35mm diameter tissue culture plates was 
poured off and the monolayer washed thoroughly with 2ml ice cold PBS. The cells 
were fixed with 1 % glutaraldehyde in PBS for lh at 4°C. The fixative was washed off 
with two washes of PBS and 2ml of histochemical reaction mixture for /3-galactosidase 
activity added. Staining was allowed to proceed for at least lh at 37°C and then the 
reaction mixture was washed off several times with distilled water. Positively stained 
cells are blue. /3-galactosidase liberates 5-bromo 4-chloro 3-indolyl from X-gal which 
is oxidised by ferricyanide to form a blue indigo dye (Pearson et al., 1963). 
Ferrocyanide prevents further oxidation to a colourless indigo compound. Occasionally 
crystals formed on the plates but they were easily removed by incubation at 37 °C for 
2h in a solution equivalent to the /3-galactosidase stain without X-gal followed by 
further washing with water. The fixed cell sheets were then stained for 12h with a 
counterstain, Carmalum, to reveal all the cells in a contrasting pink colour. The stain 
was washed off with distilled water and the plates dried upside down in air at room 
temperature. Coverslips were mounted in aqua mount and the blue cells counted under 
a dissecting microscope. Photographs were taken using a Zeiss Axioskop with an MC 
80 camera set at 12 volts. One blue and two neutral density filters were needed in the 
lighting conditions during daytime. Kodak Gold II ASA 100 film for colour prints was 
used throughout.
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4. RESULTS
4.1. Objectives
Herpes simplex virus is characterised by the pathogenic property of establishing 
latency in the neuronal cells of sensory and autonomic ganglia during primary infection 
of man. Once established, latency can be maintained for the lifetime of the host. 
However, the latent virus can be reactivated and replicate giving rise to clinically 
important recurrent disease. The objectives of this study were to characterise a model 
of HSV-1 latency which would allow investigation of the process at the molecular level 
and demonstrate some structural features of the latent genome in the model. The 
experimental work was based on improvement of an in vitro model of HSV latency in 
HFL cells that has been described previously (Russell and Preston, 1986; Harris and 
Preston, 1991). The final system is shown schematically in figure 3.1. It has been 
demonstrated (Harris and Preston, 1991) that infecting HFL monolayers with 5 
particles of m l814 per cell resulted in 10 - 20% of the cells retaining at least one latent 
genome. Modifications were designed with the specific intention of being able to 
increase the moi to achieve a high genome copy number per cell but without causing 
cell death. Two modifications were introduced. Firstly, the HFL cell monolayer was 
pretreated with IFN-a to reduce the expression of IE genes (Mittnacht et al., 1988) and
secondly, m l820 which produces VmwllO at low levels when infecting HFL cells, was 
used. A VmwllO deletion mutant has been shown to favour a non-lytic interaction 
with HFL cells rather than plaque formation at low moi (Stow and Stow, 1989). 
Reactivation was effected by superinfection with a virus which expressed VmwllO.
Having established latency at a high moi of up to 120 particles per cell and 
demonstrated a copy number of at least one latent genome per cell, further experiments 
were carried out to examine the structural features of the latent genome in the model 
more closely. Current evidence suggests that the latent HSV genome in vivo exists as a 
non-linear molecule (Rock and Fraser, 1983; 1985; Efstathiou et al. , 1986), probably 
an episome (Mellerick and Fraser, 1987), in a chromatin-like arrangement (Deshmane 
and Fraser, 1989). Both of these features have been examined in the in vitro model, 
the former by looking for the loss of the termini and the latter by examination of the 
pattern produced by digestion with micrococcal nuclease. Preliminary investigations 
into the size of the latent DNA molecule and also into the relationship of the genome to 
the nuclear substructure of the host cell have been performed.
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4.2. Mutant /hl820 has increased propensity to establish 
latency in vitro
The mutant ini 814 has a 12bp insertion in the gene encoding Vmw65, the virion 
tegument protein which transinduces IE gene transcription (Ace et al., 1989). As a 
consequence of the mutation, the ability of Vmw65 to transinduce IE gene expression 
and to form a protein-DNA complex with cell proteins and the IE specific regulatory 
element TAATGARAT (where R is a purine residue) is abolished. However 
accumulation of IE mRNA, and in particular VmwllO mRNA, although reduced is not 
eliminated. This renders the transinduction of IE transcription by Vmw65 unimportant 
at high moi when many of the particles, although unable to form plaques, are able to 
participate normally in the early stages of infection (Ace et al., 1989). Thus the 
addition of greater than 5 - 1 0  particles of ini 814 per HFL cell results in the 
degeneration of the monolayer even when lytic infection is blocked by the presence of 
ara-C, an inhibitor of DNA replication. Ara-C, used to prevent the breakthrough of 
replicating virus in previous experiments, did not affect the establishment of latency in 
the in vitro system (Harris and Preston, 1991). It was hypothesised that further 
measures to reduce IE protein levels after infection might reduce the cytopathic effect 
(Johnson et al., 1992) and thus enable a higher moi to be used. A further mutation was 
introduced into in i814 by replacement of the normal VmwllO promoter with the 
MoMuLV LTR enhancer which is expressed very poorly in HFL cells to give mutant 
in i820. It has been found that in i820 produces undetectable levels of VmwllO mRNA 
under IE conditions (J. Daksis and C. M. Preston, personal communication). The 
effect of these mutations on the particle per pfu ratio is shown in table 4.1.
Confluent monolayers of HFL cells on 30mm diameter tissue culture plates were 
inoculated with virus in a 200/d inoculum which was allowed to adsorb for lh. The 
medium was then made up to 2ml with EHu5. This prevents extracellular spread of the 
virus by neutralizing any released virions. It does not prevent the intercellular spread 
of virus which eventually forms a plaque. Thus the plaque arises from one infected cell 
which has become productively infected and the virions have spread via cell to cell 
contact into the neighbouring fibroblasts. Infection was allowed to proceed at 37 °C for 
48h before the monolayers were inspected for plaque formation.
From the results presented in table 4.1, it is evident that the same number of 
plaques (6) resulted from 0.0001 particles per cell of 1814R as 1 particle per cell of
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VIRUS PARTICLES PER CELL PLAQUES PER PLATE
1814R 0.1 cpe
0.01 >200
0.001 36
0.0001 6
ini 814 10 cpe
1 11
0.1 1
0.01 0
ini 820 10 148
1 6
0.1 0
0.01 0
TABLE 4.1: THE MUTANTS in!814 AND ini 820 HAVE REDUCED PL APT IK 
FORMING ABILITY ON HFL CELLS COMPARED WITH 1814R
Each 30mm diameter plate of confluent HFL cells was inoculated with a 200/nl viral 
inoculum and maintained at 37°C for lh to allow adsorption and penetration of virus. 
1.8ml of EHu5 was added, incubation continued for 48h, the monolayer stained with 
Giemsa and the plaques counted. Plaque numbers greater than 200 per plate cannot be 
counted accurately because of coalescence but are indicated as > 200 since the 
monolayers were still intact, unlike those largely destroyed by the cpe.
(The figures are from a single experiment but it was repeated with consistent results)
ini820 which represents a 10^-fold increase in the particle per pfu (p:pfu) ratio. The 
rescued virus 1814R, is essentially a wild type HSV control (Ace et al., 1989). The 
increase in the p:pfu ratio of in\ 820 compared with inl814 is at least 2-fold in that 1 
particle per cell of ini 814 produces twice as many plaques as 1 particle per cell of 
ini 820. A similar result is seen in the data from the untreated cells in table 4.2. Here 
the number of plaques (49) from 0.001 particles per cell of 1814R is of the same order 
as the number (38) from 10 particles per cell of in i820 i.e an increase in the ratio by a 
factor of 10^. As for ini 814, 10 particles per cell produced nearly 4 times as many 
plaques as the same moi of ini 820. This is in accord with unpublished observations
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(C.M. Preston, personal communication) in which the p:pfu ratio on HFL cells is 10^ - 
5 x 105 for ml 814 whereas it is 10^ for ini 820 and 10 - 50 for 1814R. It is concluded 
that the effect of the double mutation is to decrease the propensity of the virus to form 
plaques on HFL cell monolayers.
4.3. IFN-a pretreatment inhibits replication of /hl814 and 
M820
IFN-a is known to inhibit IE gene transcription (Mittnacht et al., 1988; Oberman 
and Panet, 1988; 1989). Therefore the expected effect of pretreating HFL monolayers 
with IFN-a would be to reduce the IE transcription of the infecting virus and thus its 
cytopathogenicity. The results of the pretreatment of cells with 10^ units of IFN-a/ml 
for 16h prior to infection with virus are presented in table 4.2. The IFN-a was washed 
out with EF10 immediately prior to inoculation with a 200fil viral inoculum as 
described above.
The results show that pretreatment of the cells with IFN-a at 1(P units/ml reduced 
the plaque forming ability of 1814R, ini 814 and ini 820. The effect was more marked 
at lower moi in that 0.001 particles per cell of 1814R were more effectively prevented 
from forming plaques than 0.01 particles of the same. Thus the plaque forming ability 
of ini 820 can be even further reduced. Pretreatment of cells with IFN-a makes it 
possible to infect with ini 820 at a higher moi than ini 814 without the production of 
plaques. From table 4.2 it can be seen that even at 100 particles per cell ini 820 still 
produces only 5 plaques. These plaques represent virus which does not undergo latent 
infection, unlike the majority of the infecting particles, and although only a small 
percentage of the total such viruses need to be prevented from replicating. The 
replication inhibitor ara-C was used to achieve this when required.
As discussed in section 1.4, IFN-a and IFN-7 are very different in their biological 
activities. Their modes of action are likely to differ too in that combination treatments 
have been reported to give rise to a synergistic enhancement of antiviral activities 
(Samuel and Knutson, 1983; Czamiecki et al., 1984). One paper (Klotzbucher et al., 
1990) reported that pretreatment of mouse splenic macrophages with murine IFN-7 led 
to a dose dependent reduction in HSV-1 yield comparable to that obtained with IFN-a/ 
/?. The data suggested a translational inhibition of IE gene expression by IFN-7 , unlike 
IFN-a//3 which appeared to inhibit IE gene expression at the transcriptional level. The
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use of IFN-7 as well as IFN-a in inhibiting plaque formation on HFL monolayers was 
explored. The results are presented in tables 4.2 and 4.3. It is evident from table 4.2 
that IFN-y is not as effective as IFN-a in further reducing the plaque forming abilities 
of the mutants ml 814 or ini 820 and the data in table 4.3 confirms this for the mutant 
ini 814 and also demonstrates that there is no cumulative effect of IFN-a and IFN-y. 
The discrepancy between these results and others (Klotzbucher et al., 1990) might be 
explicable on the grounds of a higher dose causing partial reversal of HSV-1 growth 
inhibition i.e. maximum inhibition was observed at 200-500 units of IFN-y/ml which 
declined when higher doses were used (Klotzbucher et al., 1990). The use of IFN-y 
has no place in the in vitro system being developed with in i820 infection of HFL cells.
VIRUS PARTICLES 
PER CELL
PLAQUES PER PLATE
NO IFN-a IFN-a IFN-y
1814R 0.1 cpe >200 cpe
0.01 >200 98 >200
0.001 49 7 69
ml814 100 cpe >200 cpe
10 146 1 42
1 1 0 2
0.1 1 0 0
ml 820 100 cpe 5 cpe
30 >200 0 147
10 38 0 5
1 1 0 0
TABLE 4.2: PRETREATMENT WITH IFN-a REDUCES THE TTTRE OF 1814R.
ml 814 AND ini 820
30mm diameter plates of confluent HFL cells were mock pretreated or pretreated with 
IFN-a or IFN-y at 10^ units/ml for 16h. After washing the monolayer, a 200^1 viral 
inoculum was applied and maintained at 37°C for lh to allow adsorption and 
penetration of virus. 1.8ml of EHu5 was added, incubation continued for 48h, the 
monolayer stained with Giemsa and the plaques counted. Plaque numbers greater than 
200 per plate cannot be counted accurately because of coalescence but are indicated as 
> 200 since the monolayers were still intact, unlike those largely destroyed by the cpe.
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In the tables 4.2 and 4.3 it is evident that the mutants are more sensitive to the 
inhibitory effects of IFN-a than the revertant 1814R which has a wild type phenotype. 
The data in table 4.2 show that pretreatment with IFN-a produces a reduction in the 
plaque forming ability of ini 820 by more than 200-fold and between a 100 and 200- 
fold reduction in the plaque forming ability of ini 814. In contrast it only reduces the 
plaque forming ability of 1814R by about 5-fold. It appears that the introduction of the 
mutations has enhanced the susceptibility of the virus to the inhibitory effects of IFN-a.
The reduced efficiency of the plaque forming ability of in i814, apparent when 
comparing the tables 4.1, 4.2 and 4.3, is thought to be a consequence of declining viral 
infectivity resulting from repeated thawing and freezing of virus stocks. To overcome 
this viral stocks were stored as small aliquots and used twice at the most.
VIRUS PARTICLES 
PER CELL
PLAQUES PER PLATE
NOIFN IFN-a IFN-7 IFN-a + -7
1814R 0.1 cpe >200 cpe >200
0.01 >200 142 >200 126
0.001 30 17 76 23
ini 814 1000 >200 6 cpe 25
100 10 1 52 1
10 0 0 0 0
TABLE 4.3; PRETREATMENT WITH IFN-7 HAS NO EFFECT ON THE 
REPLICATION OF ini 814 IN HFL CELLS
30mm diameter plates of confluent HFL cells were mock pretreated or pretreated with 
IFN-a, IFN-7 or IFN-a and IFN-7 together at 10^ units/ml for 16h. After washing 
the monolayer, a 200/xl viral inoculum was applied and maintained at 37°C for lh to 
allow adsorption and penetration of virus. 1.8ml of EHu5 was added, incubation 
continued for 48h, the monolayer stained with Giemsa and the plaques counted. Plaque 
numbers greater than 200 per plate cannot be counted accurately because of coalescence 
but are indicated as > 200 since the monolayers were still intact, unlike those largely
destroyed by the cpe.
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From these experiments it has been shown that a high moi of at least 30 particles 
per cell can therefore be achieved without plaque formation by infecting with the 
double mutant ini 820 following pretreatment of HFL cells with 10^ units/ml of IFN-a. 
An even higher moi of 100 should be possible if the low background of breakthrough 
virus capable of causing plaques but not cpe is controlled with an inhibitor of viral 
replication such as ara-C.
4.4. The effect of IFN-a pretreatment persists for at least 72 
hours
As discussed in section 1.4, the effect of IFN is mediated by the induction of 
permanent changes in the cell, part of which is attributable to the synthesis of new 
proteins.
PARTICLES 
OF ml 814 
PER CELL
PLAQUES PER PLATE, 
INFECTED Oh POST IFN-a 
PRETREATMENT
PLAQUES PER PLATE, 
INFECTED 72h POST IFN-a 
PRETREATMENT
NO IFN-a IFN-a NO IFN-a IFN-a
100 62 0 79 10
10 2 0 24 0
1 0 0 1 0
0.1 0 0 0 0
TABLE 4.4: THE EFFECT OF IFN-a PRETREATMENT PERSISTS FOR AT 
LEAST 72h FOLLOWING REMOVAL.
Eight 30mm diameter plates of confluent HFL cells were pretreated with IFN-a at 10^ 
units/ml for 16h. A further 8 were mock pretreated. After washing the monolayers, 
either a 200/d viral inoculum of ini 814 was added or 2ml of fresh EF10 was added for 
72h, removed and then a 200/d viral inoculum of ini 814 applied. Following 
inoculation the monolayer was maintained at 37°C for lh to allow adsorption and 
penetration of virus. 1.8ml of EHu5 was added, incubation continued for 48h, the 
monolayer stained with Giemsa, and the plaques counted. The figures given are from a 
single experiment but it was repeated with consistent results.
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If this is the case in this system, removal of IFN-a after pretreatment should not 
lead to an immediate loss of its effect on the inhibition of the infecting virus. 
Monolayers pretreated with IFN-a at 10^ units/ml for 16h were thoroughly washed 
with medium to remove all traces of the IFN and maintained for a further 72h at 37 °C 
prior to infection with ml 814. The plaque forming ability of the mutant was 
determined 48h later. The results are given in table 4.4. The reduced plaquing 
efficiency of the virus compared with the earlier experiments is explained above.
The results show that an effect on the plaque forming ability of ml 814 after the 
washing out of IFN-a is still present 72h later. This suggests that the antiviral 
mechanism of IFN-a on HSV-1 infection of HFL cells is via long term induced 
changes rather than an effect that requires its continued presence. This would include 
the induction of new proteins or modifications such as phosphorylation to those proteins 
already in existence.
4.5. Investigation of the duration of pretreatment with IFN-a
To investigate the minimum period of interaction to achieve maximum inhibition by 
IFN-a, HFL monolayers were pretreated with IFN-a for various lengths of time up to 
16h prior to infection. It can be seen from the results given in table 4.5 that there is an 
effect on the plaque forming ability of ml 814 even with a short exposure to IFN-a 
pretreatment in that the number of plaques was nearly halved by a 2h IFN-a 
pretreatment interval. By 5h this number was reduced to 18%. To completely abolish 
the plaque forming ability of ini 814 a longer exposure was required which in this 
experiment was extended to 16h. Thus the effects of IFN-a require continued 
stimulation in the initial stages of establishing the antiviral state which becomes 
unnecessary once the changes have been fully induced. These observations suggest that 
changes induced by the pretreatment can accumulate during the early part of the 
process, in support of the contention that the effects of IFN-a include permanent 
modifications such as in the absolute levels of the mediators by the synthesis of new 
proteins or the rate of synthesis of existing proteins as well as alterations in their 
activities, for example by phosphorylation.
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PLAQUES PER 
PLATE AFTER 
16h PRE­
TREATMENT
PLAQU 
PLATE 
5h I 
TREA1
ES PER 
AFTER 
>RE- 
rMENT
PLAQUES PER 
PLATE AFTER 
2h PRE­
TREATMENT
PLAQU 
PLATE 
Oh I 
TREA1
ESPER
AFTER
>RE-
[MENT
NO
IFN-a
IFN-a NO
IFN-a
IFN-a NO
IFN-a
IFN-a NO
IFN-a
IFN-a
118 0 113 21 103 59 170 167
TABLE 4.5: THE EFFECT OF IFN-a PRETREATMENT FOR Oh. 2h. 5h and 16h 
ON THE PLAQUE FORMING ABILITY OF ini 814
Each 30mm diameter plate of confluent HFL cells was pretreated with IFN-a at 10^ 
units/ml for 16h, 5h, 2h or Oh. After washing the monolayer, a 2Q0fil viral inoculum 
of 100 particles of in i814 per cell was applied and maintained at 37°C for lh to allow 
adsorption and penetration of virus. 1.8ml of EHu5 was added, incubation continued
for 48h, the monolayer stained with Giemsa and the plaques counted. Results of a
single experiment.
4.6. Combined effects of HMBA and IFN-a
It has been shown that the presence of HMBA in the cell culture medium is able to 
overcome the replication defect of ini 814 (McFarlane et al. , 1992). The effect can be 
achieved by an exposure to the agent for as short as 1.5h early after infection and 
appears to result from an increase in the production of IE mRNA. Since the action of 
IFN-a also appears to be at the level of IE mRNA production, it was of interest to 
determine whether one of these reagents was dominant over the other. This might 
provide further clues as to their modes of action. HFL monolayers were pretreated 
with IFN-a as usual but the viral inoculum on some monolayers contained 5mM 
HMBA, which was maintained at the same concentration throughout the incubation. 
Some monolayers which were inoculated with virus and incubated without HMBA 
present were treated with HMBA 24h later. The results are presented in table 4.6.
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PARTICLES 
PER CELL 
OF ini 814
PLAQUES PER PLATE
NO IFN-a 
NO HMBA
IFN-a 
NO HMBA
NO IFN-a 
HMBA
IFN-a
HMBA
IFN-a
HMBA
(24h)
100 cpe >200 cpe cpe >200
10 >200 1 cpe 173 6
1 18 0 >200 7 0
0.1 0 0 >200 1 0
0.01 0 0 28 0 0
TABLE 4.6: THE CUMULATIVE EFFECT OF HMBA AND IFN-a ON THE 
PLAQUE FORMING ABILITY OF in!814.
30mm diameter plates of confluent HFL cells were pretreated with or without IFN-a 
at 103 units/ml for 16h. After washing the monolayers a 200/xl viral inoculum of 
M 814 with or without 5mM HMBA was added and the monolayer was maintained at 
37°C for lh to allow adsorption and penetration of virus. Following adsorption and 
penetration of virus 1.8ml of EHu5 was added with or without 5mM HMBA and the 
incubation continued for 48h. On 5 plates, HMBA to 5mM was not added to the 
inoculum nor the EHu5 until 24h afterwards. The monolayer was stained with Giemsa, 
and the plaques counted. The figures given are from a single experiment but it was
performed twice.
The results confirm that HMBA is very effective in overcoming the mutation in 
M814 in the absence of IFN-a pretreatment (columns 1 and 3). However in those 
cells which have been pretreated with IFN-a, the number of plaques generated by 
HMBA treatment (column 4) is much the same as those from cells that have had no 
pretreatment (column 1) although less than those cells that have had HMBA treatment 
only (column 3). Thus it appears that HMBA can partially overcome the effect of IFN- 
a  if given early in infection. Neither of these agents is totally dominant over the other
i.e. in the presence of IFN-a HMBA is still effective but IFN-a is also inhibitory in the 
presence of HMBA. The negative effect of IFN-a and the positive effect of HMBA on 
the replicating ability of ini 814 combine to produce a result similar to the phenotype 
under normal conditions. The results in column 5 show that by 24h HMBA is
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ineffective. This finding is unlikely to be due to the pretreatment with IFN-a since the 
loss of responsiveness of ml 814 to HMBA in the absence of IFN-a with time has 
already been reported (McFarlane et al., 1992). It is more likely to be because the 
viral genome has become latent in which condition it is refractory to all transactivators 
with the exception of VmwllO (Harris and Preston, 1991).
4.7. Reactivation of virus from IFN-a pretreated cells is as 
efficient as from untreated cells
Previous investigators have shown that reactivation of ml 814 requires the presence 
of VmwllO (Harris and Preston, 1991). They demonstrated that in vitro the retained 
virus ml 814 could be reactivated by superinfection with the temperature sensitive 
mutant tsK which expresses VmwllO at the non-permissive temperature in a 
multiplicity dependent manner. This had been demonstrated earlier in a forerunner of 
the in vitro latency system, in which latent HSV-2 was also reactivated by tsK in a 
highly efficient manner (Russell and Preston, 1986). To investigate whether this was 
a lso  true in the in vitro latency model using IFN-a pretreated monolayers infected with 
m l820, latently infected HFL cells which had either been pretreated with IFN-a or left 
untreated were superinfected with tsK. As shown in table 4.7 superinfection with tsK 
at 0.1 pfu per cell was able to reactivate the double mutant in i820 in IFN-a pretreated 
cells as efficiently as ini 814 from untreated cells. At 0.1 particles per cell it is 
expected that 2000 cells will have retained one particle with the potential of forming a 
plaque based on an estimated p:pfu value of 50. Superinfection at 0.1 pfu per cell of 
tsK at the non-permissive temperature should therefore produce 200 plaques. The 
numbers of plaques produced in the experiment approximates to this figure.
Thus IFN-a pretreatment does not affect reactivation by tsK. It is concluded that 
the genome is not irreversibly inactivated by this pretreatment. Furthermore in 
addition to overcoming the IFN-a effect, tsK is also able to overcome the defect in 
Vmw65 and the reduced VmwllO expression inherent in m l820. Unlike tsK, HMBA 
is incapable of completely reversing the effects of IFN-a and defective Vmw65 (table 
4.6).
It is also apparent that the plaquing efficiency of tsK at 31 °C was unaffected by 
IFN-a pretreatment. Although IFN-a had been removed 24h prior to infection with 
tsK, table 4.4 shows that the effect of IFN-a on m l814 persists for up to 72h following
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its removal. It may be that ml 814 is more sensitive to inhibition by IFN-a than tsK as 
is shown with the wt virus in table 4.2. Maintainance of the culture at 31 °C following 
infection with tsK might also inhibit the effect of IFN-a pretreatment on the virus.
VIRUS PARTICLES 
PER CELL
SUPERINFECTION TEMP
(°C)
PLAQUES PER PLATE
NO IFN-a IFN-a
ml 814 0.1 mock 38.5 0 0
ml 814 0.1 0.1 pfu per cell tsK 38.5 110 82
ml 820 0.1 mock 38.5 1 0
ml 820 0.1 0.1 pfu per cell tsK 38.5 177 193
mock 0 0.1 pfu per cell tsK 38.5 0 0
mock 0 20 pfu tsK 31 16 18
mock 0 200 pfii tsK 31 184 111
TABLE 4.7: tsK REACTIVATES VIRUS EFFICIENTLY FROM IFN-a
PRETREATED CELLS
HFL cells were grown on 30mm diameter plates pretreated with IFN-a at 10^ units/ml 
for 16h or untreated. After washing, the cells were inoculated with a 200/xl viral 
inoculum and the monolayer was maintained at 37°C for lh to allow adsorption and 
penetration of virus. 1.8ml of EF10 was added, incubation continued for 24h, 
medium removed and the cells superinfected with a 200pi inoculum of tsK. This virus 
was allowed to adsorb and penetrate the cells for lh, 1.8ml of EHu5 was added and the 
incubation continued for a further 48h or 72h at the non-permissive (38.5°C) or 
permissive (31 °C) temperatures respectively. Plates were stained with Giemsa and the 
plaques counted. The figures given are from a single experiment but it was performed
twice.
4.8. IFN-a pretreatment reduces IE mRNA accumulation
To confirm that IFN-a pretreatment reduces IE mRNA accumulation as reported by 
others (Mittnacht et al., 1988; Oberman and Panet, 1988), in HFL cells, dot blot
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FIGURE 4.1; PRETREATMENT WITH IFN-a REDUCES THE ACCUMULATION
OF VmwllO mRNA.
HFL cells were grown on 50mm diameter plates and mock pretreated or pretreated with 
IFN-a at 10^ units/ml for 16h. After removal of the IFN-a by washing, the 
monolayers were inoculated with virus at 150 particles per cell together with 
cycloheximide at 25jug/ml in a 400pil inoculum and maintained at 37°C for lh to allow 
adsorption and penetration of virus. 5ml of EF10 containing cycloheximide at 25/zg/ml 
was added and incubation continued for another 2h. RNA was prepared, diluted to
3.0, 1.0 and 0.3/xg in 50/xl of 20 x SSC and applied sequentially left to right to a 
nitrocellulose membrane. The membrane was hybridised with a ^^P-labelled DNA 
fragment from the VmwllO (a) and (b) or actin (c) genes. Panels (a) and (b) show
different exposures of the same blot.
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hybridisation was performed. Monolayers infected with ml 814 or 1814R in the 
presence of the protein synthesis inhibitor cycloheximide were harvested and the RNA 
extracted. The total amount of RNA was determined in each extract and various 
amounts were immobilised on a nitrocellulose membrane for hybridisation with specific 
probes. The DNA fragment from the IE110 gene was used as a marker for IE mRNA 
and from the actin gene as a marker for host cell mRNA. The results are shown in 
figure 4.1. In figure 4.1a it is evident that a I fig dilution of total RNA from IFN-a 
pretreated cells infected with m l814 has approximately the same amount of VmwllO 
mRNA as a 0.3/xg dilution of total RNA from untreated similarly infected cells. Thus 
there is at least a 3-fold reduction in VmwllO mRNA following pretreatment with IFN- 
a. The effect is not so clear at this exposure for cells infected with 1814R but the 
shorter exposure shown in figure 4.1b demonstrates that the effect is essentially the 
same. The effect of IFN-a pretreatment on the general level of mRNA synthesis as 
exemplified by actin mRNA and shown in figure 4. lc  is not to the same extent.
4.9. Cycloheximide does not inhibit the effect of IFN-a
If the mechanism of IFN-a action is mediated via the synthesis of new proteins, the 
addition of the protein synthesis inhibitor, cycloheximide, should indirectly inhibit the 
effect of IFN-a. Experimental conditions were set up such that the effect of IFN-a 
could be inhibited but not potential lytic infection following its removal. This was 
achieved by pretreating the monolayers with both IFN-a and cycloheximide. HFL cells 
are unable to withstand exposure to cycloheximide for a period greater than 5h but it 
has been shown in table 4.5 that IFN-a is over 80% effective by this time. Before the 
inoculation with virus the monolayers were washed repeatedly to remove all traces of 
cycloheximide which, if still present, would prevent protein synthesis essential to a 
productive infection. The results are given in table 4.8.
The results show that the presence of cycloheximide does not alter the ability of 
IFN-a to inhibit the effect it has on ml 814 or ini 820. Thus the action of IFN-a does 
not require the synthesis of new proteins while it is exposed to the cells.
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VIRUS PARTICLES PLAQUES PER PLATE
PER CELL NO IFN-a IFN-a NO IFN-a IFN-a
NOCH NOCH CH CH
ml 814 100 cpe cpe cpe cpe
10 cpe 135 cpe cpe*
1 14.5 1 20.5 1.5
0.1 0 0 0 0
in i820 100 cpe 159 cpe 88.5
10 27 0 31.5 1.5
1 1 0 1 0
TABLE 4.8: THE EFFECT OF IFN-a AND CYCLOHEXIMIDE ON THE PLAQUE 
FORMING ABILITY OF i/?1814 AND ml 820
HFL monolayers were cultured on 30mm diameter plates and pretreated with IFN-a at 
103 units/ml and cycloheximide at 25/ig/ml in various combinations for 5h. The cells 
were washed four times at 37 °C with EF10 by gentle rocking of each plate for 2min 
and blotting them dry between each wash. The viral inoculum was applied in 200fi\ 
and the monolayer was maintained at 37°C for lh to allow adsorption and penetration 
of virus. Following this, 1.8ml of EHu5 was added and the incubation continued for 
48h. The overlay was poured off, the monolayer stained with Giemsa, and the plaques 
counted. The figures shown are mean values of duplicate samples. (*much less 
extensive than cpe in the absence of IFN-a and presence of CH)
4.10. Configuration of the viral DNA in the high multiplicity 
latency model
The in vitro latency model is based on a reduction of IE gene expression achieved 
by using a virus that expresses a mutant Vmw65, replacement of the VmwllO 
promoter with the MoMuLV enhancer and pretreatment of the cells with IFN-a. At 
the moi used some virus will not go latent but remains potentially lytic and thus ara-C 
is included in the medium to prevent replication of this background virus. 
Superinfection with tsK shows that reactivation can be achieved with high efficiency.
In vivo, latent HSV-1 DNA bears the characteristic of being non-linear (Rock and 
Fraser, 1983; 1985; Efstathiou et al., 1986) and is transcriptionally silent with the
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exception of the latency associated transcripts (Stevens et al., 1987). Other 
investigators have suggested that it is maintained as a circular episome (Mellerick and 
Fraser, 1987). Hence the latent genome is structurally distinct to the DNA of a 
productively infecting virus. Earlier studies using an in vitro model and a low moi of 5 
particles per cell (Harris and Preston, 1991), demonstrated that ini 814 DNA is retained 
at relatively low abundance in a non-linear configuration during latency. It is 
important to know whether in the modified system of IFN-a pretreatment and using a 
higher moi of the virus ini 820, the latent viral genome is also largely in the non-linear 
configuration. HFL monolayers pretreated with IFN-a were infected at a moi of 50 
particles of in i820 per cell and incubated in the presence of ara-C for 24 or 48h. The 
DNA was extracted, cleaved with Bam HI and fractionated on a caesium chloride 
gradient to separate viral from host cell DNA. The samples containing the viral DNA 
underwent electrophoresis on an agarose gel, were blotted onto a nylon membrane and 
hybridised with a ^^P-radiolabelled DNA fragment. The fragment used was the 
purified joint spanning fragment, HSV-1 Bam HI k, radiolabelled to high specific 
activity by the random primer extension method. Progression from the linear to the 
non-linear configuration over 48h is evident by the gradual disappearance of the 
terminal sequences but the persistence of the joint sequences as is shown in figure 4.2. 
Although most of the termini had disappeared by 24h the process was not complete 
until 48h had elapsed. At a lower moi of 5 particles per cell and using ml 814 (Harris 
and Preston, 1991) the first sign of disappearence of the termini was apparent at 5h but 
it was a full 48h post infection before they were undetectable. Latent HSV-2 produced 
by infecting HFL cells at the supraoptimal temperature also becomes an endless 
molecule (Preston and Russell, 1991) but in contrast to HSV-1 this developed more 
slowly and was not complete until 4 days post infection. Since the joint became 
bimolar relative to the unique sequences (Preston and Russell, 1991), it appears that the 
loss of the termini is due to their fusion to yield an additional joint. The simplest 
model to explain this phenomenon is circularisation of the linear genome. In the 
experiment shown in figure 4.2 the lack of Bam HI terminal sequences is not due to the 
protocol since terminal fragments were not lost following fractionation on caesium 
chloride gradients of the DNA samples which contain a mixture of Bam HI digested 
mock infected HFL cell DNA and virion DNA (data not shown). Pretreatment with 
IFN-a had no apparent effect on the physical form adopted by the genome in that the 
same pattern was observed in both pretreated and untreated cells (data not shown). The 
doublet hybridisation signal which occurs at the joint is due to a variation in the number 
of reiterated "a" sequences. The reason for the differences in the intensities of the 
signals corresponding to the two termini and joint fragments is not clear but it is
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FIGURE 4.2: THE ml 820 GENOME ADOPTS THE NON-LINEAR 
CONFIGURATION AFTER 48h IN THE IN  VITRO LATENCY SYSTEM.
HFL cells were grown on 90mm diameter plates and pretreated with IFN-a at 103 
units/ml for 16h. After the removal of the IFN-a the plates were infected with ml 820 
at 70 particles per cell or mock (m) infected and the monolayers were maintained at 37 
°C for lh to allow adsorption and penetration of virus. EF10 medium to 15ml per 
plate and containing ara- C at 50/xg/ml was added and incubation was continued for 24 
or 48h. The cells were harvested, DNA extracted from nuclei and cleaved with Bam 
HI at 100 units per sample in a total volume of 500fA. Viral DNA was separated from 
the host cell DNA by fractionation on a caesium chloride gradient, repurified and half 
of the total electrophoresed in a 1 % agarose gel and analysed by Southern blotting.
The DNA was hybridised with the ^^P-radiolabelled fragment Bam HI k which 
recognises sequences at the joint (k) and termini (q and s). Standards containing 1.5, 5
and 15ng of ml 820 DNA are also shown.
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probably a reflection of the hybridisation procedure. The intensities are different again 
in figure 4.20 where the band corresponding to the termini is more intense than the 
band corresponding to the joint.
It is concluded that the modifications utilised do increase the propensity to undergo 
latent infection and the genome continues to behave in a fashion analagous to that seen 
at a lower moi (Harris and Preston, 1991) and as demonstrated in vivo (Rock and 
Fraser 1983; 1985; Efstathiou et al., 1986). The result gives credence to the model as 
mimicking one of the hallmarks of latent infection in vivo.
4.11. Viral DNA can be specifically detected in the presence 
of host cell DNA
Fractionation of DNA extracted from the infected cells on caesium chloride 
gradients into viral and host cell specific nucleic acid components prior to further 
investigation by hybridisation was performed to eradicate non-specific binding of the 
^ P -r a d io la b e lle d  Bam HI k fragment to cellular sequences. It is however, undesirable 
as it imposes limitations on the yield of the viral DNA and the number of samples that 
can be readily analysed. As the non-linear configuration has been demonstrated in this 
model (figure 4.2) only the presence of the viral DNA, rather than its structure, needs 
to be shown for many experiments. Ideally it should be possible to identify specifically 
the viral DNA in the extracts without having to resort to removing the host cel] DNA. 
This has been achieved using a pTKl 2.4kb fragment, encompassing the TK gene, as 
probe. This hybridises to the p fragment from a Bam HI digest of HSV-1. DNA from 
infected cells was prepared and cleaved with Bam HI but the caesium chloride 
centrifugation step was omitted. Hybridisation of the ^^P-radiolabelled fragment from 
pTKl was specific for the viral DNA even in the presence of host cell DNA as is 
illustrated in figure 4.3. The viral DNA was clearly identified by hybridisation of the 
pTKl fragment to the Bam HI digested standard of 25ng ml 820 (lanes si and s2) and 
there was no non-specific binding to cellular sequences in the mock infected 
unfractionated extract (lane m). In the latently infected cell extracts viral DNA was 
clearly identified. The unfractionated band represents 8% of the original material and 
the fractionated band 25% of the original material. Since the bands in lanes 1 and 3 
are of approximate intensity it follows that about 68% of the ini 814 DNA was lost by 
fractionation. The band in lane 4 is only at the most half the intensity of the hand in
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FIGURE 4.3: THE HSV-1 GENOME CAN BE DETECTED SPECIFICALLY BY 
THE 32P-RADIOLABELLED DNA FRAGMENT pTKl IN THE PRESENCE OF
HOST CELL DNA
DNA was extracted from infected HFL monolayers grown on 90mm diameter plates 
and cleaved with Bam HI at 100 units per sample in a total volume of 500/d. 250/d of 
each sample was fractionated on a caesium chloride gradient. Following the 
electrophoresis of 40/d of unfractionated (uf) and 125/d fractionated (f) material in a 
0.6% agarose gel and Southern blotting, the DNA was hybridised with the 32p_ 
radiolabelled 2.4kb fragment from pTKl. Lanes 1 - 4 are from HFL cells pretreated 
with IFN-a at 10  ^units per ml for 16h, infected at 70 particles per cell for 24h and 
incubated in EF10 containing ara-C at 50/xg/ml. Lanes 1 and 3 represent material from 
1771814 and lanes 2 and 4 from 7/71820 infected cells. The autoradiograph was exposed 
for 48h. Also shown is a standard of 25ng 7/71820 DNA exposed for both 48h (si) and 
2.5h (s2) and a mock (m) infected sample. The bands in lanes 3 and 4 migrate 
differently because of the large amount of DNA loaded into the wells.
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lane 2 which means that over 80% of the ini 820 DNA was lost by fractionation. Thus 
fractionation on caesium chloride gradients reduces the yield of latent genomes 
considerably but it is no longer necessary and hence more viral DNA will be available 
from the samples in the next generation of experiments. By comparison with the 25ng 
ini 820 standard following a 2.5h exposure of the autoradiograph with the 48h 
exposure, the unfractionated DNA in lane 1 contains at least 1.25ng of ini 814 DNA 
and in lane 2 probably 2.5ng if not more of inl820 DNA. This is from 8% of the 
original material i.e. from 560 000 cells since 7 x 10^ cells form the monolayer on a 
90mm diameter plate. As 10^ genomes approximates to 1.5ng, 1.25ng represents 
about 8 330 000 genomes. In other words this latency model has at least 15 viral 
genomes per host cell and justifies introducing the modifications to the system.
It has been demonstrated that the in vitro model of latency that has been developed 
has the features of the latent genome in vivo in that it is non-linear and it extends to 
more than 15 genomes per cell which should allow further investigation of latency at 
the molecular level.
4.12. Latent viral genomes can be reactivated from most of 
the cells in an infected monolayer.
To investigate further the presence of at least one viral genome in each latently 
infected cell in a monolayer a recombinant virus possessing the lacZ  gene was used. 
The virus, in i884, has the IE110 promoter driving the lacZ  gene inserted into the TK 
gene of ini 820. Expression of the inserted gene can be observed directly by the 
activity of its enzyme product, /3-galactosidase. The presence of /3-galactosidase can be 
demonstrated by the blue colouration of the cell produced when the enzyme is provided 
with the appropriate substrate. Since the latent genome is transcriptionally silent except 
for the LATs (Stevens et al., 1987) the recombinant virus can be used to investigate 
gene expression during latency. Reactivation can be effected by superinfection with 
1814R. To stop the spread of reactivated virus from cell to cell in the monolayer 
brefeldin A is included in the medium after the superinfecting virus has adsorbed. 
Brefeldin A (Pelham, 1991) blocks release of virions into the extracellular medium. It 
does not affect nucleocapsid formation but no enveloped virus particles are observed in 
the cytoplasm. Published studies indicate that brefeldin A induced retrograde 
movement of molecules from the Golgi to the endoplasmic reticulum early in infection 
arrests the ability of the host cell to support maturation and egress of enveloped viral
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particles (Cheung et al. , 1991). Unlike ara-C, brefeldin A will allow the reactivated 
genome to replicate and thus the signal will be higher and more easily detected. The 
blue colour arising from /3-galactosidase activity is a marker for each cell which has 
retained a latent viral genome and has been reactivated by the superinfecting virus. As 
is shown in table 4.9 and figure 4.4, the presence of /3-galactosidase is evident in the 
majority of the cells of a latently infected monolayer superinfected with 1814R, unlike 
the latently infected monolayer that has been mock superinfected and in which few cells 
stain blue (figure 4.5). The result shows that the IE110 promoter has been silenced by 
the establishment of the latent state. Although mock superinfection produces about 500 
blue cells and presumably represents a background of breakthrough virus, this accounts 
for less than 0.1 % of the total cells infected and does not significantly affect the results 
from this model nor their interpretation. As is seen in table 4.2 infection with 100 
particles of ini 820 per cell in an IFN-a pretreated monolayer still gives rise to the 
formation of 5 plaques. This similarly represents breakthrough virus although the 
numbers of plaques are only one hundredth of the breakthrough blue cells. The 
observation suggests that either there are genomes which have not undergone latent 
infection which are capable of transcribing but are unable to form detectable plaques or 
alternatively, it is a reflection of the sensitivity of the /3-galactosidase detection assay 
compared with plaque formation in this system. It has been found using ini 884 and 
looking for blue plaques under EHu5 that there are small plaques approximating in 
number to blue cells produced in the presence of brefeldin A (C.M. Preston, personal 
communication). At a lower moi of 7.5 particles per cell only about 20% of the cells 
become blue when superinfected with 1814R (table 4.9 and figure 4.6) This suggests 
that at this moi only 20% of the cells harbour a latent genome that can be reactivated, 
consistent with the results of previous investigators (Harris and Preston, 1991) who 
found that at a moi of 5 particles of ml 814 per HFL cell between 13 and 21% of cells 
contained a potentially active genome that could be reactivated by superinfection with 
tsK. Co-infection of M 884 and 1814R produce similar levels of blue cells (table 4.10) 
as are produced by the superinfection experiments (table 4.9). This result shows that 
superinfection is highly efficient at reactivating the genome to equate with the activity 
from a genome that has not been switched into the latent pathway but whose 
predisposition has been overcome by the co-infecting virus.
Therefore the high moi latency tissue culture model does give rise to at least one 
latent viral genome per cell which is transcriptionally silent but can be induced to be 
transcribed by superinfection. It is hypothesised that this induction of transcription is a 
model for reactivation of the latent viral genome in vivo.
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FIGURE 4.4: /3-GALACTOSIDASE ACTIVITY IN LATENTLY INFECTED CELLS 
AT HIGH MOI SUPERINFECTED WITH 1814R
HFL cells were grown on 30mm diameter plates and pretreated with IFN-a at 10  ^
units/ml for 16h. After the removal of the IFN-a the monolayers were infected with 
m l884 at 75 particles per cell and and the monolayer was maintained at 37°C for lh to 
allow adsorption and penetration of virus. Medium EF10 containing ara-C at 50^g/ml 
was added and incubation continued for 64h. At 64h, the monolayers were thoroughly 
washed with EF10 to remove the ara-C and superinfected with the 1814R at 5 pfu per 
cell. After lh to allow adsorption and penetration of the superinfecting virus, EF10 
containing brefeldin A at 3/xg/ml was added and incubation continued for a further 8h. 
The plates were then washed twice with ice cold PBS, fixed with 1% glutaraldehyde, 
washed again with PBS and stained for the presence of /3-galactosidase. Positively 
stained cells are blue. The monolayers were counterstained with carmalum which 
renders the remaining cells which are negative for /3-galactosidase, pink. Magnification
x 2.5.
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FIGURE 4.5: ff-GALACTOSIDASE ACTIVITY IN MOCK SUPERINFECTED
LATENTLY INFECTED CELLS
Latency was established in HFL cells with ml 884 and /3-galactosidase assayed as 
described in the legend to figure 4.4, but were mock superinfected after 64h in the 
presence of brefeldin A at 3^ig/ml. Positive blue cells (a) and background blue staining 
(b) also found on mock treated monolayers are indicated by arrows. Magnification x
2.5.
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FIGURE 4.6: ff-GALACTOSIDASE ACTIVITY IN CELLS LATENTLY INFECTED 
AT LOW MQI SUPERINFECTED WITH 1814R
Latency was established in HFL cells with ynl884 and 0-galactosidase assayed as 
described in the legend to figure 4.4, except a lower moi of 7.5 particles of 7771884 per
cell was used. Magnification x 2.5.
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It has been reported (Kosv-Vnenchak et al., 1992, Abstracts of the 17th 
International Herpesvirus Workshop, Edinburgh, Scotland.) that optimal immediate 
early and early HSV gene expression in cultured trigeminal ganglia requires the 
synthesis of viral DNA. To investigate whether this is the case in the tissue culture 
latency model, reactivation was effected in the presence or absence of the DNA 
synthesis inhibitor ara-C. As is shown in the results in table 4.9, when ara-C was 
omitted following superinfection there is no difference in the number of blue cells 
obtained compared with superinfection in the presence of ara-C. At a high moi a 
difference might not be apparent since the result is qualitative rather than quantitative in 
that one active genome will render a cell as blue as a cell with many active genomes. 
However, at lower moi ranging from 7.5 - 0.075 particles per cell the result is the 
same in that there is still no difference in the number of blue cells following 
superinfection of latently infected monolayers in the presence or absence of ara-C. The 
data shown in table 4.10 give the number of blue cells resulting from co-infecting with 
these two viruses at two moi of ini 884 as in the superinfecting experiments. It is the 
result of a single experiment and the proportion of blue cells arising from 75 and 7.5 
particles of ini 884 is lower than would be expected if compared with the data in table 
4.9. It is nevertheless clear from these two tables of data that superinfection is an 
efficient means of reactivating latent virus since the number of blue cells resulting from 
a superinfection is not less than those from a co-infection in which the predisposition of 
ini 884 to latency has been negated by the simultaneous presence of 1814R. These 
findings suggest that viral DNA synthesis is not required for activation of the IE110 
promoter upon superinfection, and imply that reactivation of the entire genome is not 
dependent upon genome replication.
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PARTICLES 
PER CELL OF 
in i884
SUPERINFECTION ARA-C BREFELDIN A NUMBER OR 
PROPORTION 
OF BLUE CELLS 
PER PLATE
75 mock + + 540 (—0.05%)
75 mock — + 423 (—0.04%)
75 1814R @ 5 pfu/cell + + >95%
75 1814R @ 5 pfu/cell — + >95%
7.5 1814R @ 5 pfu/cell + + — 20%
7.5 1814R @ 5 pfu/cell — + -20%
0.75 1814R @ 5 pfu/cell + + -5 %
0.75 1814R @ 5 pfu/cell — + -5 %
0.075 1814R @ 5 pfu/cell + + I o o o T o 5
0.075 1814R @ 5 pfu/cell — + -1000  (-0 .1% )
mock 1814R @ 5 pfu/cell — + 0
TABLE 4.9: fl-GALACTOSIDASE ACTIVITY FOLLOWING SUPERINFECTION 
OF LATENTLY INFECTED MONOLAYERS
Latency was established in HFL cells with in i884 and /3-galactosidase assayed as 
described in the legend to figure 4.4 except that the moi was varied and the monolayers 
were superinfected with mock or with 1814R at 5 pfu per cell in the presence of 
brefeldin A at 3/xg/ml and in the presence or absence of ara-C at 50/xg/ml. Blue, 
positively stained cells, were counted or determined as a proportion of the total number
of cells on the plate.
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PARTICLES 
PER CELL OF 
ini 884
CO-INFECTION ARA-C BREFELDIN A APPROXIMATE 
PROPORTION 
OF BLUE CELLS 
PER PLATE
500 1814R @ 5 pfu/cell + + 100%
500 1814R @ 5 pfu/cell — + 100%
75 1814R @ 5 pfu/cell + + 30%
75 1814R @ 5 pfu/cell — + 70%
7.5 1814R @ 5 pfu/cell + + 50%
7.5 1814R @ 5 pfu/cell — + 30%
TABLE 4.10: fl-GALACTOSIDASE ACTIVITY FOLLOWING CO-INFECTION
OF MONOLAYERS
HFL cell monolayers were co-infected with ini 884 and 1814R at the specified 
multiplicities in the presence of brefeldin A at 3^g/ml and in the presence or absence of 
ara-C at 50/xg/ml. The monolayers were washed at 8h post infection and cells 
expressing 0-galactosidase detected as descibed in the legend to figure 4.4.
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4.13. VmvvllO is required for the reactivation and expression 
of the lacZ Gene
Evidence that the transcriptional activator Vmwl 10 has a role in the reactivation of 
latent virus has been described above (section 1.3.5). In cells containing reactivated 
ml884, Vmwl 10 is provided by the superinfecting virus 1814R. It follows that if 
Vmwl 10 is required for the reactivation of latent ini 884, a superinfecting virus such as 
d/1403 with a mutation in the Vmwl 10 gene (Stow and Stow, 1986), should be unable 
to effect reactivation and this will be apparent by the failure of the superinfecting virus 
to turn latently infected cells blue when stained for /3-galactosidase activity. 
Monolayers latently infected with ini 884 at 75 particles per cell were mock 
superinfected or with d/1403 or 1814R. Reactivation was determined by quantifying 
the number of blue cells produced. The results are presented in table 4.11. Even with 
a high multiplicity of 5 pfu per cell the superinfecting virus d/1403 is still incapable of 
reactivating the latent virus ml 884. The result demonstrates the requirement for 
Vmwl 10 in this system to bring about transcriptional activation of the latent genome.
PARTICLES PER CELL SUPERINFECTION BLUE CELLS
OF ml 884 PER PLATE
75 mock 1 387 (-0.04% )
75 d/1403 @ 5 pfu/cell 1 729 (-0.07% )
75 1814R @ 5 pfu/cell >90%
TABLE 4.11: fl-GALACTOSIDASE ACTIVITY FOLLOWING SUPERINFECTION 
OF LATENTLY INFECTED MONOLAYERS WITH d/1403
Latency was established in HFL cells with ml 884 and 0-galactosidase assayed as 
described in the legend to figure 4.4 except that the monolayers were superinfected 
with mock, d/1403 or 1814R at 5 pfu per cell and following adsorption and penetration 
of the virus incubated in the presence of brefeldin A at 3/ng/ml. Blue, positively 
stained cells, were counted or determined as a proportion of the total number of cells
on the plate.
110
Results
The results presented in section 4.12. and figure 4.5. demonstrate that the IE110 
promoter driving the lacZ gene is inactive when ini 884 is in the latent state. The data 
presented in table 4.11 suggest that it is insensitive to Vmw65, which normally 
activates it. A feature of the latent herpesvirus genome is, with the exception of the 
LATs, its transcriptional silence (Stevens et al., 1987). Thus other promoters are 
inactive during latency in vivo. The inactivity of other promoters during latency in 
vitro was examined. The virus ini 883 is derived from ini 820 and has the inserted lacZ  
gene under the control of the HCMV promoter. It was used to examine the activity of 
the HCMV promoter during latency in the in vitro model. Monolayers latently infected 
with inl883 were mock superinfected or with d/1403 or 1814R. The data in table 4.12 
show that ini 883 behaves in the same manner as ini 884, confirming the transcriptional 
silence of the genome during latency with respect to another promoter. It was apparent 
during this experiment that the cells infected with ini 883 and reactivated by 1814R 
became blue at a much more rapid rate and more intensely than their ini 884 infected 
counterparts. This observation is explained by the greater potency of the HCMV 
promoter relative to the IE110 promoter. In a similar experiment the virus ini 835 was 
also used as the latently infecting virus. This mutant is derived from ini 814 and has 
the E. coli lacZ  gene under the control of the SV40 promoter replacing the LAT 
promoter. It too did not produce many blue cells following a mock superinfection, 
although just above a background count, and yet could also be reactivated efficiently if 
superinfected with 1814R. This result shows that another promoter gives the same 
effect as the HCMV promoter and the IE110 promoter, that the site of insertion is not 
critical and that ini 814 can be used as well as ini 820.
4.14. Thymidine kinase activity as a marker for reactivation 
of the latent genome
During latency in animal systems the TK gene, in common with the rest of the 
genome except LATs, becomes silent. Using the available mutants it is possible to 
investigate the activity of this gene during latency and after reactivation in the in vitro 
model. The mutant ini 820 has a normal TK gene but the superinfecting virus, ini 863, 
has a disruption in the TK gene. The mutant ihl863 is otherwise wild type. Thus any 
TK activity that is measured must reflect transcription from the ini 820 genome. 
Monolayers latently infected with ini 820 were superinfected with ini 863 and the cells 
harvested at either lh or 8h later following adsorption. The supernatant after lysis of 
the cells was retained for assay of TK activity. The results are presented in table 4.13.
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VIRUS SUPERINFECTION NUMBER OR 
PROPORTION OF BLUE 
CELLS PER PLATE
ini 883 @ 0.5 pfu/cell mock 823 (—0.08%)
ini 883 @0 . 5  pfu/cell d/1403 @ 5 pfu/cell 868 (—0.09%)
ini 883 @0 . 5  pfu/cell 1814R @ 5 pfu/cell >95%
ini 884 @ 75 p/cell mock 243 (—0.02%)
ini 884 @ 75 p/cell d/1403 @ 5 pfu/cell 436 (-0.04% )
ini 884 @ 75 p/cell 1814R @ 5 pfu/cell >95%
ini 835 @ 50 p/cell mock -1 %
ini 835 @ 50 p/cell 1814R @ 20 pfu/cell >95%
TABLE 4.12: THE HMCV Uni883) IE110 (ini 884) AND SV40 (ini 835) 
PROMOTERS ARE INACTIVE IN THE IN  VITRO LATENCY MODEL.
Latency was established in HFL cells with ini 884 and j3-galactosidase assayed as 
described in the legend to figure 4.4 and in addition latency was also established with 
ini 883 or ini 835. The titre of ini 883 was too low for a particle count, therefore the 
titre on BHK cells in the presence of HMBA was used. The monolayers were 
superinfected with mock, d/1403 or with 1814R at 5 pfu per cell in the presence of 
brefeldin A at 3/xg/ml. Blue, positively stained cells, were counted or determined as a 
proportion of the total number of cells on the plate.
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EXPERIMENTAL CONDITIONS CPM//xg PROTEIN
latent mock / mock superinfected 153 96 364
latent in i820 / mock superinfected nd nd 299
latent ini 820 / ini 863 superinfected lh 186 191 378
latent ini 820 / ini 863 superinfected 8h with ara-C 592 972 3093*
latent in i820 / ini 863 superinfected 8h without ara-C 1272 1244 4168
co-infected ini 820 and ini 863 8h with ara- C 686 635 3482
co-infected ini 820 and ini 863 8h without ara- C 927 848 2546
TABLE 4.13: THYMIDINE KINASE ACTIVITY OF LATENT AND
REACTIVATED ini 820
HFL monolayers were grown on 50mm diameter plates and pretreated with IFN-a at 
103 units/ml. Cells were mock or latently infected with ini 820 at 120 particles per cell 
for 63h or 70h. At 63h or 70h infected cells were mock superinfected or superinfected 
with ml 863 at 7.5 pfu per cell. At 63h uninfected cells were co-infected with ini 820 
at 120 particles per cell and in i863 at 7.5 pfu per cell. Ara-C was used at 50^tg/ml. 
At 72h all the plates were harvested and the cells lysed. The lysate was retained for the 
determination of thymidine kinase activity. The results of three experiments are shown 
and each figure is the mean of duplicate assays with the exception of the co-infected 
samples which were only performed singly and the result marked with an asterisk since 
the replicate sample gave a highly anomalous result of 13684 cpm//xg protein, nd =
not done
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The results given in the table 4.13 and compared with mock infected cells show that 
HFL cells latently infected with ini 820 have no detectable viral TK activity. This was 
expected in view of the absence of expression of the lacZ  gene from the ini 883, ini 884 
and ini 835 genomes during latency (sections 4.12 and 4.13). After superinfection for 
lh with ini 863 there was still no thymidine kinase activity measurable, but by 8h a 10 
fold increase in the enzyme activity from background was observed. This activity was 
at the same level as that produced by co-infecting the two viruses for 8h, showing that 
the reactivation of ini 820 by ihl863 is efficient. The absence of ara-C leads to a 
slightly greater activity as would be expected if the reactivated virus is permitted to 
replicate and consequently provide more expressible DNA.
4.15. Latent genome size and organisation
The genome of HSV-1 is a double stranded DNA molecule that is unit length and 
linear. The latent HSV-1 (F) genome lacks the terminal restriction fragments Bam HI s 
and p but has a bimolar joint fragment Bam HI sp generated by the fusion of s and p. 
This has been shown to be true in the in vitro latency system where the joint spanning 
Bam HI k fragment of HSV-1 strain 17 is generated by the fusion of the terminal 
fragments s and q (Harris and Preston, 1991 and section 4.10). It follows that the 
latent genome must be organised into an endless form. There are a number of physical 
structures which could give rise to an endless form and these are illustrated in figure
1.5. They are an autonomous circular molecule of either unit length or as a 
concatemer, a linear molecule of either unit length or concatemeric and integrated into 
the host cell genome or an autonomous linear concatemer. Current evidence favours an 
autonomous circular molecule of unknown size (Mellerick and Fraser, 1987).
It is possible using field inversion electrophoresis technology to separate large 
molecules of DNA and, furthermore, large linear molecules from circular molecules of 
the same size. Linear molecules have a greater mobility than circular molecules 
although the precise mechanisms underlying the migratory properties of these 
molecules is not understood (Hightower and Santi, 1989). Nuclear material of infected 
cells was embedded in agarose and electrophoresed in a field subjected to inversion. 
To avoid the viral genomes becoming entangled with the high molecular weight cellular 
DNA and thus impeding their progress in the gel, the agarose blocks were exposed 
toAse I. No restriction site exists for this enzyme in the ini 820 genome and it will
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FIGURE 4.7: SEPARATION OF COMPLETE LYTIC AND LATENT VIRAL 
GENOMES FROM HOST CELL DNA
Mock (lane 4), lytically (lane 3) or latently (lane 2) infected cells embedded in agarose 
blocks were digested with proteinase K and then with 200 units of Ase I for 4h prior to 
loading on a 1 % agarose gel. Other lytically infected cells (lane 1) embedded in 
agarose blocks were digested with proteinase K but not Ase I. Lytically infected cells 
had been infected with 1814R at 15 pfu per cell for 6h and latently infected cells, 
following IFN-a pretreatment, with ml 820 at 120 particles per cell in the presence of 
50jug/ml ara-C for 48h before harvesting. Field inversion electrophoresis with a field 
strength of 120 - 180 volts on a logarithmic scale was performed using a Rotaphor at 
13°C over 48h. The other parameters were a switching interval of 5 - 90s on a linear 
scale and a switching angle of 235° - 250° on a logarithmic scale. The samples were 
electrophoresed from the front of the chamber and the field moved with the power on.
The gel was depurinated prior to Southern blotting and hybridisation with the ^2p_ 
radiolabelled 2.4kb fragment from pTKl.
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therefore remain intact whether circular or linear whereas the host genome will be 
extensively digested. The result is seen in figure 4.7.
No hybridisation to mock infected HFL cell was detected (lane 4). In lane 1 there 
is a large amount of viral DNA high up in the gel as well as lower down. The lower 
band corresponds to a lambda ladder marker of 145.5 kb (not shown) when the gel was 
photographed under ultraviolet illumination. This approximates to 150kb and 
presumably represents the unit length 1814R genome. The DNA at the top of the gel 
must represent higher orders of organisation during replication such as rolling circles. 
Since 1814R is vulnerable to digestion with Ase I it appears as a smear in lane 3 which 
runs beyond the unit length representing digestion to fragments less than 150kb. In 
lane 2 there are two distinct populations of in\ 820 DNA. The lower band is unit length 
linear DNA but at the top of the gel there is a band of DNA of a different organisation. 
It is suggested that this is the latent ini 820 genome. It is not possible to determine 
whether this is a unit length or concatemeric circular molecule nor whether it is 
integrated or autonomous. No quantitative comparison between the two bands is valid 
because the differences in physical organisation of the DNA might affect efficiency of 
transfer to the hybridisation membrane.
The utilisation of field inversion electrophoresis was technically very demanding 
and frustrating. One early experiment was very suggestive of an autonomous latent 
genome migrating more slowly than the viral DNA from lytically infected cells but 
despite intensive efforts to optimize the experimental conditions this could not be 
repeated. It should be possible to refine the technique to a much higher degree and the 
results, a typical example of which is shown in figure 4.7, would be much improved. 
The technology opens up the possibility of exploring and exploiting the differences in 
structure between lytic and latent genomes and once the optimal conditions for 
separating the two have been determined it should be feasible to investigate the 
temporal aspects of the changes between the structures and how this relates to the 
establishment of and reactivation from latency.
4.16. Latent viral DNA is associated with a nuclear 
substructure
The existence of a nucleoskeleton has been hypothesised as a necessary structure to 
organise the chromatin in the nucleus. However, the presence of such a structure has
116
Results
been controversial because the various candidates which include matrices, scaffolds and 
cages have all been isolated under very non-physiological conditions. One method 
involves extraction of the subnuclear components using high concentrations, such as 
2M, of salt. This yields a variety of complexes termed ghosts, matrices, scaffolds, 
folded chromosomes and nuclear cages. Others have claimed that the structures 
detected microscopically are merely results of coagulation arising during the isolation 
procedures. Thus sceptics have argued that the nuclear substructures are isolation 
artefacts with no counterparts in vivo (Cook, 1988). It is not surprising therefore that 
there is little agreement as to the nature of the nucleoskeleton which is synonymously 
called the nuclear matrix or the nuclear scaffold.
Conditions approximating physiological have been used to demonstrate successfully 
that essentially all active polymerases are attached to a nuclear structure (Jackson and 
Cook, 1986a; 1986b; Jackson et al. , 1988) and that this is the active site of replication 
and transcription (Jackson and Cook 1985b; 1986a). This structure has been termed 
the nucleoskeleton (Jackson and Cook 1985a; 1985b) to distinguish it from those 
isolated under hypertonic conditions.
Nascent DNA is looped by attachment to the skeleton and interest has centred on 
whether this is determined by specific sequences. If attachment is specific then the 
sequence involved should resist nucleolytic attack and pellet with the nuclear 
substructure. If there is no specificity in the attachment then there will be neither 
enrichment nor depletion of a particular sequence in the pellet. Specific association has 
been demonstrated by incubating matrices with pure DNA fragments (Cockerill et al., 
1987) and matrix-associated regions have been functionally defined (Cockerill and 
Garrard, 1986; Gasser and Laemmli, 1986; Webb et al., 1991) The attachment 
hypothesis provides the nucleoskeleton with an active rather than a passive role. Gene 
activation and inactivation is envisaged as being related to attachment and detachment 
to the skeleton which is dynamic, existing in different forms and in a constant flux 
between assembly and disassembly. Nuclear matrix proteins may be expressed in a cell 
specific manner (Fey and Penman, 1988). Thus the nucleoskeleton has a potential role 
in gene expression through the association with DNA via the matrix-associated regions 
(Cockerill and Garrard, 1986) and the cell specific proteins of which it is composed.
Integrated viral genes in cell lines transformed by polyoma virus or avian sarcoma 
virus lie close to the point of attachment to the nuclear substructure (Cook et al., 
1982). The in vitro tissue culture model provides the opportunity to investigate
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whether the herpesvirus genome associates with the nucleoskeleton either during a 
productive or latent infection and if this regulates its expression.
To investigate the possibility of the HSV-1 genome associating with the nuclear 
matrix, nuclear preparations were made from cells variously infected with in\ 820. The 
sub-nuclear structure, the matrix, was extracted from the nuclei using a high 
concentration of salt and collected on a sucrose cushion. To show that the nuclei had 
been further fractionated both the pellet and the supernatant arising from the matrix 
preparation were assayed for protein content by the Bradford method (Bradford, 1976). 
The pellet fraction yielded up to 17/zg of protein and the supernatant up to 40/zg. The 
combined pellet and supernatant protein content approximates to about 10% of the total 
cellular protein which is the predicted amount in a nuclear preparation. The 
photograph of the stained gel (figure 4.8a) shows that the cellular DNA is largely 
present in the pellet with very little appearing in the supernatant i.e. the reverse of the 
protein distribution, thereby validating the method used as a successful fractionation 
technique.
Figure 4.8a shows that the DNA is confined to the pellet fraction with the exception 
of lane 6 where more DNA is present in the supernatant. This is due to contamination 
of the supernatant fraction with material from the corresponding pellet fraction. This 
was evident during the preparation and is because of the viscosity of the matrix which 
makes a clean separation difficult. This difficulty is also the reason for the loss of the 
DNA from lane 5 which was also apparent during the preparation. The material from 
one sample is shown in two lanes (4) and the outside lane of these two is shown in part 
(b) since this lane contains the DNA. Thus all the DNA in the nucleus is contained 
within the nuclear subffaction. The viral DNA is also confined to this fraction as is 
shown in figure 4.8b. This co-purification of the viral genome and the host cell matrix 
is apparent in the early stages of latent infection at lh (lanes 9 and 10), 8h (lanes 7 and 
8) as well as when latency is fully established by 72h (lanes 1-4).
118
pellet
1 2 3 4 5 6 7 8 9  10 4
Results
supernatant
1 2 3 4 5 6 7 8 9  10 4
FIGURE 4.8(a): UNDER CONDITIONS PREDISPOSING TO LATENCY THE 
VIRAL DNA IS ASSOCIATED WITH THE NUCLEAR SUBSTRUCTURE
IFN-a pretreated monolayers were infected with ml 820 for lh (lanes 9 and 10), 8h 
(lanes 7 and 8) or 72h (lanes 1 - 6) in the presence of ara-C. The samples in lanes 5 
and 6 were from monolayers superinfected with ml 863 8h prior to harvesting. 
Matrices were prepared and also the top half of the supernatant fraction retained. Both 
supernatant (250/xl) and pellet (100/xl) fractions were incubated with proteinase K 
overnight, the DNA extracted, cleaved with 30 units of Eco RI for 3h and 25/txl 
electrophoresed in a 1 % agarose gel for 18h. The gel was photographed under 
ultraviolet light. The top half of the panel is material from the pellet fraction and the 
bottom half from the supernatant fraction.
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FIGURE 4.8(h): UNDF.R CONDITIONS PREDISPOSING TO LATENCY VIRAL 
DNA IS ASSOCIATED WITH THE NUCLF.AR SUBSTRUCTURE
The gel shown in figure 4.8(a) was blotted and the membrane hybridised with the
radiolabelled 2.4kb fragment from pTKl.
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The results of a similar experiment to investigate whether an association with the 
matrix also occurs during a lytic infection are shown in figures 4.9a and 4.9b. The 
revertant 1814R was used to infect cells in the presence or absence of replication and 
protein synthesis inhibitors. When replication was allowed to continue for 8h after 
inoculation viral DNA was present both in the pellet and supernatant fractions, lanes 1 
and 2, as would be expected. The DNA present in the supernatant fraction presumably 
represents progeny genomes. This distribution between matrix and nucleoplasm was 
prevented by the presence of cycloheximide as is shown in lanes 5 and 6. Lanes 3 and 
4 show that inhibition of replication by ara-C confined the productively infecting 
genome to the nuclear substructure. Since 1.5ng represents 10^ genomes, the intensity 
of the band in lane 12 approximates to 16 x 10^ genomes. The monolayer was infected 
at 800 particles per cell which is 160 x 10^ particles per plate and half of the 
preparation was run on the gel. Thus the intensity of the bands in the pellet fractions 
is, as; expected, greater than the intensity of the band in lane 12. Taken together the 
results shown in figures 4.8b and 4.9b indicate that viral DNA associates with the host 
cell nuclear substructure early in infection irrespective of whether it then becomes 
productive or latent.
i
Ii
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FIGURE 4.9a: WILD TYPE VIRAL DNA IS ASSOCIATED WITH THE 
NUCLEAR SUBSTRUCTURE EARLY IN INFECTION
Monolayers were inoculated with 1814R at 800 particles per cell (lanes 1 - 8) or mock 
infected (lanes 9 and 10) and incubated for a total of 8h under various conditions with 
or without inhibitors of protein synthesis, effected by cycloheximide or replication, 
effected by ara-C. No inhibitors were present in lanes 1 and 2, ara-C was present in 
lanes 3, 4, 7 and 8 and cycloheximide was present in lanes 5, 6, 7 and 8. Pellet or 
matrix (p) and supernatant (s) fractions were prepared and are denoted by odd and even 
numbers respectively. The fractions were incubated with proteinase K overnight, the 
DNA extracted, dissolved in 100/xl of buffer, cleaved with 50 units of Eco RI for 2.5h 
and 50/xl electrophoresed in a 0.6% agarose gel for 18h. Two standards of 5 and 25ng 
of DNA were run in lanes 11 and 12 respectively. The gel was photographed under 
ultraviolet light. Material apparent between lanes 1 and 2 arises from overspill of
DNA from lane 1.
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FIGURE 4.9b: WILD TYPE VIRAL DNA IS ASSOCIATED WITH THE 
NUCLEAR SUBSTRUCTURE EARLY IN INFECTION
The gel shown in figure 4.9a was blotted and the membrane hybridised with the 32P-
radiolabelled 2.4kb fragment from pTKl.
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4.17. The latent viral genome in viiro does not have a 
chromatin-like structure
Earlier investigators have found that during latency the viral DNA is associated 
with nucleosomes in a chromatin structure (Deshmane and Fraser, 1989). Micrococcal 
nuclease attacks the linker regions between the nucleosomes in chromatin and generates 
a series of multimeric units based on the 140bp nucleosomal core (Whitlock and 
Simpson, 1976). These can be visualised as a ladder when run in a 2% gel. If the 
number of units of the enzyme or the incubation time is increased a more extensive 
digestion occurs with fewer large multimers and many more smaller ones produced. 
To examine whether the HSV-1 DNA in the in vitro latency model associates with 
histones to form chromatin, HFL monolayers variously infected with virus were 
subjected to micrococcal nuclease digestion. The results are shown in figures 4.10a, 
4 .10b, 4.1 la  and 4.1 lb. The photographs of the stained gels, figures 4 .10a and 4.1 la, 
show the nucleosomal ladder produced by digestion of all the extracted DNA. 
However, the viral DNA whether in the early stages of infection or when latent, as 
shown in figure 4 .10b, does not give rise to this pattern. In addition, there is much 
more viral DNA near the origins of those tracks from the early stages of infection 
(lanes 1 - 12) than in the tracks from a latent infection (lanes 13 - 15). This 
observation suggests that the viral DNA is more resistant to digestion early in infection 
than when latent and this is investigated later. The reduced amount of hybridisation in 
lane 13 (figure 4.10b) is probably a result of poor transfer of high molecular weight 
DNA to the membrane since there is a reasonable quantity present in the gel well prior 
to Southern blotting (figure 4.10a). Depurination of the DNA (see section 4.15) was 
not performed for this experiment.
To confirm that the non-nucleosomal structure of the viral DNA is not merely a 
feature of the TK gene, pTKl transformed 143TK-  cells which have the TK gene 
under the control of the TK promoter, were also subjected to micrococcal nuclease 
digestion. This cell line consists of a mixture of colonies from 143TK-  cells 
transformed with pTKl and was donated by M. McFarlane. Figure 4.11b shows that 
the TK gene in this cell line is nucleosomal, in contrast with the same gene in latently 
infected untransformed cells.
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FIGURE 4.10a: TOTAL DNA FROM HSV-1 INFECTED HFL CELLS PRODUCES 
A NUCLEOSOMAL PATTERN WHEN DIGESTED WITH MICROCOCCAL
NUCLEASE.
HFL monolayers on 50mm diameter plates and variously infected with virus were 
harvested, lysed and their DNA subjected to micrococcal nuclease digestion. The 
extracted DNA was redissolved in 100/xl of water containing 10/xg of ribonuclease and 
50/u.l was electrophoresed in a 2% gel composed of 1.5% NuSieve®, 0.5% agarose 
and ethidium bromide at 0.5/xg/ml. The gel was photographed under ultra violet light. 
Lanes 1, 2, 3,7,8 and 9 were infected with wild type HSV-1 at 120 particles per cell. 
Lanes 4, 5, 6 and 10 to 15 were infected with /nl820 at 120 particles per cell. The 
virus was present for lh (lanes 1-6) ,  8h (lanes 7 - 12) or had established latency ( I S ­
IS). Lanes 7 - 1 5  had been treated with ara-C but only lanes 13-15 pretreated with 
lFN-a. Lanes 1, 4, 7, 10 and 13 were digested for 0 min, lanes 2 ,5, 8, 11 and 14 for 
2 min and lanes 3, 6, 9, 12 and 15 for 5 min with 7.5 units of micrococcal nuclease.
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FIGURE 4.10b: VIRAL DNA DOES NOT FORM NUCLEOSOMES WHEN 
DIGESTED WITH MICROCOCCAL NUCLEASE.
The gel shown in figure 4 .10a was blotted and the membrane hybridised with the 32p_
radiolabelled 2.4kb fragment from pTKl.
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FIGURE 4.11a: TOTAL DNA FROM MOCK AND LATENTLY INFECTED HFL 
CELLS AND IN A pTKl TRANSFORMED CELL I.INE IS NUCLEOSOMAL
HFL cells mock (lanes 1 - 4) or latently infected with ml 820 at 120 particles per cell 
(lanes 5 - 8) or pTKl transformed cells (lanes 9-12)  were grown on 50mm diameter 
plates, harvested, lysed and their DNA subjected to micrococcal nuclease digestion. 
Lanes 1, 5 and 9 were digested for 0 min, lanes 2 ,6 and 10 for 2 min with 7.5 units, 
lanes 3, 7 and 11 for 10 min with 22.5 units and lanes 4 ,8 and 12 for 30 min with 45 
units, of micrococcal nuclease. The extracted DNA was redissolved in 100/H of water 
containing lO t^g of ribonuclease and 30/xl was electrophoresed in a 2% gel composed of 
1.5% NuSieve®, 0.5% agarose and ethidium bromide at 0.5^tg/ml. The gel was 
photographed under ultra violet light.
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FIGURE 4.11b: THE TK GENE IS NUCLEOSOMAL IN A pTKl TRANSFORMED 
CELL LINE BUT NOT IN THE LATENT VIRAL GENOME
The gel shown in figure 4.1 la. was blotted and the membrane hybridised with the 32p-
radiolabelled 2.4kb fragment from pTKl.
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4.18. The latent viral genome is more sensitive to micrococcal 
nuclease digestion than in the early stages of infection
Although some of the proteins associated with the viral genome including the DNA- 
binding and nucleocapsid proteins have been described, very little is known about the 
proteins which are associated with the intracellular viral genome. The term 
',u1ncoating,l has been used to describe the processes involved in the preparation of the 
input genome for expression and this envisages some form of change to the nature or 
disjtribution of the proteins on the viral DNA. It is likely that during transcription, 
replication and latency the DNA will have a different arrangement of these proteins. 
Thue nature of these proteins, the degree or extent of their association may well be 
reflected in the sensitivity of the genome to digestion with nucleases. Increased 
sensitivity to digestion with DNase I has been reported to be associated with changes in 
conformation (Axel et al., 1978; Elgin, 1982) and others have documented parental 
HSV-1 DNA being converted within the first hour of infection to a form sensitive to 
DNase I and suggested to be concomitant with the "uncoating" of the genome 
(Oberman and Panet, 1989). The result shown in figure 4.10b. suggests that early in 
infection the viral genome is more resistant to micrococcal nuclease digestion than 
when it has become latent. To explore this further, the DNA from ini 820 infected 
cells digested with micrococcal nuclease was further cleaved with Eco RI. This yields 
a 2.4kb band which will hybridise with its counterpart, the 2.4kb Eco RI fragment, 
pTKl. The degree of sensitivity to micrococcal nuclease will be reflected in the 
amount of DNA recovered in this band. The more sensitive the DNA is, the less will 
be seen on hybridisation. Figures 4 .12a and 4 .12b show that the latent viral genome is 
much more sensitive to digestion than the genome which has only been in the cells for 
2.5h. The degree of sensitivity is displayed in table 4.14. It shows that early in 
infection 42% of the viral DNA was digested by a 30 minute exposure to 45 units of 
micrococcal nuclease whereas in latently infected cells 80% of the viral DNA was 
digested by the same treatment. Also shown in table 4.14 are the absolute values of the 
viral DNA early and late in infection but before digestion with micrococcal nuclease. 
There was a loss of 35% of the viral DNA when latency had been establised at 72h 
compared with the amount of DNA present shortly after infection.
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FIGURE 4.12a: THE LATENT VIRAL GENOME IS MORE SENSITIVE TO 
MICROCOCCAL NUCLEASE DIGESTION THAN SHORTLY AFTER INFECTION
HFL monolayers on 50mm diameter plates were infected with ini 820 at 120 particles 
per cell. Following adsorption and penetration of the virus for lh, the infection was 
continued for a further 1.5h (lanes 1 - 5) or 72h i.e. into latency (lanes 6 - 10). The 
lysed nuclei were digested with micrococcal nuclease as follows: lanes 1 and 6, 0 units 
for 0 min; lanes 2 and 7, 7.5 units for 2 min; lanes 3 and 8, 22.5 units for 5 min; lanes 
4 and 9, 22.5 units for 15 min and lanes 5 and 10 with 45 units for 30 min. The 
extracted, digested DNA was cleaved with 10 units of Eco RI for 12h in a 100/xl 
reaction and 25fil electrophoresed in a 1 % agarose gel for 18h. The gel was 
photographed under ultra violet light.
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FIGURE 4.12h: THE LATENT VIRAL GENOME IS MORE SENSITIVE TO 
MICROCOCCAL NUCLEASE DIGESTION THAN SHORTLY AFTER INFECTION
The gel shown in figure 4 .12a. was blotted and the membrane hybridised with the 32p.
radiolabelled 2.4kb fragment from pTKl.
131
Results
DURATION
OF
INFECTION
EARLY (1.5h) LATENT (72h)
ENZYME
UNITS
0 7.5 22.5 22.5 45 0 7.5 22.5 22.5 45
DIGESTION 
TIME (min)
0 2 5 15 30 0 2 5 15 30
% OF DNA 
PRESENT
100 108 101 71 58 100 32 26 30 20
ABSOLUTE VALLIE AT 0 MINUTES % LOSS OF DNA
EARLY (1.5h) LATENT (72h)
34043 22136 35
TABLE 4.14; QUANTIFICATION OF THE SENSITIVITY OF THE VIRAL 
GENOME TO MICROCOCCAL NUCLEASE SHORTLY AFTER INFECTION AND
DURING LATENCY
The DNA bands shown in the autoradiograph depicted in figure 4.12b. were quantified 
by storage phosphor technology. The amount of DNA present in the band at 0 min and
0 units is arbitrarily defined as 100%.
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Since there is a marked difference in the sensitivity of the genome when latent 
compared with soon after infection it was decided to follow the change in sensitivity as 
the genome proceeds to latency. The results are shown in figures 4.13a and 4.13b and 
table 4.15. HFL cells were infected with m l820 under conditions predisposing to 
latency. The monolayers were harvested and the nuclei extracted at 1, 8, 16, 24 and 
72h after adsorption and penetration of virus and the DNA digested with micrococcal 
nuclease. The data show that a significant change in the sensitivity to micrococcal 
nuclease had occurred by 16h, when 74% of the viral DNA had been digested, and this 
change persisted to 72h when there was still 70% digestion of the viral DNA. The 
DNA had acquired nearly all of this significant sensitivity to micrococcal digestion at 
8h in the absence of IFN when 63% had been digested, which suggests that a structural 
change in the genome as it becomes latent occurs by about 8h following adsorption and 
penetration of the virus. The loss of viral DNA relative to the amount at lh after 
infection and as latency was established is also shown in table 4.15. This was 
considerable at 78% and is much more than the 35% lost in the earlier experiment 
shown in table 4.14. In the data from table 4.14 the first value was from material 
infected for half and hour longer than the corresponding value in table 4.15 which 
would account for part of the difference. It is evident that as latency is established 
there is a significant loss of the input DNA presumably destroyed by cellular processes. 
The result at 8h in the presence of IFN was not consistent with the others and it was 
suspected that there was some loss of DNA in the sample digested with 0 units as can 
be appreciated from lane 5 in figure 4.13a and would account for the anomaly. This 
was confirmed by the results shown in figures 4 .14a and 4 .14b and table 4.16.
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FIGURE 4.13a: INCREASE IN SENSITIVITY TO MICROCOCCAL NUCLEASE 
DIGESTION AS THE VIRAL GENOME PROCF.F.DS TO LATENCY.
Nuclei from cells infected with in i820 at 120 particles per cell from lh to 72h were 
subjected to digestion with micrococcal nuclease. Each successive digest in a quartet 
from left to right is with 0 units for 0 min (lanes 1, 5, 9, 13, 17 and 21); 7.5 units for 
2 min (lanes 2, 6 ,10, 14, 18 and 22); 22.5 units for 10 min (lanes 3, 7, 11, 15, 19 and 
23) and 45 units for 30 min (lanes 4, 8, 12, 16, 20 and 24). Following digestion the 
DNA was extracted and cleaved with 10 units of Eco RI for 18h in a 100/nl reaction 
and 25fi\ electrophoresed in a 1 % agarose gel for 18h. The gel was photographed 
under ultra violet light. Comigrating bands in the undigested samples arise from Eco
RI restriction of cellular DNA
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FIGURE 4.13h: INCREASE IN SENSITIVITY TO MICROCOCCAL NUCLEASE 
DIGESTION AS THE VIRAL GENOME PROCEEDS TO LATENCY.
The gel shown in figure 4 .13a. was blotted and the membrane hybridised with the ^2p_
radiolabelled 2.4kb fragment from pTK l.
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UNITS (u) OF 
ENZYME/TIME 
(min) OF 
INCUBATION
% VIRAL DNA PRESENT AT VARIOUS TIMES FOLLOWING
INFECTION
lh 8h +IFN 8h -IF N 16h 24h 72h
(0 u/0 min 100 100 100 100 100 100
7.5 u/2 min 73 181 64 68 59 82
22.. 5 u/10 min 75 135 38 33 21 38
45 u/30 min 59 110 37 26 12 30
ABSOLUTE VALUE AND % OF VIRAL E 
FOLLOWING INFECTION PRIOI 
MICROCOCCAL N1
>NA LOST AT VARIOUS TIMES 
1 TO DIGESTION WITH 
(JCLEASE
lh 8h -IFN 16h 24h 72h
0 u/0 min 
% loss relative to lh
354182
100
198364
44
124877
65
130331
63
76801
78
TABLE 4.15; QUANTIFICATION OF MICROCOCCAL NUCLEASE 
SENSITIVITY OF THE VIRAL GENOME AS IT PROGRESSES TO LATENCY
The DNA bands shown in the autoradiograph depicted in figure 4.13b. were 
quantified by storage phosphor technology. The DNA band present at 0 min and 0
units is arbitrarily defined as 100%.
IFN-a has been used in the in vitro latency model to further reduce VmwllO 
expression and thereby enhance the tendency of ini 820 to proceed to the latent form. 
The effect of IFN-a pretreatment on the acquisition of increased sensitivity to 
micrococcal nuclease by the viral genome was investigated. From the results shown in 
figures 4 .14a and 4 .14b and table 4.16 it is apparent that at 8h there is no difference in 
sensitivity between monolayers pretreated with IFN-a and those untreated subsequently 
infected with ini 820. The result is similar to that in table 4.15 from an 8h infection in 
the absence of IFN. Thus 63 - 64% of the viral DNA had become sensitive to 
digestion with micrococcal nuclease at 8h after penetration of the virus whether IFN 
was present or not. There was no change in the absolute amounts of viral DNA at 8h 
in IFN-a! treated cells compared with untreated cells.
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FIGURE 4.14a: THE EFFECT OF IFN-a ON THE MICROCOCCAL NUCLEASE 
SENSITIVITY OF THE VIRAL GENOME 8h AFTER INFECTION
HFL cells grown on 50mm diameter plates and either pretreated with IFN-a at 10^ 
units/ml or untreated were infected with 120 particles per cell of /nl 820 for 8h in the 
presence of ara-C at 50/xg/ml. Nuclei were digested with micrococcal nuclease as 
follows: 0 units for 0 min (lanes 1 and 5); 7.5 units for 2 min (lanes 2 and 6); 22.5 
units for 10 min (lanes 3 and 7) and 45 units for 30 min (lanes 4 and 8). Following 
digestion the DNA was cleaved with 10 units of Eco RI for 18h in a 100/d reaction and 
25/d electrophoresed in a 1 % agarose gel for 18h. The gel was photographed under
ultra violet light.
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FIGURE 4.14b: THE EFFECT OF IFN-a ON THE MICROCOCCAL NUCLEASE 
SENSITIVITY OF THE VIRAL GENOME 8h AFTER INFECTION
The gel shown in figure 4 .14a. was blotted and the membrane hybridised with the 32p_
radiolabelled 2.4kb fragment from pTKl.
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UNITS (u) OF 
ENZYME/TIME (min) 
OF INCUBATION
% VIRAL DNA PRESENT 
FOLLOWING INFECTION FOR 8h
NO IFN-a IFN-a
0 u/0 min 100 100
7.5 u/2 min 83 84
22.5 u/10 min 44 26
45 u/30 min 36 36
ABSOLUTE VALLFE AT 0 MINUTES % LOSS OF DNA
8h -IF N 8h +IFN
55195 54432 1.4
TABLE 4.16: QUANTIFICATION OF THE EFFECT OF IFN-a ON THE 
MICROCOCCAL NUCLEASE SENSITIVITY OF THE VIRAL GENOME 8h
AFTER INFECTION
The DNA bands shown in the autoradiograph depicted in figure 4 .14b. were quantified 
by storage phosphor technology. The DNA band present at 0 min and 0 units is
arbitrarily defined as 100%.
4.19. Micrococcal nuclease sensitivity of reactivated latent 
DNA
Earlier experiments (section 4.14 and table 4.13) have demonstrated that ini 863 is 
able to reactivate latent in i820. The mutant ini 863 is wild type virus with the HCMV 
promoter driving the lacZ  gene inserted into the TK gene. Cleavage with Eco RI 
produces a 2.0kb and a l.Okb fragment from the TK gene due to the presence of an 
Eco RI site in the inserted gene. Since similar digestion of in i820 produces a 2.4kb 
fragment from the TK gene it is possible to identify both viruses when present together 
by hybridisation with the 2.4kb pTKl ^ P - r a d i o l a b e l l e d  fragment. Experiments were 
undertaken to investigate the micrococcal nuclease sensitivity of the reactivated latent
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genome. The micrococcal nuclease sensitivity of the reactivated ini 820 genome and 
the in i863 genome after superinfection, but without replication, for lh and 8h is shown 
in figure 4.15b and table 4.17. The upper bands in the first quartet represent the TK 
gene of the latent in i820 after lh superinfection with in i863. It was more sensitive to 
micrococcal nuclease digestion than the middle and lower bands which represent the 
TK gene from the superinfecting virus. This is shown by the digestion of 63% of the 
latent genome by 45 units of micrococcal nuclease at 30 minutes compared with only 
35% of the superinfecting genome. In the second quartet the effect of superinfection 
for 8h is shown. The upper band from the latent virus, now presumably accessible for 
transcription, showed the same sensitivity i.e. 63% digestion as the latent genome 
whereas the superinfecting genome, also transcriptionally active, remained relatively 
resistant with only 33% at a maximum being digested after the same incubation. The 
results show that the latent genome, despite being reactivated, still remains sensitive to 
the nuclease. The superinfecting genome however, continues to be relatively resistant 
even after 8h.
To illustrate this point further the experiment above was repeated with different 
viruses so that the latent genome sensitive to micrococcal nuclease digestion will be 
apparent in the middle and lower bands of a quartet and the relatively resistant 
transcribing input DNA in the upper band of a quartet. Latent ini 884 was reactivated 
by superinfection with 1814R. Eco RI digestion of 1814R will produce a 2.4kb 
fragment and of in i884 two smaller fragments, of size 2.0 and l.Okb, when hybridised 
with pTKl. This is the reverse situation of the experiment in figures 4.15a and 4.15b 
and table 4.17 and is shown in figures 4.16a and 4.16b and table 4.18. The result 
confirmed the findings of continuing sensitivity of the latent genome even when 
reactivated with 66% and 83% digestion occuring at the end of the defined incubation 
time after lh and 8h from superinfection respectively and the relative resistance of the 
superinfecting non-replicating viral DNA with 34% and 44% digestion under the same 
conditions. In figure 4 .16b two exposures of the same blot are shown. The difference 
in sensitivity between the latent and the superinfecting virus can be appreciated by 
comparing the two panels since the intensity of the band in the lower panel representing 
1814R has been made comparable to the intensity of the middle band in the upper panel 
which represents the latent virus m l884.
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FIGURE 4.15a; MICROCOCCAL NUCLEASE SENSITIVITY OF REACTIVATED 
AND SUPERINFECTING GENOMES IN THE PRESENCE OF ARA-C
HFL monolayers on 50mm diameter plates mock (lanes 5 and 6 ) or latently infected 
with 2/71820 at 120 particles per cell (lanes 1 - 4  and 7-10)  were superinfected with
7.5 pfu per cell of 2/71863 and maintained for lh (lanes 1 - 4) or 8h (lanes 7 - 10) in the 
presence of ara-C. Digestion with micrococcal nuclease was as follows: lanes 1, 5 and 
7, 0 units for 0 min; lanes 2 and 8, 7.5 units for 2 min; lanes 3 and 9, 22.5 units for 10 
min and lanes 4, 6 and 10, 45 units for 30 min. All the samples were cleaved with 10 
units of Eco RI in a 100/zl reaction for 18h and 25fi\ was run in a 1 % agarose gel. The 
gel was photographed under ultra violet light.
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FIGURE 4.15b: MICROCOCCAL NUCLEASE SENSITIVITY OF REACTIVATED 
AND SUPERINFECTING GENOMES IN THE PRESENCE OF ARA-C
The gel shown in figure 4 .15a. was blotted and the membrane hybridised with the 32p_
radiolabelled 2.4kb fragment from pTKl.
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DURATION OF 
SUPERINFECTION
lh 8h
ENZYME UNITS (u) 0 7.5 22.5 45 0 7.5 22.5 45
INCUBATION TIME 
(min)
0 2 10 30 0 2 10 30
%DNA
2.4kb 100 77 38 27 100 50 35 27
2.0kb 100 123 78 65 100 64 60 67
l.Okb 100 133 82 66 100 68 69 82
TABLE 4.17: QUANTIFICATION OF MICROCOCCAL NUCLEASE 
SENSITIVITY OF REACTIVATED AND SUPERINFECTING GENOMES IN THE
PRESENCE OF ARA-C
The DNA bands shown in the autoradiograph depicted in figure 4.15b were quantified 
by storage phosphor technology. The DNA band present at 0 min and 0 units is
arbitrarily defined as 100%.
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FIGURE 4.16a: MICROCOCCAL NUCLEASE SENSITIVITY OF REACTIVATED 
AND SUPERINFECTING GENOMES IN THE PRESENCE OF ARA-C
HFL monolayers on 50mm diameter plates latently infected with ml 884 at 120 
particles per cell were superinfected with 7.5 pfu per cell of 1814R and maintained for 
lh (lanes 1 - 4) and 8h (lanes 5 - 8) in the presence of ara-C. Digestion with 
micrococcal nuclease was as follows: lanes 1 and 5, 0 units for 0 min; lanes 2 and 6,
7.5 units for 2 min; lanes 3 and 7, 22.5 units for 10 min and lanes 4 and 8, 45 units for 
30 min. The samples were cleaved with 10 units of Eco RI for 18h in a 100/d reaction 
and 25jd run in a 1 % agarose gel. The gel was photographed under ultra violet light.
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FIGURE 4.16b: MICROCOCCAL NUCLEASE SENSITIVITY OF REACTIVATED 
AND SUPERINFECTING GENOMES IN THE PRESENCE OF ARA-C
The gel shown in figure 4.16a was blotted and the membrane hybridised with the 32p_ 
radiolabelled 2.4kb fragment from pTKl. The lower panel is a shorter exposure of the 
upper panel to enable a direct comparison of the sensitivities between the middle band 
of the upper panel representing ml 884 and the upper band of the lower panel
representing 1814R to be shown.
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DURATION OF 
SUPERINFECTION
lh 8h
ENZYME UNITS (u) 0 7.5 22.5 45 0 7.5 22.5 45
INCUBATION TIME 
(min)
0 2 10 30 0 2 10 30
%DNA 2.4kb 100 97 91 66 100 75 81 56
2.0kb 100 102 56 34 100 35 29 17
TABLE 4.18: QUANTIFICATION OF MICROCOCCAL NUCLEASE 
SENSITIVITY OF REACTIVATED AND SUPERINFECTING GENOMES IN THE
PRESENCE OF ARA-C
The DNA bands shown in the autoradiograph depicted in figure 4 .16b were quantified 
by storage phosphor technology. The DNA band present at 0 min and 0 units is
arbitrarily defined as 100%.
Another experiment with 1814R, at a lower moi of 0.75 pfu per uninfected cell was 
performed to demonstrate that the relative resistance of 1814R when used as the 
superinfecting virus shown in figure 4.16b and table 4.18 was not a consequence of the 
high multiplicity, 7.5 pfu per cell, employed. The results are shown in figure 4.17b 
and table 4.19. They demonstrated that even at a lower moi the transcribing, albeit 
non-replicating, superinfecting genome retained the pattern of relative resistance 
compared with the transcribing, previously latent genome. Thus 70% of the viral DNA 
from latently infected cells is sensitive to micrococcal nuclease digestion either at lh or 
8h following superinfection whereas only 53% and 38% of the superinfecting DNA is 
sensitive under the same conditions and at the same respective times.
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FIGURE 4.17a: THE 1814R GENOME IS RELATIVELY RESISTANT TO 
MICROCOCCAL NUCLEASE DIGESTION AFTER INFECTION AT LOW MOI.
HFL monolayers on 50mm diameter plates were infected for lh (lanes 1 - 4) and 8h 
(lanes 5 - 8 )  with 0.75 pfu per cell of 1814R in the presence of ara-C. Digestion with 
micrococcal nuclease was as follows: lanes 1 and 5, 0 units for 0 min; lanes 2 and 6,
7.5 units for 2 min; lanes 3 and 7, 22.5 units for 10 min and lanes 4 and 8, 45 units for 
30 min. The samples were cleaved with 10 units of Eco RI for 18h in a 100/zl reaction 
and 25fi\ run in a 1 % agarose gel. The gel was photographed under ultra violet light.
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FIGURE 4.17b: THE 1814R GENOME IS RELATIVELY RESISTANT TO 
MICROCOCCAL NUCLEASE DIGESTION AFTER INFECTION AT LOW MOI.
The gel shown in figure 4.17a was blotted and the membrane hybridised with the ^2p_
radiolabelled 2.4kb fragment from pTKl.
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DURATION OF 
INFECTION
lh 8h
ENZYME UNITS (u) 0 7.5 22.5 45 0 7.5 22.5 45
INCUBATION TIME 
(min)
0 2 10 30 0 2 10 30
%DNA 100 74 49 47 100 72 70 62
TABLE 4.19: QUANTIFICATION OF THE RELATIVE RESISTANCE OF THE 
1814R GENOME TO MICROCOCCAL NUCLEASE DIGESTION AFTER
INFECTION AT LOW MOI.
The DNA bands shown in the autoradiograph depicted in figure 4 .17b were quantified 
by storage phosphor technology. The amount of DNA present in the band at 0 min and
0 units is arbitrarily defined as 100%.
4.20. Micrococcal nuclease sensitivity of replicating DNA
Micrococcal nuclease sensitivity is evident by 8h into a latent infection with ini 820, 
figure 4.13b and table 4.15. Such sensitivity is not acquired by either ini 863 or 1814R 
after the same interval, figures 4.15b, 4.16b and 4.17b and tables 4.17, 4.18 and 4.19. 
These latter two are not as predisposed to latency as ini 820 since they express IE genes 
in the same amounts as wild type HSV-1. Thus it is in the progress to latency in the 
presence of ara-C that the genome becomes more sensitive to digestion with 
micrococcal nuclease. The predisposition of in i820 to a latent infection can be 
overcome by simultaneous infection with a virus supplying the IE gene product 
VmwllO such as 1814R or in i863. This has been demonstrated by the expression of 
the lacZ  gene in all cells co-infected with m l884 and 1814R (table 4.10). HFL 
monolayers were simultaneously infected with in i820 and ini 863 for 8h in the absence 
of IFN-a pretreatment. The micrococcal nuclease sensitivity of the genomes of the two 
viruses when co-infected and maintained for 8h in the presence or absence of ara-C was 
investigated and is shown in figure 4.18b and table 4.20. Under these two different 
conditions both viral genomes have the same sensitivity to micrococcal nuclease but 
they are either both resistant, as in the presence of ara-C when over 80% remains
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FIGURE 4.18a: THE ml 820 AND /ill 863 GENOMES HAVE THE SAME 
MICROCOCCAL NUCLEASE DIGESTION PATTERNS WHEN CO-INFECTED
FOR 8h.
HFL monolayers on 50mm diameter plates were co-infected for 8h with 120 particles 
per cell of ml 820 and 7.5 pfu per cell of ml 863 in the presence (lanes 1 - 4) or 
absence (lanes 9 - 12) of ara-C or mock infected (lanes 5-8) .  Digestion with 
micrococcal nuclease was as follows: lanes 1, 5 and 9, 0 units for 0 min; lanes 2, 6 and 
10, 7.5 units for 2 min; lanes 3, 7 and 11, 22.5 units for 10 min and lanes 4, 8 and 12, 
45 units for 30 min. Following cleavage with 10 units of Eco RI for 18h in a 100/xl 
reaction, 30/xl were run in a 1 % agarose gel. The gel was photographed under ultra
violet light.
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FIGURE 4.18b: THE ml 820 AND Ail 863 GENOMES HAVE THE SAME 
MICROCOCCAL NUCLEASE DIGESTION PATTERNS WHEN CO-INFECTED
FOR 8h.
The gel shown in figure 4.18a was blotted and the membrane hybridised with the 32p_ 
radiolabelled 2.4kb fragment from pTKl. The panel showing lanes 9 - 1 2  was derived 
from a l/2h exposure in contrast with the panel showing lanes 1 -8  which was obtained
from a 22h exposure.
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DURATION OF CO- 
INFECTION
8h+ara-C 8h—ara-C
ENZYME UNITS (u) 0 7.5 22.5 45 0 7.5 22.5 45
INCUB/lTION t im e
min)
0 2 10 30 0 2 10 30
%DNA
2.4kb (ini 820) 100 99 66 81 100 52 43 32
2.0kb (ini 863) 100 106 68 80 100 53 41 27
l.Okb (ini863) 100 107 81 85 100 54 34 24
VIRUS ABSOLUTE
MINI
VALUE AT 0 
UTES
INCREASE IN DNA 
(FOLD)
8h + ara-C 8h —ara-C
ini 820 (2.4kb) 
ini 863 (2.0kb) 
in i863 (l.Okb)
35176
110190
46549
1038787
3093414
1343852
29.5
28
29
TABLE 4.20: QUANTIFICATION OF SENSITIVITIES OF THE ini 820 AND 
in\ 863 GENOMES TO MICROCOCCAL NUCLEASE DIGESTION WHEN CO-
INFECTED FOR 8h.
The DNA bands shown in the autoradiograph depicted in figure 4 .18b were quantified 
by storage phosphor technology. The amount of DNA present in the band at 0 min and
0 units is arbitrarily defined as 100%.
undigested, or they are both sensitive, as in the absence of ara-C with between 68% 
and 76% being digested. In the absence of ara-C most of the DNA will be progeny 
DNA, in contrast with co-infection in the presence of ara-C where it is only input virus 
DNA. When replication is permitted both viruses appeared to replicate at the same rate 
with an increase in viral DNA after 8h of about 30-fold (table 4.20).
Both the reactivated and superinfecting viral genomes in all the data shown had 
been prevented from replicating by the presence of ara-C. To investigate whether 
replication is associated with an alteration in the sensitivity to nuclease digestion,
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monolayers retaining latent ini 820 were reactivated by superinfection with ini 863 in 
the absence of ara-C. The results are presented in figures 4 .19a and 4 .19b and table 
4.21. They show that the replicated genome is more sensitive to nuclease digestion 
than when prohibited by ara-C from entering the replicative cycle. The micrococcal 
nuclease sensitivity acquired by the input DNA as it progresses to replication is the 
same as that of the latent DNA. Thus the latent genome and the replicating genome 
have the same degree of sensitivity to micrococcal nuclease digestion. A possible 
explanation is that they share similar structural properties such as circularisation in that 
it has been shown that the in vitro latent genome is non-linear (section 4.10) and that 
during a lytic infection rolling circle intermediates are formed en route to replication 
(Roizman and Sears, 1990). Alternatively, the protein coating of the genome in both 
stages, although different, nevertheless confers a sensitivity not present when the DNA 
is only being transcribed. Another suggestion is that in establishing latency the genome 
acquires a potentially replicative structure either in terms of its configuration or protein 
coating but the actual process of replication does not occur. In other words the latent 
genome is ready for replication as soon as the appropriate signal, hypothesised to be 
VmwllO, is received. Another interesting observation shown in table 4.21 was that the 
latent viral genome replicated following superinfection at a significantly greater rate 
than the superinfecting virus. This was surprising since following co-infection the 
replication rates are identical, table 4.20. The result suggests that either the latent virus 
is capable of replicating more efficiently than the input virus, which could be a 
reflection of its physical state, or that ini 863 is more sensitive to the residual effects of 
IFN-a than the reactivated ini 820.
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FIGURE 4.19a: THE REPLICATING SUPERINFECTING GENOME IS AS 
SENSITIVE TO MICROCOCCAL NUCLEASE DIGESTION AS THE LATENT
GENOME.
HFL monolayers on 50mm diameter plates latently infected with in\ 820 at 120 
particles per cell were superinfected with ini 863 at 7.5 pfu per cell and maintained for 
8h in the presence (lanes 1 - 4) or absence (lanes 7 - 10) of ara-C or mock infected 
(lanes 5 and 6). Digestion with micrococcal nuclease was as follows: lanes 1, 5 and 7, 
0 units for 0 min; lanes 2 and 8, 7.5 units for 2 min; lanes 3 and 9, 22.5 units for 10 
min and lanes 4,6 and 10, 45 units for 30 min. Following cleavage with 10 units of 
Eco RI for 18h in a 100/xl reaction, 25/d (lanes 1 - 6) or 5/d (lanes 7 - 10) were run in 
a 1 % agarose gel. The gel was photographed under ultra violet light.
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FIGURE 4.19b: THE REPLICATING SUPERINFECTING GENOME IS AS 
SENSITIVE TO MICROCOCCAL NUCLEASE DIGESTION AS THE LATENT
GENOME.
The gel shown in figure 4 .19a was blotted and the membrane hybridised with the ^2p_ 
radiolabelled 2.4kb fragment from pTKl. The panel showing lanes 7 - 1 0  was derived 
from a 4h exposure in contrast with the panel showing lanes 1 - 6 which was obtained
from an 18h exposure.
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CONDITIONS OF 
SUPERINFECTION
ARA-C PRESENT ARA-C ABSENT
ENZYME UNITS (u) 0 7.5 22.5 45 0 7.5 22.5 45
INCUBATION TIME 
(min)
0 2 10 30 0 2 10 30
%DNA
2.4kb (ini 820) 100 48 30 25 100 66 46 22
2.0kb (ini863) 100 67 54 58 100 65 47 23
l.Okb (ini863) 100 70 56 58 100 71 50 27
VIRUS ABSOLUTE
MINI
VALUE AT 0 
JTES
INCREASE IN DNA 
(FOLD)
8h + ara-C 8h — ara-C
ini 820 (2.4kb) 
in i863 (2.0kb) 
in i863 (l.Okb)
9665
71598
15546
92035
123567
20718
9.5
1.7
1.3
TABLE 4.21: QUANTIFICATION OF THE SENSITIVITIES OF THE 
REPLICATING SUPERINFECTING GENOME AND THE LATENT GENOME TO 
MICROCOCCAL NUCLEASE DIGESTION .
The DNA bands shown in the autoradiograph depicted in figure 4 .19b were quantified 
by storage phosphor technology. The amount of DNA present in the band at 0 min and
0 units is arbitrarily defined as 100%.
4.21. Presence of linear and circular molecules following 
latent infection at high multiplicities of infection
The MoMuLv enhancer that has been inserted into the viral genome of ini 814 to 
produce ini 820 lies in the long terminal repeat. The effect of cleaving the genome 
with Bam HI and hybridising with ^ P - r a d i o l a b e l l e d  "Moloney enhancer fragment" will 
produce one 5.75kb band if the molecule is circular since only Bam HI k fragments 
containing the MoMuLv enhancer will be generated and two bands of 5.75kb and 
3.05kb if linear since the MoMuLv enhancer will be present in both the Bam HI k and
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s fragments. Other viral genomes such as ini 863 which do not have the MoMuLv 
enhancer will be undetected by the "Moloney enhancer fragment". It is therefore 
possible to demonstrate the relative amounts of the circular and linear forms of ini 820 
by quantification of the bands arising from the joint and terminal fragments. The 
results given in figure 4.20 and table 4.22 were based on a single experiment and only 
tentative conclusions are drawn. As table 4.22 shows cells latently infected with 75 or 
120 particles of in i820 retained between 81 and 72% of the viral DNA as circular 
molecules. This is less than the number of circular molecules shown in figure 4.2 
where nearly all the genomes were circular and in which monolayers were grown on 
90mm plates and may have received a slightly lower moi. In addition the result in 
figure 4.2 arises from material that had been fractionated on caesium chloride 
gradients. The lower moi in table 4.22 has a higher proportion of circular molecules. 
The observed changes on superinfection with ini 863 or d/1403 were small and may not 
be significant. The results from the micrococcal nuclease digestion experiments 
showed no change in sensitivity when superinfected with ini 863 and this has been 
interpreted as demonstrating no major structural change occurring. If this 
interpretation is correct it is not surprising that d/1403 does not significantly alter the 
population of circular to linear molecules either. The results of this experiment suggest 
that at a moi of 120 particles per cell up to 28% of the molecules have remained linear. 
These might not be genuinely latent molecules and could account for the 20 - 30 % of 
resistance to micrococcal digestion consistently found in cells latently infected at this 
moi. Evidence to support this suggestion has recently been obtained (L.H. Robinson, 
personal communication) and is described in the discussion.
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FIGURE 4.20: CIRCULAR AND LINEAR GENOMES DURING LATENT 
INFECTION WITH ml 820 AT HIGH MOI AND FOLLOWING SUPERINFECTION
WITH ml 863 OR d/1403.
HFL monolayers on 50mm plates latently infected with ml 820 at 75 and 120 particles 
per cell were superinfected for 8h with 7.5 pfu per cell of either ml 863 or d/1403 in 
the presence of ara-C. The samples were cleaved with 20 units of Bam HI for 18h in a 
100//1 reaction and 25/d run in a 1% agarose gel. The 32p_radiolabelled pmlsp6 
440bp Bfr I / Bam HI fragment was used for the hybridisation. The upper band in each 
lane originates from non-linear DNA and the lower band in each lane from linear
DNA.
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PARTICLES PER 
CELL
120 75
SUPERINFECTING
VIRUS
NONE ini 863 d/1403 NONE ini 863 d/1403
% CIRCULAR 
MOLECULES
72 52 82 81 68 95
TABLE 4.22: QUANTIFICATION OF THE PERCENTAGE OF CIRCULAR 
GENOMES DURING LATENCY AND REACTIVATION WITH ini 863 AND
<#1403.
The DNA bands shown in the autoradiograph depicted in figure 4.20 were quantified 
by storage phosphor technology and the percentage of circular molecules as a 
proportion of the total number of genomes determined.
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5. DISCUSSION
Each subfamily of the herpesviruses, although sharing common morphological 
properties and the ability to establish latent infection, has a distinct pattern of gene 
organisation and regulation. Each possesses its own particular transactivator genes with 
characteristic elements in the promoters of the IE and E genes. Thus the mechanisms 
underlying lytic infection and those involved in the establishment and maintenance of 
latency are likely to be specific to each subfamily. IE genes are transcribed shortly 
after infection even in the absence of protein synthesis or presence of protein synthesis 
inhibitors (Clements et al., 1977). The HSV-1 genome encodes five IE genes, namely 
IE175, IE110, IE68, IE63 and IE12, and the expression of at least three of these is 
critical to the outcome of the infection. Thus IE175 and IE63 are essential for the 
subsequent activation of the E and L genes and hence productive infection, IE175 and 
IE110 are potent but differentially acting transactivators and IE175 is able to down 
regulate its own and other promoters. Upon infection of cells the virion delivers its 
tegument protein Vmw65 which complexes with the cellular Oct-1 DNA binding 
protein and other factors to specifically activate the BE promoters. Evidence is 
accumulating that the decision as to whether infection proceeds to lysis or latency is 
taken at the initial stages of infection prior to any substantial expression of the infecting 
genome.
One of the most important sources of evidence to support this hypothesis comes 
from experiments based on the mutant ml 814. This virus has a defective Vmw65 
(Ace et al. , 1988), is unable to transinduce IE gene expression (Ace et al. , 1989) and is 
predisposed to latent infection in vitro (Harris and Preston, 1991) and in vivo (Steiner 
et al. , 1990). The in vitro findings have been confirmed (section 4.2 and table 4.1). 
At higher moi the predisposition to latency is overcome (table 4.1). It is proposed that 
this is because there is a basal rate of transcription of IE genes independent of 
activation by Vmw65 which exceeds threshold levels at higher moi and drives the 
infection into the productive cycle. If this argument is correct it implies that a low moi 
leads to only a low level of expression of the IE genes and latency ensues. Thus the 
level or rate of expression of the IE genes is suspected to be the critical factor in 
determining the outcome of an infection with HSV-1. To analyse latency at the 
molecular level it is desirable to achieve levels of latent infection greater than one latent 
genome in about 20% of the cells as has already been reported (Harris and Preston, 
1991). Ideally, the level of latent infection would be in 100% of the cells but to do this
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the moi has to be increased. If expression of IE genes is the critical factor then in 
addition to loss of the activator Vmw65, measures to reduce the basal rate of IE gene 
transcription should further favour the latency pathway and permit higher moi without 
ensuing cpe. The mutant ini 820 has, as well as the Vmw65 mutation, the IE110 
promoter substituted by the MoMuLV enhancer. This would be expected to reduce the 
transcriptional activity of the IE110 gene in cells of a human origin with a concomitant 
fall in cytopathogenicity. Others have shown that ini 820 produces undetectable levels 
of VmwllO mRNA under IE conditions (J.I. Daksis and C.M. Preston, personal 
communication). This prediction has been borne out by the reduced plaquing ability of 
the double mutant (section 4.2 and table 4.1) and it permits a higher moi than 
previously used with ini 814. The result lends further support to the hypothesis that 
reduced IE gene expression is the key to the switch to latent infection.
TK~ HSV mutants are able to establish latency in mouse trigeminal ganglia (Coen 
et al., 1989). The expression of the lytic genes of these mutants during the 
establishment of latent infection is restricted (Kosz-Vnenchak et al., 1990). Although 
the LATs were detected there were minimal levels of productive gene and particularly 
IE gene expression. Why the mutation should affect IE gene expression is not clear. 
Nevertheless, severely reduced IE gene expression is again associated with latent 
infection as has been shown with the mutants m l814 and m l820 (section 4.2 and table 
4.1). In addition these observations demonstrate that the predisposition to latency 
associated with reduced IE gene expression evident with ml 814 and ml 820 is not 
restricted to an inhibitory mechanism directed by a mutant Vmw65.
IFN has been shown to reduce HSV-1 IE gene expression. The transcription of the 
genes encoding IE175 (Mittnacht et al. , 1988) and IE110 (De Stasio and Taylor, 1990) 
is inhibited by this cytokine. Pretreatment of the host cells with IFN offers yet another 
means of reducing IE transcription from the incoming genome if the mechanism is at 
least in part different to a direct effect on Vmw65. The replication of both the mutants 
ml814 and ml820 as well as the rescued virus 1814R has been shown to be inhibited 
by IFN-a pretreatment but the mutants are more sensitive to the cytokine than the 
revertant (section 4.3 and tables 4.2 and 4.3). Similarly, in table 4.7, tsK at the 
permissive temperature was not as sensitive as ml 814 or ml 820 to the effect of IFN-a. 
Reduction in IE gene expression appears to enhance the susceptibility of virus to the 
inhibitory effects of IFN-a pretreatment. Further investigation has shown that 
pretreatment with IFN-a reduces the accumulated amount of mRNA, at least in terms 
of the IE110 gene, in this model (section 4.8 and figure 4.1). This is in accord with 
the data of other investigators who have demonstrated that IFN-a inhibits transcription
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(Mittnacht et al., 1988). Once more the increased efficiency of latent infection is 
associated with reduced IE gene expression adding more weight to the hypothesis.
The mechanism as to how IFN-a might reduce the level of IE gene transactivation 
has been explored by a number of investigators but no definitive conclusions have been 
reached (section 1.4.4). It is clearly later than the stage of uncoating in agreement with 
an earlier report (Obermann and Panet, 1989). If the IFN-a effect were absolute and 
prevents uncoating only there would be no difference in the plaquing ability between 
ini 814 and ini 820 following IFN-a pretreatment. The additional defect in the latter 
virus can only be apparent once the virus has become transcriptionally active, for which 
the genome presumably must be uncoated. The plaquing ability of ini 820 is less than 
ini 814 following IFN-a pretreatment (section 4.3 and tables 4.2 and 4.3). Neither is 
the inhibitory effect of IFN-a operating solely and directly on Vmw65. If it were then 
the effect of IFN-a on the rescued virus 1814R would be expected to reduce it to the 
plaquing ability of in i814 which it does not (tables 4.2 and 4.3) and since in i814 has a 
defect in Vmw65 and already is unable to transactivate the IE genes any further 
inhibitory activity at this site will be ineffective. As tables 4.2, 4.3 and figure 4.1 
show, IFN-a has a cumulative effect on the plaquing ability and IE110 mRNA 
production of the Vmw65 mutants. The results from later experiments also argue 
against an uncoating defect induced by IFN-a pretreatment. If the genome were not 
uncoated it would not be expected to be sensitive to superinfection nor to digestion with 
micrococcal nuclease. Sensitivity of the genome to both of these manipulations has 
been shown, to superinfection in figure 4.4 and tables 4.7 and 4.9 and to micrococcal 
nuclease digestion in figure 4.12b and table 4.14. Furthermore, as is shown in figures 
4.14b and table 4.16, there is no difference in the sensitivity of the genome to 
micrococcal nuclease digestion from cells latently infected in the presence or absence of 
IFN-a pretreatment.
These results suggest that the site of action of IFN-a in the in vitro model is either 
on the components of the transcription complex which determines basal transcriptional 
activity or a direct effect on IE gene transcription. This could be achieved by 
modification of pre-existing cellular factors, the induction of new proteins or a 
combination of both. A potential target is Oct-1. Down-regulation of this protein by 
IFN-a has been reported and hypothesised as the cause of IE gene transcription failure 
(section 1.3.2; Dent et al., 1991). The results presented in section 4.3 and tables 4.2 
and 4.3 are consistent with this hypothesis. The possibility that IFN-a pretreatment 
affects the components of the IEC was investigated in the in vitro model using gel 
retardation assays. No effect on Oct-1 was demonstrated but the method may not be
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sufficiently sensitive to detect a change in the amount and the data are not shown. An 
alternative up-regulation of the repressor Oct-2 (section 1.3.2) seems unlikely since this 
octamer-binding protein is lymphocyte- and neurone- specific and probably not present 
in HFL cells although no formal investigations have been reported to establish this 
latter statement.
The mutant tsK, which expresses the EE110 gene normally, is able to reactivate the 
double mutant from IFN-a pretreated cells in a highly efficient manner (section 4.7 and 
table 4.7). The monolayers initially infected with ini 820 were superinfected with fsK 
24h later. The effect of IFN-a is still apparent at 24h following its removal (section 
4.4 and table 4.4). After 24h the latent genome of m l814 is no longer sensitive to 
transactivation by Vmw65 (Harris and Preston, 1991) thus the provision of VmwllO 
by the superinfecting virus is not only able to overcome the defect in Vmw65 but also 
the anti viral effect of IFN-a. This is further evidence that the inhibitory mechanism of 
IFN-a must operate prior to transcription of the IE genes.
The results presented in section 4.4 and table 4.4 show that the effect of IFN-a 
pretreatment is still present at 72h following its removal. This suggests that the 
stimulus induces irreversible changes in the cell which could be accounted for either by 
modifications to existing proteins by a secondary messenger or induced new proteins or 
the induction of new proteins which themselves mediate the IFN-a effect. A whole 
range of effects on mRNA production following IFN treatment has been documented 
including the continued accumulation of some mRNAs but not others after it has been 
removed (Friedman et al. , 1984). The effect of IFN-a as an anti viral agent is 
apparent at 2h of treatment although maximal levels of inhibition are not established 
until the cells have been pretreated for 16h (section 4.5 and table 4.5). This is in 
keeping with the suggestions made above as to how the IFN-a effect is mediated. 
Induced proteins which correlate with the development of the anti viral state have been 
seen to accumulate, albeit at different rates, within a few hours of treatment with IFN 
(Rubin and Gupta, 1980; Gupta, 1981). The finding that cycloheximide does not 
prevent the effect of IFN-a pretreatment on viral replication (section 4.9 and table 4.8) 
implies that it does not depend on the synthesis of new proteins. This is difficult to 
envisage in the light of experimental evidence which has shown that inhibition of RNA 
synthesis with actinomycin D prevents IFN-a from establishing the anti viral state 
(Gupta, 1981) and the hypotheses developed to explain its anti viral activity (section 
1.4.3). In the experiment detailed in table 4.8, IFN-a pretreatment and cycloheximide 
exposure were simultaneous and both were washed out prior to infection of the 
monolayer. If the secondary messenger for mediating IFN-a can be generated without
163
Discussion
protein synthesis it may remain in the cells even though the stimulus is removed. Once 
the protein synthesis inhibition is relieved the secondary messenger will then be able to 
induce the necessary proteins to effect the desired response. As the cycloheximide is 
removed just before inoculation there still might be opportunity for the induction of 
new proteins to interfere with the productive infection of the virus. This would 
reconcile the data presented in table 4.8 with the prevailing evidence and hypotheses 
concerning IFN action. This could be investigated by determining the IE mRNA levels 
rather than plaque formation when cycloheximide is present throughout the course of 
the experiment.
IFN-a pretreatment reduces the level of IE mRNA (section 4.8, figure 4.1). This 
is likely to lead to reduced levels of IE proteins. If there is a critical level of IE protein 
which determines whether an infection proceeds to lysis or latency then IFN-a may be 
effective in favouring latency by further depressing IE protein levels below this 
threshold amount, or as would occur in a population of infected cells, shift the curve 
describing the normal distribution of IE protein concentration to the left. If HMBA 
operates in the opposite direction serving to elevate the IE protein levels and shift the 
curve to the right, this would in effect restore the phenotype. This is what occurs in 
the presence of these two agents, neither of which is dominant over the other (section 
4.6 and table 4.6).
The question that arises is how IE gene expression might be overcome or inhibited 
in vivo so that latency rather than lysis occurs. A relative loss in the tegument protein 
Vmw65 is a possibility especially if the distance from the periphery where infection 
occurs to the site of gene transcription in the neuronal nucleus is large. In traversing 
this distance by axoplasmic transport, opportunity would be available for this 
transcriptional activator to be modified or even destroyed. The neurone is unique with 
its long axon and distant cell body relative to the epithelial surface which provides a 
possible explanation as to why latency could be favoured in such cells. This suggestion 
is however difficult to sustain if latency can be established in other cells. Reports of 
latent infection in extra neural tissues have been published (sections 1.2.1 and 1.2.3.) 
although no clear distinction between bona M e  latent infection and viral persistence 
was made in some of these experiments. In an experiment designed to test the 
hypothesis that latent infection of sensory neurones results from the failure of Vmw65 
to be transported from the nerve ending to the nucleus it was concluded that the 
absence of the viral transactivating factor alone could not account for the establishment 
of latency (Sears et al. , 1991).
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For the putative VZV IE genes, ORFs 4, 61, 62 and 63 see Davison and McGeoch, 
1986; Shiraki and Hyman, 1987.
For the homologue of Vmw65, ORF 10 found in VZV see Davison and Scott, 1986.
For the three EBV proteins, BZLF-1 , BMLF-1 and BRLF-1 see Countryman and 
Miller, 1985; Lieberman et al. , 1986 and Hardwick et al. , 1988.
For HCMV ORFs Ul123, Ul122, Ul36-38 and U<§3 see Sternberg et al., 1985; 
Kouzarides et ah, 1988 and Weston, 1988.
For the major IE region of HCMV see Stinski et al., 1983.
Discussion
There is good evidence that repression of IE gene expression operates in neurones 
(section 1.3.2). Cell specificity of repressors such as Oct-2 would account for the 
restriction of latent infection to certain host cells such as the neurone. Since octamer 
binding proteins have a role in the formation and activity of the IEC, a repressor 
mechanism at this point in the viral life cycle would be highly effective in switching off 
gene expression. This site would also have room for other repressors that might be 
available as a result, for example, from stimulation by IFN.
The role of the IE genes of other human herpesviruses in switching between a lytic 
and latent infection has not been investigated. This is largely because there is a paucity 
of knowledge about temporal gene expression in these viruses. The VZV genome has 
the putative IE genes, ORFs 4, 61, 62 and 63 but these have been identified primarily 
through sequence homology to the HSV genes namely Ul54 (Vmw63), IE110, IE175 
and Usl(Vmw68) respectively. A homologue of Vmw65, ORF 10, is also found in 
VZV. VZV latency differs in a number of respects to HSV-1 latency not least in that it 
is largely established in the non-neuronal cells of the sensory ganglia. At least three 
EBV proteins, BZLF-1, BMLF-1 and BRLF-1, induced early in the lytic replicative 
cycle have been identified as transactivators of gene expression with a distinct spectrum 
of activation effects on EBV promoters. One of these, BMLF-1, is analogous to HSV- 
1 IE63 and may have a role in activation from latency. The latent state of EBV is 
different to HSV-1 in that there has to be ongoing replication to maintain the copy 
number per cell as the B lymphocyte continues to divide. HCMV EE gene expression is 
predominantly from ORFs Ul 123, Ul 122, Ul 36-38 and U§3. The Ul 123 and 
Ul 122 proteins originate from two contiguous regions called IE1 and IE2 which form 
part of the major IE region. Approximately 88% of the IE viral RNA hybridises to this 
region. The major IE promoter (MIEP) directs the expression of both IE1 and EE2. 
The IE1 protein transactivates the MEEP, several heterologous promoters and augments 
the transactivating activity of the 84kd EE2 protein. The IE2 protein is able to 
transactivate homologous and heterologous promoters alone or augmented by IE1. The 
IE2 transcripts encode several mRNAs which translate into proteins of 84, 55 and 
40kd. The 55kd protein activates the MIEP whereas the 84 and 55kd proteins down 
regulate the MIEP. Thus HCMV has functionally similar major IE proteins to those in 
HSV. All of these IE gene products undoubtedly have a role in HCMV early gene 
regulation but their place if any, in the pathway leading to a latent infection has not 
been established.
Once HSV-1 latency has been established the viral genome is distinguished from the 
input DNA in terms of its organisation and expression (sections 1.2.3 and 1.2.4).
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Most of the experimental evidence to date indicates that the latent genome has a non­
linear configuration. The most likely explanation for the data is circularisation of unit 
length molecules. In the in vitro model the terminal fragments are lost as latency 
becomes established (section 4.10 and figure 4.2) which is consistent with latency in a 
similar model at lower moi (Harris and Preston, 1991) and with HSV-2 latency in vitro 
(Preston and Russell, 1991). That this in vitro model mimics the non-linear 
organisation of the viral DNA during latency in vivo, which might be reasonably 
considered as a defining feature of a latent infection, enhances its suitability as a model 
system for in depth investigations into this process at the molecular level. Evidence is 
also available to suggest that the latent non-linear molecule is present as a circular 
genome, an episome (section 1.2.3). The results with the in vitro model (section 4.15 
and figure 4.7) also suggest that the non-linear DNA is autonomous which again 
supports the contention that this is a valid model of latency.
Little is known about the non-linearity or otherwise of the other human 
herpesviruses during latency. In EBV transformed lymphocytes the latent genome is a 
circular episome analogous to what is proposed for the latent HSV-1 genome in vitro 
and in vivo. Circularisation occurs within 24h of infection of these B lymphocytes 
(Hurley and Thorley-Lawson, 1989) which are non-permissive for EBV replication 
which is a similar time course for HSV-1 to become non-linear as latency is established 
in the in vitro model (section 4.10).
The replication of HSV-1 probably proceeds via a rolling circle mechanism 
(Roizman and Sears, 1990) and this may well apply to the other members of the 
subfamily. It is claimed that a proportion of HSV is circular in the particle 
(Poffenberger and Roizman, 1985). The linear molecules of EBV DNA isolated from 
cultured producer cells probably arise from circular intermediates (Shaw, 1985). 
Similarly VZV adopts circular forms via the genomic termini during infection although 
whether this is a covalent link or one held together by a protein has not been 
established (Kinchington et al., 1985). Replication of HCMV is also considered likely 
to occur via a rolling circle mechanism (Stinski, 1991). It could be argued that 
organisation into a non-linear configuration is a prerequisite for the efficient replication 
of the infecting DNA. By extending this argument, latent viral DNA in a non-linear 
and specifically circular arrangement could be in a state suitable for replication. If this 
is the case then it would appear that the latent pathway has circumvented the block in 
the lytic pathway to bring the genome to a condition in which it is immediately ready to 
replicate once the correct stimulus is received.
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The concept of the nucleoskeleton as a structure similar to the cytoskeleton has been 
the subject of much controversy because of the highly artificial conditions under which 
it has been purported to have been isolated or visualised. Most preparations have used 
high salt extraction methods because chromatin tends to aggregate under isotonic 
conditions. Sceptics have contended that such high salt extraction methods produce 
artifactual structures which cannot be related to the in viw  situation and have dismissed 
the evidence for the existence of a nuclear substructure. The problem has been 
compounded by the fact that the artifacts produced under high salt conditions arise 
partly from the aggregation of nascent DNA and polymerases, vital elements of the 
replication machinery. These difficulties and objections have been overcome by first 
encapsulating cells in agarose microbeads prior to lysing their membranes in a 
"physiological" buffer (Jackson et al. , 1988).
In early experiments, nascent DNA was found to be tightly associated with a 
nuclear substructure termed the nuclear matrix (Berezney and Coffey, 1975). 
Numerous reports have followed claiming to show that replicating DNA attaches to the 
nuclear matrix (Wanka et al., 1977; Dijkwel et al., 1979) but the question of 
artifactual structures had remained as a nagging doubt. However, using gentler 
techniques the findings have been supported and although only residual chromatin 
remained attached to the intermediate filament most of the polymerase activity was 
retained suggesting that the active enzyme was attached to the skeleton (Jackson et al., 
1988). Subsequently the active polymerases were shown to be focally clustered within 
the nucleus and each focus to fire in a synchronous manner (Cook, 1991). This is 
further evidence in favour of an underlying structure serving to organise and integrate 
polymerase activity. Recently the sites of replication have been visualised under 
electron microscopy to be attached to the skeleton. The focal sites of synthesis persist 
even after eluting the majority of the chromatin and these have been shown to contain 
DNA polymerase-a and proliferating cell nuclear antigen (Hozak et al., 1993).
It is arguable from the above findings that the high salt methods are valid as a 
means of extracting the nuclear substructure and these were used to investigate the 
association of the viral DNA with it in the in vitro model. As is discussed in section 
4.16 and shown in figures 4.8b and 4.9b the viral DNA is associated with the nuclear 
substructure very soon after infection and must do so almost immediately after entering 
the nucleus. There was no detectable difference in this association between viral DNA 
isolated at lh, 8h or 72h as it progresses to the latent state. Association of DNA with 
the nuclear skeleton may be a prerequisite to replication and this was demonstrated in 
the early stages of an infection which would under normal conditions be productive
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(figure 4.9b). Thus the viral genome appears to adopt a topological position as soon as 
it reaches the nucleus which is maintained even though there are further organisational 
changes to be undertaken as it becomes latent. This may be because the spatial 
arrangement is vital for these subsequent changes to occur or to place the DNA in a 
position ready to reactivate and replicate as soon as the appropriate stimulus is received 
or the host conditions become favourable. The attachment of the DNA is not 
dependent on nucleosomal organisation since it is not detached even though 90% of the 
chromatin is removed (Jackson et al., 1988). If the viral DNA had to acquire the 
relevant cellular proteins to become nucleosomal in order to associate with the 
nucleoskeleton, that association must occur within lh of infection (figure 4.8b).
The formation and maintenance of chromatin as occurs in all eukaryotic DNA is 
essential for it to be compacted within the nucleus. In addition the position of 
nucleosomes on the DNA template has the potential to facilitate regulated transcription 
of the genes. There is a large body of experimental evidence to suggest that the 
association of regulatory elements with histones will preclude their recognition by 
transactivating factors (Felsenfield, 1992). Whereas some transcription factors are able 
to bind to the DNA when it is wrapped around the histone core others are prevented 
from binding because of the severe deformation of the structure. Thus the organisation 
of the DNA into chromatin imposes structural hindrances to the interaction of 
transcription factors with their recognition elements. It follows that DNA that is non- 
nucleosomal might be more susceptible to transactivation and hence in a state of 
heightened readiness for gene expression.
The discovery of viral DNA being organised into nucleosomes akin to eukaryotic 
DNA was first reported in extracts of SV40 infected cells (Griffith, 1975). Although 
bearing some identity with cellular nucleosomes differences have been reported (Bellard 
et ah, 1976). An interesting difference is that many of the viral nucleosomes are at 
some distance apart from one another connected by bridges of naked DNA of irregular 
length as revealed by electron microscopy and confirmed by nuclease digestion (Bellard 
et al., 1976). There have been conflicting reports of viral chromatin lacking histone 
HI (Bellard et al., 1976; Varshavsky et al., 1976; Ponder et al., 1978) but since this 
particular histone is associated with the region of DNA between the nucleosomes it 
might explain the variable spacing of nucleosomes in the viral DNA.
The structure of the genome from a number of DNA viruses has been investigated 
in terms of its nucleosomal organisation by digestion with micrococcal nuclease. 
During the whole of their productive life cycles and in their virions, SV40 and polyoma
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virus nucleoprotein complexes digested with micrococcal nuclease yield a ladder of 
nucleosomal fragments (Griffith, 1975; Ponder et al. , 1978). In contrast, EBV DNA 
during the whole of the productive cycle, at least in a producer cell line, is 
nonnucleosomal (Shaw et al., 1979). However, in the latent state it is different and the 
majority of the EBV DNA appears to become associated with nucleosomes and 
organised into chromatin (Shaw et a l, 1979; Dyson and Farrell, 1985). Another 
variation occurs with adenovirus type 2 which appears to adopt a chromatin 
arrangement only during part of the replication cycle (Dery et al., 1985). With this 
virus the typical nucleosomal pattern following micrococcal nuclease digestion was only 
generated from intranuclear parental DNA (Tate and Philipson, 1979; Sergeant et al., 
1979) and not from the virion (Tate and Philipson, 1979). At lh post infection the viral 
DNA produced a smear following digestion but at 6h up to 50% of the viral DNA had 
a nucleosomal pattern similar to that of the cellular chromatin. Such a pattern was not 
seen in partially uncoated virus or isolated cores. In cells productively infected with 
HSV-2 the viral DNA exists in either form. Nucleosomes accounted for 37% of the 
replicating HSV-2 nucleoprotein at 10 - 12h post infection which suggests that the 
DNA is only organised into nucleosomes at a late stage (Hall et al., 1982). This is in 
contrast with HSV-1 lytic infection in tissue culture cells (Mouttet et al., 1979; 
Leinbach and Summers, 1980; Sinden et al., 1982) and in mice (Muggeridge and 
Fraser, 1986) where the majority of the replicating DNA is clearly nonnucleosomal. 
One report suggests that most of the regions of the HSV-1 genome during latency are 
organised into nucleosomes and that this might be a mechanism of silencing gene 
expression or that the silenced genome is vulnerable to being converted into chromatin 
(Deshmane and Fraser, 1989). It seems that the existence of viral chromatin is not a 
universal characteristic of DNA viruses and that viral transcription commonly occurs 
on nonnucleosomal DNA.
The demonstration of the nonnucleosomal pattern in micrococcal nuclease digests of 
HSV-1 DNA at lh and 8h after infection in the in vitro model (section 4.17 and figures 
4.10b and 4.11b) is in agreement with the findings of other investigators as cited 
above. These results are with respect to the TK gene and it is inferred that a similar 
situation prevails throughout the rest of the genome during replication although it is 
possible that a small stretch of DNA not associated with nucleosomes has been detected 
only. The persistence of this pattern in the latent genome (section 4.17 and figures 
4.10b and 4.11b) is however in stark contrast to the published data (Deshmane and 
Fraser, 1989). The material analysed in this report was taken from the brain stems of 
mice infected by comeal scarification and shown to harbour latent virus by explant 
reactivation assay. The sensitivity of their method only permitted them to analyse
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samples containing >3pg of latent HSV-1 DNA per f i g  of micrococcal nuclease 
digested cellular DNA and much of the material was therefore unsuitable. It was 
assumed that the samples harbouring lower concentrations would give similar results. 
In addition the viral DNA was not digested at the same rate as the cellular chromatin 
and this delay might reflect different conformational structures. The latent HSV-1 
genome in the brain stem is remarkably resistant to reactivation (Cabrera et al., 1980) 
which might be a reflection of its acquisition of a chromatin structure and may be the 
explanation for the different result in the in vitro model (section 4.17 and figures 4.10b 
and 4.11b). In the latter case it has been possible to reactivate the latent genome 
consistently (sections 4.7 and 4.12, tables 4.7 and 4.9 and figure 4.4) which might be 
easier to achieve if the genome is nonnucleosomal. An alternative explanation to the 
genome being nonnucleosomal is that the nucleosomal organisation fails to protect it 
against micrococcal nuclease attack. Some investigators have shown that although 
micrococcal nuclease digestion of DNA from adenovirus produces a digest of 
heterogeneous lengths it is nevertheless clearly nucleosomal when viewed by electron 
microscopy (Vayda et al., 1983; Mirza and Weber, 1982). To resolve this paradox it 
has been suggested that the nucleosomes are formed from precursor proteins into 
prochromatin which could be converted to chromatin by proteolytic processing (Mirza 
and Weber, 1982). It is hypothesised that prochromatin protects the DNA against 
micrococcal nuclease digestion. Since there is no difference in the micrococcal nuclease 
digestion pattern between HSV-1 DNA in the early stages of infection and when latent, 
it appears that the latent genome is in a state in which it can rapidly commence 
replication when favourable conditions prevail. Thus these results once more suggest 
that during latency the genome has been arrested at a stage just short of replication and 
is poised to switch into replication as soon as the appropriate signals arrive. The 
pathway to this stage is not necessarily the same pathway as followed in the normal 
course of replication. The data given in table 4.21, where the latent DNA was 
replicated much more efficiently than the superinfecting viral genome, support this 
hypothesis.
Further analysis at other sites in the DNA needs to be carried out to show that the 
nonnucleosomal organisation is present throughout the latent genome and not merely at 
the TK gene. An extension of these investigations into the organisation of proteins on 
the DNA of the latent genome would be with similar analyses using DNase I. 
Nonnucleosomal DNA has increased sensitivity to this enzyme (Eissenberg et al., 
1985). Regions exist at intervals in chromatin which are free of nucleosomes and the 
DNA at these sites has been found to have relative sensitivity to cleavage by DNase I. 
They have been termed DNase hypersensitive sites and are frequently found at or near
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the 5* end of the gene which suggests a possible role in activation of transcription. It 
has been found that both active and potentially active genes are preferentially sensitive 
to digestion by DNase I with localised sites of hypersensitivity. The high degree of 
sensitivity compared to the surrounding chromatin is not necessarily limited to DNase I 
and may apply to micrococcal nuclease also (Kaye et al. , 1984). In this paper it is 
reported that the enhanced sensitivity to micrococcal nuclease was not only relative to 
inactive genes but to naked DNA as well. Thus genes which are open or accessible for 
expression are, it would seem, simultaneously vulnerable to attack from nucleases. 
There have been many reports of more rapid or extensive cleavage by nucleases in the 
transcribed regions of chromatin compared with untranscribed controls (Komberg and 
Lorch, 1992). A more rapid digestion to the nucleosomal ladder by micrococcal 
nuclease is indicative of enhanced susceptibility to digestion of the linkers between 
nucleosomes following activation of the gene, whereas a loss of the nucleosomal ladder 
and the resultant smear is more likely to arise from enhanced susceptibility to digestion 
within the nucleosome. Such altered patterns of digestion are very suggestive of a 
fundamental structural change once the DNA is transcribed and this is likely to take 
place prior to or concomitant with the initiation of transcription. Identical DNA 
sequences can differ in DNase I sensitivity depending on their locations. Furthermore, 
although DNase hypersensitive sites lack nucleosomal structure, there is evidence that 
non histone proteins bind in and around these sites. Thus conformational differences or 
a change in the nature of the proteins covering the DNA may be responsible for the 
enhanced susceptibility to nuclease attack.
Latent viral DNA in the in vitro model has been shown to acquire an increased 
sensitivity to digestion by micrococcal nuclease with respect to the TK gene (section 
4.18 and figures 4.12b, 4.13b and 4.14b and tables 4.14, 4.15 and 4.16) and it is 
hypothesised that this pertains to the rest of the genome. This is relative to DNA 
shortly after infection (figure 4.12b and table 4.14) and also to DNA that has been 
prevented from replicating by ara-C but is nevertheless transcriptionally active (figures 
4.15b, 4.16b and 4.19b and tables 4.17, 4.18 and 4.21). If transcription is suppressed 
as happens in the model to favour latency, sensitivity is still acquired at about 8h as the 
genome proceeds to the latent state (figure 4.13b and table 4.15). It is suggested that 
the increased sensitivity is a reflection of the structural changes that have occurred as 
the genome has become latent in terms of its non-linearity and possibly its associated 
proteins too. The transcribing but not replicating genome does not have such changes 
conferred upon it and maybe for this reason it remains relatively resistant. The 
replicating genomes will have a population of circular intermediates unlike those 
merely transcribing which might be the explanation for the difference in sensitivity. If
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this suggestion is true it again envisages the latent genome to be in an arrested state 
immediately prior to replicating and in a heightened condition ready to respond to the 
incoming signal (table 4.21).
It could be argued that the DNA becomes more sensitive to micrococcal nuclease 
merely as a result of uncoating. Uncoating is a non-specific term to embrace all the 
events after the virus has penetrated the cell until its genome is in a state of readiness to 
express its functions. In herpesvirus infection the capsid is presented at the nuclear 
pores and the viral DNA or a DNA-protein complex released into the nucleus. It is 
unlikely that free DNA would exist in the nucleus after uncoating since it is a highly 
charged molecule. It is more likely that following uncoating it either retains some viral 
proteins or associates with others. All the preparations of viral DNA used in the 
micrococcal digests are nuclear so it would have to be argued that the genome entering 
the nucleus 2.5h post inoculation (figure 4.12b and table 4.14) has not been fully 
uncoated and continues to be resistant to digestion. This argument would also have to 
be applied to ini 863 and ini 884 at 8h post infection, since under non-replicating 
conditions they too remain resistant (figures 4.15b and 4.16b and tables 4.17 and 
4.18). Furthermore ini 863 is transcriptionally active at 8h as demonstrated by its 
ability to reactivate latent in i820 (table 4.13). It is difficult to imagine how a genome 
can be transcriptionally active and not be completely uncoated. At this stage it is, by 
definition, uncoated.
During latency HSV-1, HSV-2, pseudorabies virus and bovine herpesvirus all 
express large amounts of RNA from a single region in their genomes, overlapping and 
antisense to one of the IE genes (Stevens et al., 1987; Rock et al., 1987b; Cheung, 
1989; Croen et al., 1991). The role of these LATs is still obscure although most of the 
evidence suggests that they have no absolute part to play in the establishment or 
maintenance of latency (section 1.3.4). On the other hand there are some reports 
which indicate that these RNAs might be important for efficient reactivation from the 
latent state (section 1.3.4). In latent VZV infection five regions of the genome are 
expressed to yield RNAs in very low abundance (Croen and Straus, 1991). They are 
found in cells other than neurones within the sensory ganglia (Croen et al., 1988). 
This is different to the expression of LATs. Latent VZV reactivates much less 
efficiently than HSV-1 and it is tempting to speculate that this is related to the absence 
of LATs or that its site precludes it from being subject to the same neuronal factors as 
HSV-1. EBV transformed lymphocytes also display limited transcription of the viral 
genome. Genes expressed in cell lines include a family of six nuclear antigens 
(EBNAs), the latent membrane protein (LMP) and three RNAs which do not appear to
172
Discussion
be translated. Only one of these, EBNA-1, which is essential to maintain the copy 
number has been shown to be present in all latently infected cells. Latent EBV 
infection is not strictly comparable to latent HSV-1 infection so no parallels between 
the two patterns of gene expression during latency can be drawn.
In the in vitro latency model viral gene expression has been silenced, at least with 
respect to four promoters. These are the VmwllO, TK, HCMV and SV40 promoters 
(sections 4.12 and 4.14, figure 4.5, tables 4.9, 4.12 and 4.13) and this is presumed to 
extend to the rest of the genome. This is characteristic of the latent state in vivo with 
the exception of the LATs. There is reason to believe that the LATs would not be 
expressed in the in vitro model. Firstly, they are likely to be neurone specific 
(Batchelor and O'Hare, 1990) and secondly, which may be related, they were 
undetectable in the predecessor of the model which was also based on HFL cells 
(Anderson, 1991). If this is true, although not investigated, it further demonstrates that 
HSV-1 latency can be established, maintained and reactivation effected without 
expression of LATs. However the role of LATs, if any, in the efficiency of 
reactivation remains undetermined and cannot be explored in this model.
The model has been shown to retain the latent viral genome which can be efficiently 
reactivated (section 4.7 and table 4.7). It has also been shown that it is possible to 
latently infect every cell in a monolayer with at least one genome that becomes 
transcriptionally silent and can be manipulated to become active as determined by the 
activity of j3-galactosidase, the product of the lacZ  gene (section 4.12, figure 4.4 and 
tables 4.9, 4.11 and 4.12). It is suggested that this mimics the switching on of the 
latent genome when reactivated. Similarly the latent genome can be manipulated to 
express the thymidine kinase gene (section 4.14 and figure 4.13), again suggested to 
mimic the situation occurring during reactivation. The superinfecting virus, tsK which 
efficiently reactivates in i820 (section 4.7 and table 4.7), provides VmwllO at the non- 
permissive temperature. Latent ini 884 and ini 883 cannot be reactivated by d/1403 
which lacks VmwllO (section 4.13 and tables 4.11 and 4.12). It is concluded that 
latent HSV-1 in the in vitro model requires VmwllO for reactivation. This is 
consistent with the earlier findings (Harris and Preston, 1991) and with much of the 
experimental data published to date (section 1.3.5). Thus the silent latent genome 
remains sensitive to transactivation by VmwllO. A comparison can be made with the 
change from latent to lytic EBV infection. This is mediated by expression of the gene 
BZLF-1 which is silent during latency and is a transactivator of some EBV promoters. 
In some ways the reactivation of HSV-1 in the model is analogous to the initiation of 
the lytic pathway following the initial infection. The balance between a lytic or latent
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infection has been tipped in favour of the latter by the inhibition of IE and specifically 
IE110 gene expression. This again suggests that the latent genome has arrived at the 
point of entering the productive cycle albeit by an alternative pathway, awaiting the 
arrival of the transactivator VmwllO. Since reactivation inevitably involves replication 
of the genome, and this by a rolling circle mechanism, it would be expected that 
circular molecules will persist even though the genes have become active. In figure 
4.20, circular molecules are shown to be present during latency and superinfection with 
in i863 or with d/1403. The presence of ara-C during superinfection prevented 
replication in this experiment so that there are no linear molecules generated by entry 
into the productive cycle. Even in the latent infection there are a number of linear 
molecules still present at a level of up to 28% (table 4.22). This is surprisingly high in 
view of the earlier data. It might account for the residual micrococcal nuclease 
resistance once latency has been established. As is presented in the tables 4.14, 4.15, 
4.16, 4.17, 4.18 and 4.21 micrococcal nuclease sensitivity usually levels out at about 
20 - 30% of the total viral DNA. It is postulated that sensitivity is a property of the 
circular molecule and the residual resistance is due to the persistence of linear 
molecules from the time of the original infection. Support for this hypothesis has been 
provided by the subsequent experiments of others in which latent ini 820 was digested 
with micrococcal nuclease, restricted with Bam HI and hybridised with the Moloney 
enhancer fragment. Micrococcal nuclease sensitivity was largely confined to the band 
generated by circular molecules with little change in the band generated by the linear 
DNA (L.H. Robinson, personal communication).
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The in vitro model that has been described has been shown to be valid for the 
further investigation of latency at the molecular level and should contribute to an 
understanding of the biology of this phenomenon. The work has potential for exploring 
further aspects of the physical organisation of the latent genome, examination of viral 
gene expression and its control during latency and analysis of the mechanism of 
reactivation.
Having established that the latent genome is circular (section 4.10 and figure 4.2) 
and can be separated from linear molecules by field inversion electrophoresis (section 
4.15 and figure 4.7) it should be possible to refine the technology and use it to 
demonstrate unit length or concatenated structures during latency. It might also be a 
useful tool to analyse other changes in the latent genome following reactivation if this 
alters the mobility of the molecule under these conditions. The proportion of circular 
to linear molecules needs to be examined in greater depth using the MoMuLv enhancer 
fragment (section 4.21) at a lower initial moi. Since these methods differentiate 
circular and linear molecules it would be possible to examine the sensitivity of these 
two forms to micrococcal nuclease digestion under different conditions and to establish 
if it is the linear form which accounts for the residual resistance to digestion.
It should be possible to further characterise the association of the viral DNA with 
the nucleoskeleton. Cleavage with restriction enzymes could be used to investigate 
whether a particular sequence, which would become enriched in the pellet fraction, 
attaches it to the matrix. The effects of reactivation could also be explored if there is a 
specific association of the genome with the substructure. The properties of drugs which 
might interfere with the attachment and thus have potential therapeutic use could also 
be investigated.
Nucleosomal organisation has only been demonstrated in relation to the TK gene. 
This should be extended to other genes to determine whether this is a property of the 
genome as a whole during latency.
The susceptibility of the genome to micrococcal nuclease should also be related to 
other viral genes and compared with cellular genes. The sensitivity to other nucleases
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such as DNase I could provide further information concerning the structural aspects of 
the genome.
The potential of the /3-galactosidase detection assay is considerable since it allows a 
clear demonstration of the transcribing activity of the genome at least with respect to 
the 7a cZ gene. The technique could be used to look at particular aspects of Vmwl 10 in 
effecting reactivation, the effects of drugs on preventing latency or reactivation and 
whether drugs are able to overcome the effect of IFN.
The model does not allow investigation of the LATs since they are not produced. If 
the model could be modified to express LATs this would open up a whole new avenue 
of experimentation and investigation. This might be achieved by the removal of the 
neurone specific region and its replacement with an enhancer able to drive LAT 
expression in HFL cells or adaptation of the system to include infection of neuronal 
cells.
i
i
I
I
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